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Abstract 
Craniofacial development requires progressive morphologic change, proliferation, 
differentiation and organization of chondrocytes preceding osteogenesis.  The Wnt 
signalling pathway has been involved in regulating bone development and maintenance. 
As they are fated to become bone, chondrocytes require Wnt to polarize and orientate 
appropriately to initiate the endochondral ossification program. Although the canonical 
Wnt signalling has been studied in the context of bone development, the effects of non-
canonical Wnt signalling in regulating the timing of cartilage maturation and subsequent 
bone formation in shaping ventral craniofacial structure is not well understood. In this 
thesis, I examined the role of the non-canonical Wnt signalling pathway (through the study 
of the role of wls, gpc4, wnt5b and wnt9a) in regulating zebrafish Meckel’s cartilage 
maturation to the onset of osteogenic differentiation. First, I show that disruption of wls 
resulted in a significant loss of craniofacial bone, whereas lack of gpc4, wnt5b and wnt9a 
resulted in severely delayed endochondral ossification. This demonstrates the importance 
of the non-canonical Wnt pathway in regulating coordinated ventral cartilage 
morphogenesis by directing chondrocyte polarity. Second, I found distinct cellular 
requirements within the body and midzone of the mandible. Without non-canonical Wnt 
signalling, chondrocytes within the midzone appear to remain in their prehypertrophic state 
and fail to elongate and stack. This may suggest the importance of Wnt signalling in 
determining jaw length and size. Third, I generated a double transgenic zebrabow line to 
allow cellular studies on dynamic cell behaviour during development. Finally, to further 
interrogate the role of Wnt signalling during chondrocyte maturation, I studied the role of 
intracellular Wnt trafficking. More recently, there has been increasing evidence that Wnt 
activity is not only regulated in the receiving cells but also on the level of its secretion 
(Gross and Boutros, 2013). By studying wntless (wls), a multi-transmembrane protein that 
shuttles Wnts from the Golgi to the plasma membrane, I found that wls trafficking through 
coat protein vesicles (COP) is key in neural crest specification and differentiation. These 
works provide important insights into the non-canonical Wnt signalling during 
endochondral bone formation and craniofacial lower jaw development.   
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Chapter 1. Introduction   
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1.1 General introduction  
The work in this thesis aspires to uncover the role of non-canonical Wnt signalling by 
studying several key genes; wls, wnt9a, wnt5b and gpc4 during zebrafish craniofacial 
lower jaw development. The thesis is divided into 3 areas of interest; firstly, in studying 
the function of these genes in vivo and understanding how disruption affects proper 
shaping and maturation of chondrocytes as well as endochondral bone formation; secondly 
in developing a zebrafish transgenic tool to further our understanding of chondrocytes 
dynamic cell behaviour in craniofacial development and finally, in studying the role of 
trafficking and discussing endoplasmic reticular stress in chondrogenesis.  
This introductory chapter includes a brief overview of Danio rerio as a model organism to 
study craniofacial development that will then branch into two sections, first describing 
zebrafish skeletal development and secondly highlighting molecular pathways involved in 
craniofacial development, focusing on the Wnt signalling pathway. 
1.2. Craniofacial development  
The head has the most complex architecture of the body and requires precise cellular and 
molecular interactions to form distinct shapes and structures. The combination of 
connective tissue, musculature, vasculature and innervations, derived from all germ layers; 
endoderm, mesoderm and ectoderm as well as the cranial neural crest cells all contribute to 
the craniofacial structure. Orchestrated signalling between all four cellular components 
towards the craniofacial mesenchyme (formed by cranial neural crest and mesoderm) help 
provide positional cues to determine growth, differentiation and shape. The modulation of 
this highly choreographed process makes it susceptible to genetic and environmental 
perturbations. As such, craniofacial anomalies such as orofacial clefts are the most 
common birth defect affecting approximately one in 800 live birth and results in a 
socioeconomic burden (Dixon et al., 2011).  As much of the face is derived from neural 
crest cells (NCC), studying perturbations in signalling affecting this population will help us 
understand the mechanisms underlying craniofacial malformations.  
NCC are defined as a transient population of multipotent stem cells that originate at the 
edge of the neural plate border (between the neural and non-neural ectoderm) and 
prospective epidermis (Sauka-Spengler and Bronner, 2010). They emerge from the neural 
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tube as it closes and undergo an epithelial to mesenchymal transition (EMT) by 
delaminating from the neuroepithelium and initiate extensive migrations to various parts of 
the embryo. Definitive NCCs are specified and initiate expression markers as premigratory 
cells within the dorsal neural tube. Soon after migrating to their final position, NCCs 
differentiate to form a wide range of derivatives such as neurons of the peripheral nervous 
system, melanocytes of the epidermis, craniofacial bone and cartilage, smooth muscles and 
parts of the cardiac outflow tract (Bronner and LeDouarin, 2012, Dupin et al., 2001). This 
diversity in cells and tissue derivatives led to the idea that neural crest constituted a ‘fourth 
germ cell layer’ (Hall, 2000). Figure 1 summarizes the key steps during neural crest cell 
development (using a chick embryo as an example). Below, I summarize the process of 
neural crest formation, its role in craniofacial development and related birth 
malformations.  
1.2.1. Neural crest induction  
Neural crest induction is mediated by different signals including FGFs, BMPs and WNTs 
that are secreted from surrounding tissues, forming gradients. Convergence of BMP 
gradient from the ectoderm, ectoderm-derived Wnt and mesoderm-derived Fgf signalling 
triggers upregulation of transcription factors such as Msx1/2, Pax3/7, Dlx5, Gbx2 and Zic1 
(Basch et al., 2006, Betancur et al., 2010, Huang and Saint-Jeannet, 2004). Collective 
regulation and expression of these genes, designated as ‘neural plate border specifiers’, at 
the neural plate border region then leads to neural crest specification.   
1.2.2. Neural crest specification  
The neural plate border specifier genes subsequently activate a different set of transcription 
factors in the dorsal neural tube that includes genes like Snail2, FoxD3, Ets-1, Sox8/9/10, 
Slug and c-Myc. These genes control cell cycle, proliferation, survival, delamination and 
promite epithelial-mesenchymal transition (EMT). They regulate downstream effector 
genes to start promoting migration; at which point the NCCs have specified and become an 
identifiable distinct population of multipotent migratory stem cells with the capacity for 
self-renewal (Bhatt et al., 2013). Interestingly, this stemness has been seen in adult neural 
crest cells in niches that can be readily isolated, purified, cultured and potentially used in 
clinical therapeutic applications (El-Nachef and Grikscheit, 2014, Greiner et al., 2014, 
Konig et al., 2014).  
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Figure 1. An overview of neural crest development directly taken from (Sauka-Spengler and Bronner, 
2010).  
The diagram provides a snapshot of key events during neural crest formation, migration and differentiation.  
 
1.2.3. Neural crest migration and differentiation  
Following EMT, NCCs migrate throughout the embryo and respond to various intrinsic 
and extrinsic signals to promote their proliferation and survival. Neural crest cell specifier 
genes repress epidermal and neural tube markers such as Sox2 and E-cadherin and 
upregulate factors such as cadherin-y and matrix metalloproteinases. This facilitates 
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migration by enabling EMT and promiting NCC delamination from the neuroepithelium 
(Bronner and LeDouarin, 2012, Milet and Monsoro-Burq, 2012).  
NCCs can be categorized as cranial, cardiac, vagal, trunk and sacral based on their axial 
position and the tissues they contribute to during their terminal differentiation (Bhatt et al., 
2013). Cranial NCCs give rise to craniofacial bone and cartilage along with neurons and 
glia of the cranial ganglia, smooth muscle and pigment cells. They contribute to 
craniofacial structures through their differentiation into chondrocytes to form cartilage 
anlages, osteoblasts to form bone and odontoblasts to produce teeth and dentine. Non-
cranial NCC derivatives include various cardiac structures, the enteric nervous system, 
melanocytes, secretory cells, neurons and glia of the peripheral nervous system and the 
sympathetic ganglia. (Burns and Douarin, 1998, Burns and Le Douarin, 2001, Simoes-
Costa and Bronner, 2013). The next section will focus on craniofacial development.  
1.2.4. Neural crest cell in craniofacial development 
Following delamination from the neural tube, cranial neural crest cells (CNCC) begin their 
migratory path to help form the facial prominences. The frontonasal prominences (FNP) 
arise from CNCC that migrated from the diencephalon and anterior mesencephalon while 
CNCC from the posterior mesencephalon and rhombomeres 1 and 2 of the hindbrain 
populate the first pharyngeal arch (PA1) which then forms paired maxillary prominences 
(MxP) and paired mandibular prominences (MnP) (Wilkie and Morriss-Kay, 2001). The 
face subsequently forms by integrated fusion of these five facial primordia, the FNP with 
the paired MxP and MnP that surrounds the oral cavity (Figure 2). Invagination of the 
nasal placodes then forms the medial and lateral nasal prominences to ultimately shape the 
future nose (Minoux and Rijli, 2010). Failure of the fusion of these prominences will result 
in orofacial clefts (Jiang et al., 2006).  
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Figure 2. Mandibular development and homology between humans and zebrafish 
Top left figure represents a human embryo highlighting the 1st pharyngeal arch and is fated to become the 
future mandible amongst other structures. The top right figure shows the 1st pharyngeal arch derivatives. The 
middle figure shows the developing Mandibular prominence (green), maxillary prominences (red) and 
nasofrontal prominence, a protrusion of the maxillary prominence (yellow). The mandibular prominence 
appears to fuse by 7 weeks in utero. The bottom figure shows the developing Meckel’s cartilage in zebrafish 
where two separate prominence fuses around 55 hpf and forms an arch by 96 hpf. The red protrusions in the 
bottom right figure shows the future dentary bone formation.  
A key downstream gene reported to cause syndromic Van der Woude syndrome (OMIM 
119300) with cleft lip with or without cleft palate was IRF6 that was first reported in 2002 
(Kondo et al., 2002). Since then, a wealth of research has looked at regulation of IRF6 
including the importance of the WNT-p63-IRF6 signalling at the lambdoidal junction 
(fusion of the MxP and FNP). Another factor, Sonic hedgehog (SHH) has also been 
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implicated in correct fusion at this lambdoidal junction through modulating Wnt signalling 
(Kurosaka et al., 2014).  
The mandible is derived from the MxP and mandibular processes of the 1st pharyngeal arch 
with patterning signals arising from the foregut endoderm as well as surrounding CNCC 
derived mesenchyme (Couly et al., 2002, Rochard et al., 2016). Endothelin plays a key role 
in directing post-migratory CNCC to PA1 and mandibular process. Endothelin-1 is highly 
expressed in PA1 in the surrounding ectodermal epithelium of the mandibular process and 
signalling is through endothelin receptor type A (Ednra), which is present in the underlying 
NC-derived mesenchyme. Defects in Ednra as seen in Ednra null murine embryos showed 
an increase in apoptosis of NC-derived mesenchymal cells. Developmental abnormalities 
that are most common to the mandible include micrognathia or retrognathia with midline 
clefting defects being less common. One syndrome that includes micrognathia as a 
phenotype includes Treacher Collins syndrome (TCS, OMIM 154500).  TCS is a 
craniofacial disorder with features including coloboma of the lid, micrognathia, microtia, 
hypoplastic zygomatic arches, cleft palate, slanted palpebral fissures and macrostomia. The 
genetics of TCS highlights the many different signalling pathways involved in early 
craniofacial patterning and trophic skeletal morphogenesis.  
Therefore, to further our understanding of the developmental mechanisms behind these 
malformations, we turned to basic developmental biology work to uncover cellular 
signalling pathways in morphogenesis. I use zebrafish, a telost fish as a powerful model 
organism to study craniofacial development and subsequently focused on the Wnt 
signalling pathway in mediating the shaping of craniofacial skeletal elements.  
1.3. Zebrafish as a model organism  
Craniofacial structures and morphologies are enormously diverse with the fundamental 
signalling pathways and cellular events that control the nascent skeleton found to be highly 
conserved from fish to humans. The zebrafish, Danio rerio, has been a popular model to 
study craniofacial development since the 1990s. Major differences exist between zebrafish 
and other mammals such as human or mouse model but Danio rerio present great strengths 
and advantages over other laboratory animals. Strengths of the zebrafish model include 
being low-cost for rearing facilities, short breeding cycle, high fecundity and prolific layers 
(around 600 eggs per week). Zebrafish undergo rapid ex utero embryonic development 
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making it possible to observe different structures in the embryo and therefore, an excellent 
tool for researchers to observe key steps of development as they are happening in real time. 
Additionally, zebrafish have a simplified skeleton during early larval stages, and are 
amenable to transgenesis and complex genetics. In addition, genetic manipulation of the 
embryos such as mRNA injections can be achieved. Apart from some of the primitive 
advantages of teleost as model organism, zebrafish exhibit adaptive radiation and trophic 
polymorphism making it valuable in understanding how key pathway members affect 
trophic structures and diversification (Hulsey et al., 2005). Lastly their transparency and 
size enables easy visualization of the embryo at high resolution through single and multi-
photon microscopy, allowing for their study in real time.  
Sequencing of the zebrafish genome has demonstrated that many of zebrafish genes 
present very good homology to their human orthologues thereby human mutations can 
easily be studied in zebrafish with reliable transferability. In fact, cancer models such as 
melanoma have used zebrafish for large scale chemical screens. Additionally, it remains a 
popular model in developmental studies. One of its most advantageous characteristics is 
susceptibility to gene manipulation with reliable genotype-phenotype correlations. This led 
to the use of N-Ethyl-N-Nitrosouea (ENU) or viral insertional mutagenesis that have 
uncovered many genes involved in complex developmental processes (Driever et al., 1996, 
Neuhauss et al., 1996, Amsterdam et al., 1999, Amsterdam et al., 2004, Gaiano et al., 
1996, Golling et al., 2002). More recently, gene editing using CRISPR/Cas9 has enabled 
quicker and more efficient studies of gene function in zebrafish. These papers used 
mutants known to disrupt wntless (c186; ENU),(Yu et al., 2014), wnt5b (hi12735; viral 
insertion), gpc4 (hi1688; viral insertion) (Rochard et al., 2016, Sisson et al., 2015) and 
wnt9a (CRISPR editing) (Rochard et al., 2016). To understand zebrafish a model organism 
for developmental studies, I will briefly discuss the important aspects of its embryo 
development as well as highlighting craniofacial morphogenesis.   
1.3.1. Brief zebrafish embryology  
Zebrafish embryos develop rapidly. Within the first 72 hours, a single cell will develop 
into a free-swimming larva with all major axes, organs and structures patterned. These first 
3 days are divided into seven periods of early development: zygotic, cleavage, blastula, 
gastrula, segmentation, pharyngula, hatching and early larva (Kimmel et al., 1995) (Figure 
3).  
 22 
The zygotic stage covers the first 40 minutes and starts following fertilization and ends 
when the first cleavage occurs. Fertilization activates cytoplasmic movements that stream 
from the granule-rich yolk towards the animal pole and segregates to form a blastodisc 
(one-cell). This process continues into the cleavage phase. The cleavage period starts upon 
the first cleavage of the cell or blastomere that continues to divide at approximately 15-
minute intervals. They undergo meroblastic divisions (incomplete undercutting of the 
blastomeres) and remain interconnected by cytoplasmic bridges. The first five cleavages 
are confined to the animal pole at regular orientations and the sixth cleavage occurs in the 
horizontal plane, resulting in a two-tiered arrangement of cells. This regular succession of 
cleaves will continue until the tenth time, marking the start of the blastula period, a time 
when the blastodisc begins to look ball-like (approximately 128-cell stage) (Kimmel et al., 
1995).  
Three important processes occur during the blastula period: midblastula transition (MBT), 
formation of the yolk syncytial layer (YSL) and epiboly begins. Cells of the blastula divide 
metasynchronously whereby blastomeres near the pole enter the mitotic division wave first 
and the marginal cells last. Lengthening of cell cycle marks the onset of MBT (tenth cell 
cycle; 512-cell stage). Here, the interphases lengthen, cells become motile and RNA 
synthesis increases over background maternal mRNA levels (i.e. the cells are synthesizing 
their own mRNA). The marginal blastomeres in the early blastula lie against the yolk cell 
and remain cytoplasmically connected throughout cleavage period. At the start of the 10th 
cycle, cells are further divided into three distinct populations: 1) the enveloping layer 
(EVL) forming the periderm or outer most layer that acts to surround and protect the 
embryo, 2) the deep cell layer, which develops into the embryo proper and 3) the yolk 
syncytial layer (YSL), formed from marginal cells that collapses, releases their cytoplasm 
and nuclei into the immediately adjoining cytoplasm of the yolk cell. The YSL is unique to 
teleost and does not directly contribute to the body of the embryo. Its role is to drive 
epiboly that begins at late blastula.  
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Figure 3. Schematic representation of zebrafish life cycle from zygotic stage till adulthood.  
Representative diagrams at different stages starting with zygotic period (1 cell), cleavage period (8-cells), 
blastula period (sphere), gastrula (shield and 75%-epiboly), segmentation (10-somite), pharyngula (Prim-5 
24hpf), hatching period (long-pec, 48hpf) and finally adulthood around 90 days where they are fertile.  
(Adapted from “Stages of embryonic development in zebrafish (Kimmel et al., 1995)).  
Epiboly represents the first major morphogenetic movement of the embryo and is the 
thinning and spreading of the YSL and blastodisc over the yolk cell to eventually engulf it 
completely. The bulging/doming of the inner YSL toward the animal pole marks the 
clearest sign of epiboly. Epiboly relies on functional microtubules to generate the force 
necessary for coordinated movement of cells of the blastoderm from their animal location 
towards the vegetal pole. Changes are also observed in the EVL where it flattens and 
stretches to surround the embryo and form a tightly sealed epithelial monolayer (Bennett 
and Trinkaus 1970).  
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As epiboly continues, involution, convergence and extension occur, producing the primary 
germ layers and the embryonic axis, thus marking the start of the gastrula period. This 
occurs at approximately 50% epiboly (percentage-fraction of yolk cell that the blastoderm 
covers) where a thickened marginal region or the germ ring appears. Involution produces 
this germ ring by folding the blastoderm back on itself. This rapid convergence of cells at 
one position of the germ ring causes epiboly to temporarily arrest at which point the 
embryo reaches shield stage. This marks the formation of the dorsal organizer termed the 
embryonic shield in zebrafish and is equivalent to the node in mouse, Hensen’s node in 
chick and Spemann’s organizer in amphibians (Hamburger, 1969, Zoltewicz and Gerhart, 
1997). The embryonic shield reliably marks the dorsal side of the embryo as well as 
determining the Anterior-Posterior (AP) and Dorsal Ventral (DV) axes for the first time. 
After the shield has formed, epiboly resumes and the margin of the blastoderm advances 
around the yolk. Around 90% epiboly (determined by a small yolk plug protruding from 
the vegetal pole), the dorsal epiblast thickens anteriorly to form the neural plate (future 
brain) and the deep cell multilayer starts to differentiate into cells that will eventually form 
the notochord, axial somite-derived muscles and hindbrain neurons. At 10hpf, epiboly ends 
when the blastoderm completely envelops the yolk cells (100% epiboly). Soon after 
closure, the posterior end of the embryonic axis develops the tail bud. Just anterior to the 
tail bud lies the thickened neural plate along the embryonic axis where cells will contribute 
to trunk spinal cord. Thickening is prominent near the animal pole that forms the head. In 
addition, the prechordal plate is seen to accumulate deep, anterior to the neural plate 
forming a prominent bulge, or polster of cells (see Chapter 5 for highly specific copa 
expression in this region). This polster will begin to indent the yolk cell surface in the 
midline and will eventually contribute cells to the head (Kimmel et al., 1995).  
As gastrulation ends following 100% epiboly, the segmentation periods begin. During this 
time, somites develop, major body axes are formed, the three germ layers become 
organized and the tail bud becomes more prominent. Somitogenesis appears sequentially 
from anterior to posterior and is most useful for staging. Somites consist of paired blocks 
of undifferentiated mesenchyme enclosed in epithelium that will differentiate into the 
myotome and sclerotome, both of which will then differentiate into muscle and trunk 
cartilage structures respectively. At 4-5 somites stage and by the 8-10 somites stage, early 
rudiment of the pronephros is formed and early NCCs migrations occur. The next 
landmark is the otic placode that appears around 14 somites. This marks an important stage 
where three prominent subdivisions of the brain; prosencelphalon (that later divides into 
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telencephalon and diencephalon), mesencelphalon (midbrain) and rhombeencephalon 
(hindbrain), can be distinguished. The rhombomeres begin to take shape and neural crest 
starts migrating in streams in the head and trunk. Constriction of the yolk appears in the 
posterior region and gives it a kidney bean shape, thereby forming the extension from the 
rest of the yolk. Eventually around 30-34 pairs of somites form, exhibiting the chevron 
shape. Spontaneous myotomal contractions begin marking the end of segmentation stage 
and the beginning of the pharyngula period.  
The pharyngula stage (24-48hpf) refers to when the embryo develops to the pholotypic 
stage and into a complex swimming vertebrate fish. Pigment cells differentiate and 
melanin deposition becomes visible, circulatory system forms and behavioural 
development can be observed through tactile sensitivity. At 24hpf (primitive-5 stage), the 
heart starts to beat and the pectoral fin buds form lateral to the 3rd somites. By 30hpf (prim-
15 stage), the median dorsal stripe develops due to dorsal clustering of melanophores. 
Towards the end of the pharyngula stage (high-pec 42hpf), the mandibular and hyoid 
arches become well define and xanthophores and iridophores make an appearance.  
The hatching period (48-72hpf) marks an important point in lower jaw morphogenesis. 
This section briefly describes the general changes that occur. (Detailed description of 
craniofacial morphogenesis is discussed in the next section). During this period, the 
pectoral fins, ventral cartilage structures and gills start to take shape. A small open mouth 
at around 48hpf (long-pec stage) can be readily observed midventral position between the 
eyes and provides a useful landmark for staging and imaging purposes. Differentiation of 
the first cartilage structures at the pectoral fin bud can be observed from a compact 
mesenchymal condensation. From here, chondrocytes can be observed along the trabeculae 
of the ethmoid plate and at around 55hpf, the Meckel’s bud appears along with the 
palatoquadrate (Dougherty et al., 2012). At the protruding mouth stage (72hpf), the mouth 
is wide open and the Meckel’s cartilage forms a unique arch that articulates in the midline 
with its other half as well as proximally with the palatoquadrate to form the jaw-joint. Gill 
slits can be observed at this stage and prominent buds of developing gill filaments 
including blood vessels. The first bone of the zebrafish, the cleithrum appears at the 
boundary between the first two myotomes and serves as an important anchor to the 
pectoral fin girdle. By the end of 3 dpf, the hatched larva has completed morphogenesis 
and soon after, ossification of the cartilaginous structures begins. The major aim of this 
thesis is to look at early craniofacial development stages during the hatching period and 
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how disruption of important signalling cues at the early stages (gastrulation) affects later 
development, shaping and patterning of skeletal structures and bone formation.  
1.4. Zebrafish craniofacial development and anatomy  
 
Figure 4. Graphic diagram of zebrafish ventral cartilage structures (left) and bones (right).  
A. Names of corresponding cartilage structures. Orange indicates first pharyngeal arch derivatives, light blue 
– second arch derivative and green – third arch onwards derived. B. Names of craniofacial bones at 4 dpf. 
Red indicates neural crest cell derived intramembranous bone, orange indicated neural crest cell derived 
endochondral bone and blue mesoderm derived bone. C. Alcian blue stain of a 4 dpf larvae showing 
craniofacial cartilage structures. D. Whole mount Alizarin red stain of 4 days post fertilization (dpf) larvae.  
Zebrafish have seven pharyngeal arches, which are primordial for trophic structures 
consisting of a core of mesoderm, followed by cranial neural crest cells (CNCC) and then 
lined externally by ectoderm and internally by endoderm (Mork and Crump, 2015). The 
arches are extensively patterned by surrounding signals as well as autocrine signals in 
NCC. Hox genes determine anterior-posterior axes while Endothelin-1, Jagged-Notch, 
Bmp and Dlx determines the dorsal-ventral axes, fine-tuned by Fgf, Hh and Wnt signalling 
to establish domain-specific skeletal blueprints (Kimmel et al., 2010, Mork and Crump, 
2015).  
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The first pharyngeal arch will form skeletal elements of the anterior neurocranium, the 
ethmoid plate (homologous to the human primary palate) and anterior ventral cartilage 
structures notably the bilateral Meckel’s cartilages that serve as a lower jaw. It also 
contributes to the dorsal palatoquadrates that articulate with Meckel’s to form the jaw 
joint, pterygoid processes of the palatoquatrate that forms articulation with the ethmoid 
plate (Figure 4). The second or hyoid arch forms the dorsal hyosymplectics and ventral 
ceratohyals that are connected by interhyals to create hinge or hyoid joints. The 
ceratohyals are linked in the midline to the basihyal cartilage. The hyosymplectic connects 
the central cartilage structures to the posterior neurocranium via the anterior part of the otic 
cartilage. This secures the jaw skeleton to the head. The posterior arches 3-7 will form 5 
paired ceratobranchial cartilages that support gill tissues (Piotrowski et al., 1996, Schilling 
et al., 1996). The fifth pair of ceratobranchial forms several ossified pharyngeal teeth 
(Kimmel et al., 2010) but have evolved independently of the more anterior cartilage 
structures and are not present in all teleost fish (Hulsey et al., 2005, Mehta and 
Wainwright, 2008). The final organized shape and pattern of the cartilage structures are 
summarized in (Figure 4). 
The general pathways involved in patterning the pharyngeal arches and cartilage structures 
have been shown to be highly conserved across vertebrates (Mork and Crump, 2015). One 
example of conservation between mice and zebrafish is mutations in the Endothelin-1 
(Edn1) pathway that results in changes to the mandible in  mice mutants (Kurihara et al., 
1994) as well as defective Meckel’s and ceratohyals in zebrafish edn1 mutants (Miller et 
al., 2000). In a Dlx5/6 mice mutant, two downstream Edn1 targets, homozygotes displayed 
a homeotic transformation of the lower to upper jaw suggesting key roles of the pathway in 
lower jaw morphogenesis (Depew et al., 2002).  
This deep conservation across species during early craniofacial development justifies the 
use of zebrafish as a model to study other pathways involved during this process (Mork 
and Crump, 2015). To further justify the model, skeletal elements in the zebrafish head 
have homologs in mammals. The first pharyngeal arch derivatives such as the malleus and 
incus of the mammalian middle ear have been found to be evolutionarily homologous to 
the posterior end of Meckel’s cartilage and palatoquadrate in zebrafish (Anthwal et al., 
2013). Similarly, the stapes, a second arch derivate has connections to the hyomandiblar 
and otic cartilage in fish.  
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1.5. Skeletal development  
Skeletal development is conserved among vertebrates and involves two processes; skeletal 
patterning to define the shape and location within the body and then differentiation of 
skeletal progenitors (Olsen et al., 2000). As described in the previous chapter, many of the 
facial bones and the cranium are derived from NCC compared to the parietal and axial 
bones derived from the paraxial mesoderm and the sternum and long bones formed from 
the lateral plate mesoderm. Despite these three separate cell lineages to form different 
bony structures, each gives rise to a common bone matrix secreting cell; the osteoblast 
(Rodda and McMahon, 2006, Olsen et al., 2000).  
 
Figure 5. Summary of bone formation pathway showing both endochondral and intramembranous 
ossification process with genes implicated in each stage process.  
Bone formation involves two mechanisms, intramembranous and endochondral 
ossification (summarized in Figure 5). Intramembranous ossification defines the direct 
differentiation of mesenchymal progenitors into osteoblasts for the formation of many of 
the bones of the skull and face. This thesis focuses on endochondral ossification which, in 
contrast, requires that a chondrocyte cartilaginous anlage anticipates bone formation at a 
later stage (Kronenberg, 2003). The general pathway involves chondrocytes differentiation 
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from NCCs that subsequently undergoes maturation, hypertrophy and later apoptosis to 
leave behind a matrix for invasion of osteoblasts to deposit bone.  
On a molecular level (summarized from (Kronenberg, 2003), this complex process starts 
with Sox5+, Sox6+, Sox9+ mesenchymal cells condensing at their terminal location to form 
chondrocytes. These chondrocytes are immature proliferating cells and produce 
extracellular matrix proteins such as type II collagen (Col2a1). Within the prehypertrophic 
and hypertrophic zones, chondrocytes start to mature, enlarging and becoming more distant 
from each other. Here, Sox5, Sox6 and Sox9 are down-regulated while parathyroid 
hormone 1 receptor and Indian hedgehog (Ihh) are upregulated to initiate the formation of 
hypertrophic chondrocytes. Hypertrophic chondrocytes then start to express type X 
collagen (Col10a1) and connective tissue growth factor (Ctgf) (Mackie et al., 2008). At 
this stage, osteoblast progenitors also start to mature within the periochondrial cells, an 
inner layer lying adjacent to the hypertrophic chondrocytes. Hypertrophic chondrocytes 
then down regulate Col10a1 and upregulate vascular endothelial growth factor A (Vegfa), 
metalloproteinase 13 (Mmp13) and osteopontin (Spp1) to recruit endothelial cells and 
osteoprogenitors from the periochondrium to invade the cartilage matrix left behind from 
the apoptotic chondrocytes (Olsen et al., 2000). Osteoblast precursors initially start 
expressing Runx2, master regulator of bone and cartilage cell fate and then they express 
Sp7 (Osterix), master regulator of osteoblastogenesis and type I collage (Col1a1) as they 
differentiate into early osteoblast. Osteoblasts mature even further and start to express 
mineralization genes such as Sp1 (Osteopontin) and Bglap (Osteocalcin) (Nakashima et al., 
2002).  
Hedgehog (HH) signalling plays important roles in the regulation of endochondral 
ossification (Karsenty, 2003). Ihh is produced by hypertrophic chondrocytes and signals to 
not only adjacent pre-hypertrophic chondrocytes to induce proliferation but also to 
overlying perichondral cells to induce osteoblasts differentiation (Long et al., 2006, St-
Jacques et al., 1999). This was evident when the deletion of Ihh co-receptor Smo in 
perichondral lineage cells led to a loss of endochondral bone resulting in cells adopting an 
alternate chondrogenic fate (Long et al., 2004). In contrast, elevation of Hh signalling 
through loss of its negative regulators ptc1 and ptc2 initiates osteoblast differentiation 
program in chondrocytes (Hammond and Schulte-Merker, 2009).  
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While the central dogma of endochondral ossification is the formation of bone over 
apoptotic chondrocyte scaffold, it has been suggested that some chondrocytes escapes this 
process and transdifferentiate to long-lived osteocytes or osteoblasts (Paul et al., 2016, 
Yang et al., 2014, Zhou et al., 2014). In teleost, several studies have eluded to the direct 
differentiation of periochondral cells to form endochondral bones within the developing 
larvae (Eames et al., 2012, Hammond and Schulte-Merker, 2009, Paul et al., 2016). 
Perichondral cells are affected by ihha signalling (Hammond and Schulte-Merker, 2009). 
However, how these cells receive ihha signal from the underlying hypertrophic 
chondrocyte and how the cartilage anlage affect bone development has yet to be explored.   
In addition to HH signalling, Wnt signalling also plays a critical role in skeletogenesis and 
bone homeostasis (Monroe et al., 2012). As Wnt mutations affect craniofacial 
chondrogenesis, studying the mutants in the context of bone formation will be 
advantageous. Below, I summarise Wnt signalling, the role of both the canonical and non-
canonical pathways and then focus in on the non-canonical pathway.   
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1.6. Wnt signalling 
Wnts are a family of secreted glycoproteins that play major roles during embryonic 
development. The Wnt signalling pathway is widely conserved across species from 
Drosophila, Zebrafish, Caenorhabditis elegans to mammals and display several key 
embryonic functions such as cell fate specification, cell polarity and cell induction (Nusse 
and Varmus, 1982).  
The first Wnt gene, originally termed int-1, was cloned from the mouse genome and 
originally found to be a frequent insertional target by the mouse mammary tumour virus 
(MMTV) that causes mammary gland tumourigenesis (Nusse and Varmus, 1982). Later, 
other mouse loci were also subsequently found to be integrated by the MMTV and aptly 
termed int-2 (Dickson et al., 1984) and int-3 (Gallahan and Callahan, 1987). However, 
these genes were found to be unrelated to int-1 with int-2 encoding fibroblast growth factor 
family 3 (fgf3) (Dixon et al., 1989) and int-3 a member of the notch gene family (Robbins 
et al., 1992) with obvious different mechanisms and functions. It was then found that int-1 
encodes a novel secretory glycoprotein that is identical to the product of the Drosophila 
melanogaster wingless gene and that the Drosophila homologue (Dint-1) mapped to the 
same location to wingless (Rijsewijk et al., 1987). Therefore, given that int-1, int-2 and int-
3 were fundamentally unrelated and int-1 and wg were similar, both wingless and int-1 
were amalgamated to Wnt with Wnt1 being the first Wnt gene to be characterized (Nusse 
et al., 1991).  
Insight into the mechanism of Wnt signal transduction arose from early studies of several 
mutants in Drosophila. In Drosophila, wingless mutations can cause wings to transform to 
a notum or disrupt segment polarity in larvae (Nusslein-Volhard and Wieschaus, 1980). 
porcupine, dishevelled, armadillo (Drosophila homolog of B-catenin) and pangolin 
(Drosophila homolog of Tcf) display segment polarity like wingless (Nusslein-Volhard and 
Wieschaus, 1980, Wieschaus and Riggleman, 1987). These genes have been ordered in a 
genetic pathway to understand the intercellular signalling during Drosophila 
embryogenesis (Noordermeer et al., 1994). Since then a wealth of research has augmented 
the study of Wnt signal transduction and its importance in regulating numerous 
developmental pathways.  
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Figure 6. Summary of Wnt signalling pathways.  
The two non-canonical pathways (PCP and Calcium) are on the left while the b-catenin pathway is on the 
right. The red transmembrane receptor represents frizzled alongside LRP5 or LRP6 ligand. The dotted line 
represents the cell nuclear membrane. Once the Wnt/PCP pathway is activated, it triggers a small G-protein 
(guanine nucleotide binding proteins that acts as molecular switches), Rho (RHOA) to activate ROCK which 
is implicated in regulating cellular cytoskeleton. The Wnt/PCP pathway also acts through RAC1 to mediate 
actin polymerization via JNK activation. The Wnt/Ca2+pathway also acts through a G-protein to influence 
calcium intracellular movements from the endoplasmic reticulum which increases the concentration of 
calcium and thereby activating the Protein Kinase C (PKC) pathway. It also activates calcineurin and 
calmodulin-dependent protein kinase II (CaMKII) to induce activation of nuclear factor of activated T-cells) 
NFAT that is also implicated in actin polymerization, cell fate and migration. The canonical Wnt pathway 
acts through b-catenin to activate the TCF/LEF complex and turning on of downstream WNT target genes  
(Adapted from (Nusse, 2015).  
To date, there are two main Wnt signalling pathways described and characterized; the 
canonical and non-canonical (summarized in Figure 6). In the canonical pathway, Wnt 
proteins (that includes WNT1, WNT3, WNT3A, WNT8 or WNT10B) bind to members of 
the Frizzled family on cell surfaces. This activates and stabilize b-catenin by releasing it 
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from the Axin-GSK3-APC-complex (APC = adenomatour polyposis coli). The stabilized 
b-catenin is then able to translocate to the nucleus and interact with T-cell factor/lymphoid 
enhancer factor (TCF/LEF) transcription factors. In turn, this proteic complex activates 
several downstream genes and controls programs regulating cell fate and morphogenesis 
(van Amerongen and Nusse, 2009). On the non-canonical side, two separate pathways can 
be activated by Wnt (that includes WNT4, WNT5A, WNT5B, WNT6, WNT7B, WNT9a, 
WNT11 and WNT16). They can activate two separate non-canonical pathways; one that 
regulates planar cell polarity (PCP) to stimulate cytoskeletal reorganization through the 
activation of small GTPases (Rho and Rac), also called the Wnt/PCP pathway and the 
Wnt/Ca2+ pathway that regulates calcium mobilization from intracellular stores through 
heterotrimeric G-proteins (Veeman et al., 2003). Researchers are still discovering new 
roles and functions of both of these pathways and even cross-talks (Nusse, 2015).  
1.6.1. The canonical Wnt/B-catenin signalling in skeletogenesis 
The first evidence of the role of the canonical Wnt signalling in osteogenesis came from 
studies of human and mouse mutations in the low-density lipoprotein receptor-related 
protein 5 (LRP5) which causes an increase in bone mass (in activating mutations) (Boyden 
et al., 2002) or decreased bone mass as in osteoporosis pseudoglioma syndrome (null 
mutations) (Gong et al., 2001). LRPs are co-receptors for Wnt ligands together with 
transmembrane receptors of the Frizzled (FZD) family. When  Wnt binds to the LRP/FZD 
complex, it triggers a series of downstream events via the b-catenin/LEF/TCF pathway and 
induces expression of major osteochondrogenic factors such as Runx2 (Gaur et al., 2005), 
Osteoprotegerin (OPG) (Glass et al., 2005) and RANKL (Takahashi et al., 2011) to regulate 
bone homeostasis and mass.  
Apart from homeostasis, the canonical Wnt pathway plays a role in osteoblast 
specification.  This role has been demonstrated in mouse by conditional inactivation of b-
catenin in a Prx1-cre line. In this model, the head and limb mesenchyme failed 
dramatically to develop bone. Further characterization revealed that this defect may be due 
to progenitor cells failing to express Osterix (also called sp7), a critical transcription factor 
required for osteoblast differentiation (Hill et al., 2005). Other studies conditionally 
knocking out b-catenin in the condensing mesenchyme also showed an arrest in osteoblast 
development (Day et al., 2005). Transcriptional analysis using chromatin 
immunoprecipitation (ChIP) assays revealed direct binding of TCF1 to Runx2 promoter 
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(another key transcription factor required during early osteoblast progenitor 
differentiation), suggesting that the canonical WNT signalling pathway directly regulates 
Runx2 to control osteoblast differentiation (Gaur et al., 2005). Like many aspects of 
development, the Wnt/b-catenin pathway does not act in solitude during skeletogenesis. As 
uncovered in many published works, its activity can be restricted by several other factors 
including BMP signalling (Kamiya et al., 2008), Notch overexpression (Deregowski et al., 
2006), or Sox9 (Topol et al., 2009).  
From an evolutionary perspective, varying levels of Wnt signalling activity play an 
important role as a mediator of craniofacial form and plasticity by determining the 
roundness of the upper jaw as well as exaggeration to jaw protrusion to influence foraging 
and feeding (Concannon and Albertson, 2015, Parsons et al., 2014). As most of 
craniofacial bones are NCC derived, the canonical Wnt signalling is also essential in NCC 
development and differentiation (Lewis et al., 2004, Willems et al., 2015). Alterations in 
components of the Wnt/b-catenin pathway can directly affect trophic skeletogenesis, 
including development of the maxilla and mandible as well as tooth development (Ahn et 
al., 2010, Curtin et al., 2011, Dougherty et al., 2013, Kawakami et al., 2014, Willems et al., 
2015). Previous work done in our lab showed that transcriptionally knocking down wnt9a 
affects development of both upper and lower jaw elements (Curtin et al., 2011). wnt9a 
isoform, wnt9b also controls the development of anterior skeletal structures and promotes 
dorsoventral patterning (Jezewski et al., 2008). Studies in zebrafish by another group 
showed that in addition to regulating bone mass, lrp5 plays a role in CNCC migration 
where transient knockdown experiments showed reduced proliferation of premigratory 
CNCC and thereby abnormal or absent ventral cartilage structures (Willems et al., 2015). 
In Lake Malawi cichlids, another aquatic model organism, expanded Wnt/b-catenin 
activity and increased lef1 expression in preorbital skeletal elements showed increased 
bony mineralization due to accelerated bone development (Parsons et al., 2014).  
1.6.2. The non-canonical Wnt signaling pathway in skeletogenesis  
Non-canonical Wnts have been shown to act via the b-catenin-independent pathway to 
activate the planar cell polarity (PCP) or Wnt/Ca2+ signalling (Veeman et al., 2003). Non-
canonical Wnts, Wnt/PCP and Wnt/Ca2+ controls aspects of gastrulation movements by 
driving mediolateral convergence and antero-posterior extension (termed convergent 
extension, CE) of the body axis, notably of presumptive notochord cells, organogenesis 
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and even of the palate and trophic cartilage structures (Rochard et al., 2016, Wallingford et 
al., 2002, Tada and Smith, 2000) as well as planar cell polarity as in mouse cochlea (Curtin 
et al., 2003, Wang et al., 2005). Despite the number of studies, the role of the non-
canonical pathway affecting bone homeostasis is still less understood.  
Early developmental studies in mice showed that Wnt7b acting through the Wnt-G protein 
linked PKCδ cascade promotes osteoblast differentiation (Tu et al., 2007). In another 
study, Wnt5a was shown to bind to Ror2 (a single pass receptor) and Frizzled receptors to 
enhance RANKL-dependent osteoclast differentiation and bone resorption. Interestingly, 
the lack of only one copy of Wnt5a in mice (as demonstrated in Wnt5a+/- mice) is 
sufficient to result in an osteopenic phenotype with reduced bone formation and resorption 
(Maeda et al., 2012). Maeda and colleagues also showed that Wnt5a acts in a non-cell 
autonomous manner, being secreted from osteoblast to regulate osteoclastogenesis. During 
chondrogenesis, studies performed in chick revealed that ectopic Wnt5a delays 
chondrocyte differentiation while Wnt4 promoted differentiation (Hartmann and Tabin, 
2000). In mice Wnt5a and Wnt5b were shown to regulate chondrocyte proliferation, thus 
affecting acral long bone skeletal development (Yang et al., 2003). Studies employing 
zebrafish to explore non-canonical functions of Wnts also revealed key roles in early 
pharyngeal pouch development and late craniofacial patterning (Curtin et al., 2011, Choe 
et al., 2013, Heisenberg et al., 2000, Sisson et al., 2015). However, how chondrocyte 
organization affects craniofacial bone development, especially during endochondral 
ossification remains to be understood.  
1.6.3. Wnt secretion in skeletogenesis  
Recently, genome-wide association studies have identified two SNPs (single nucleotide 
polymorphism) strongly associated with reduced bone mass that lie within the intron of 
human GPR177 gene (also known as Wntless, WLS) (Rivadeneira et al., 2009). Wls, a 
multispan transmembrane protein is conserved from C. elegans to mammals and has been 
shown to be key in the secretion of Wnt ligands by binding and accompanying Wnt to the 
cell surface (Banziger et al., 2006, Port et al., 2008). Wnt trafficking and secretion has 
been an area of interest in different fields including development. Despite Wnts being 
hydrophobic proteins, they can travel long distances to induce cell-type specific responses. 
Evidence have shown that some Wnt proteins can be packaged onto extracellular carriers 
such as exosomes to reach the receiving cell (Gross and Boutros, 2013). Therefore, to 
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achieve its paracrine effects, trafficking of Wnt from its origin cell to the recipient cell 
must be tightly regulated. Newly synthesized Wnts are directed to the lumen of the 
endoplasmic reticulum (ER) where they are palmitoleated by the ER-resident membrane-
bound O-acyltransferase Porcupine (PORCN) for Wnts to be able to bind to Wls (Coombs 
et al., 2010). Wnt-WLS complex are then transported in coatomer (COP) cargos from the 
endoplasmic reticulum to the Golgi complex and then towards the plasma membrane (Yu 
et al., 2014, Zhang et al., 2016). As the secretory COP cargos reach the cell surface, Wnts 
are released from WLS. From here, Frzb (long-range) and Glypican (a class of heparan 
sulfate proteoglycans that act short-range) proteins facilitate Wnt diffusion to the receiving 
cells (Zecca et al., 1996). Unloaded WLS is then recycled back to the trans-Golgi network 
to bind further synthesized Wnts (Belenkaya et al., 2008). Wls secretion is summarized in 
Figure 7.  
Considering the major role of Wls in Wnt signalling, dramatic effects of its mutation can 
be expected. Disruption in WLS locus has been associated with changes in human bone 
mineral density that has implications for diseases such as osteoporosis (Rivadeneira et al., 
2009). Wls -/- mice results in embryonic lethality while mesenchymal deletion resulted in 
arrested limb growth and ectodermal loss leading to agenesis of distal limb tissue (Zhu et 
al., 2012).  Osteoblast specific Wls deletion in mice resulted in dramatic reduction in 
cortical bone mass due to defective differentiation and mineralization (Zhu et al., 2012). 
Further studies using both chondrocyte and osteoblast specific conditional inactivation led 
to impairment of intramembranous and endochondral ossification by modulating cell 
proliferation and differentiation (Maruyama et al., 2013). In our lab, previous studies have 
showed that wls is required for convergence extension mechanism of the zebrafish ethmoid 
plate, a homologous structure to the human primary palate, due to defects in chondrocyte 
elongation and intercalation (Rochard et al., 2016).  
Altogether, these studies have highlighted the important role of Wnt signalling in the 
crosstalk between different cell populations during development (Gross and Boutros, 
2013). In this thesis, wls is studied in two contexts; its role in lower jaw development and 
in another chapter, neural crest cell development.  
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Figure 7. Wnt trafficking following synthesis and 
palmitoleation within the endoplasmic reticulum.  
Wnt binds to Wls and is transported in COP cargos from 
the golgi complex to the cell surface where it is released 
and diffuses across extracellular matrix with the aid of Frzb 
(long range) and gpc4 (short range). Once it reaches its 
target cell, it binds to Fzd receptors to activate downstream 
signalling effects.  
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1.7. Thesis aims and hypotheses 
1. Understand how the underlying trophic cartilage anlages affect endochondral bone 
formation and how non-canonical Wnt signalling affect shaping and patterning of 
trophic craniofacial structure.   
a. Hypothesis: We hypothesize that the cartilage provides a scaffold for bone 
development and proper shaping and size of this anlage is required for 
adequate mandibular development.  
2. Develop a model to understand dynamic chondrocyte behaviour during craniofacial 
development by utilizing a multispectral zebrabow transgenic line  
a. Hypothesis: The zebrabow line allows individual colouring of the cells thus 
enabling us to track cellular behaviour over time to allow us to see how 
cartilage stack and dynamically interact with each other.  
3. Understand how wls trafficking via cop mechanism affect neural crest development 
a. Hypothesis: We hypothesize that cop will be spatiotemporally expressed 
during development, with increasing expression in tissues with high 
metabolic activity to shuttle proteins for growth and development. As wls is 
known to be shuttled by cop, we predict that defects within the cop 
mechanism will display severe craniofacial defects.  
 
 
 
 
 
  
 39 
Chapter 2: Material and methods  
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2.1 Animals  
2.1.1. Zebrafish lines  
Zebrafish (Danio rerio) were maintained at 28°C on a 14:10 light:dark cycle (Westerfield, 
1995). Fertilized eggs were obtained following set up in breeding tanks and grown in 
incubators set at 28.5°C, left at RT; approximately 22°C (to slow development) or 31°C (to 
accelerate development). Embryos were then staged according to standard references in the 
US and agreed by the Institutional Animal Care and Use Committee (IACUC) (Kimmel et 
al., 1995). Embryos were generated from WT Tübingen. Mutant lines (gpc4hi1688Tg/+, 
wnt5bhi2735bTg/+) were obtained from ZIRC. wlsc186/+ was provided and previously 
characterized by Marnie Halpern (John Hopkins University) (Kuan et al., 2015) 
copahi1872Tg was provided by Sun Zhaoxia (Yale University). One of the two previously 
generated CRISPR wnt9a mutant line (Rochard et al., 2016) with the following target 
sequence TGTCCATTCTGCCACTGACC and harboring a -4bp deletion (allele 
c.114_117del) was used for this study. The other line with a 13 bp deletion was used as a 
control and displayed a similar phenotype, allowing validation of the first mutant line. We 
used the transgenic line Tg(sox10:GFP), Tg(sox10:mCherry), Tg(osteocalcin:GFP) (Singh 
et al., 2012), Tg(osterix:RFP-NTR) (Singh et al., 2012), Tg(sox10:creERT2) and 
Tg(ubi:zebrabow). The following transgenic lines were generated using Gateway cloning: 
Tg(ubi:copa), Tg(cmlc2:GFP,U6:gRNA copa, sox10:Cas9).  
2.1.2. Genotyping  
Zebrafish tails were cut and DNA extracted using alkaline lysis method. 100 µL of 5mM 
NaOH was added and boiled with the tail clip for at least 30 minutes. 25 µL (1:4 ratio) of 
Tris pH 8.0 was added and vortex for at least 30 seconds to pellet remaining debris. DNA 
stored at -20°C. 1µL of adult fish DNA was used in a 10 µL PCR reaction for genotyping 
and run on a 1% TE agarose gel. For preparation of genomic DNA from embryos, a similar 
protocol was use as above but quantity of NaOH is adjusted per the size of the embryo. 
Primers for genotyping fish-lines used in this study are listed below:  
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Table 1. Genotyping primers 
Gene Sequence (5’ – 3’) Tm  
c186 fwd gactgagaggaaccgctttcagtgttct 58°C 
c186 rev  agaaaggattctttagctgtactcctctgc 
wnt9a FAM Fwd agattccaatggctgcgcccacttg 60°C 
wnt9a Rev gagagatggaactgcacgctggagg 
wnt5b Fwd gggtctattcatcttcttgcctttg 62°C 
wnt5b rev tcgcttctcgcttctgttcg 
gpc4 Fwd  ccttgatctgaacttctctattctcag 60°C 
gpc4 rev aagagggctaataattgcggac 
copa 1872C1 Fwd gacgtggagcttgcgatgctg 60°C 
copa rev2 ctgtgtggtgtatttcttgaggcc 
copa MSL4 rev gctagcttgccaaacctacag 
 
 
Figure 8. Genotyping of Wnt mutants.  
A. wnt5b hi2735bTg genotyping. The 247 bp product is specific for the mutant gDNA while no product is 
generated for wild-type gDNA, as in lanes 5 and 8.  
B. kny hi1688Tg genotyping. The 285 bp product is specific for the mutant gDNA while no product is 
generated for wild-type gDNA as in lanes 2, 8 and 9.  
C. wnt9a CRISPR mutant 6-FAM microsatellite assay showing a 341 bp mutant allele peak and a 345 bp 
wild-type peak. Two peaks represent a heterozygote embryo.  
D. dCAPS assay for c186 (wls). I found the dCAPS digest often did not offer clean bands when ran on a 
1.5% agorose gel at low voltage. Therefore, I often sequenced the PCR product using the reverse genotyping 
primer which shows the C > T mutation (as indicated by the bold red T nucleotide in the bottom image 
(heterozygote as there is equal intensity of both the T and C nucleotide, compared to the WT).  
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2.1.2.1. Derived cleaved amplified polymorphic sequence (dCAPS) assay 
Genotyping of c186 allele (wntless) was performed using dCAPS assay (Kuan et al., 
2015). In this assay, a restriction enzyme recognition site that includes the single 
nucleotide polymorphism (SNP) is introduced into the PCR product by a primer containing 
one or more mismatches to the template DNA. The PCR product modified in this manner 
is then subjected to the restriction enzyme digestion and the presence of absence of the 
SNP is determined by the resulting restriction pattern and bands compared on a 1% 
agarose gel. Here, genomic DNA for c186 allele was PCR amplified using the primers 
noted in Table 1.  
The forward primer contains a mismatch, generating a DNA fragment that is sensitive to 
XbaI disgestion in the c186 allele but not in WT. Following XbaI digestion at 37°C 
overnight, the PCR product can be readily visualized on a 1% agarose gel with a running 
time of 2 hours to adequately separate out the smaller DNA fragment (Kuan et al., 2015).  
Complement to the dCAPS assay for c186 genotyping, PCR products were at times sent 
for sequencing using the reverse primer and sequences analysed for the point mutation.  
2.1.2.2. Microsatellite DNA fragment analysis  
Gene editing by CRISPR-Cas9 methodology created indels in the coding region of our 
genes of interest. We used the size variations to design genotyping primers. Forward 
primers were fluorescent dye-labelled with 6-carboxyfluorescein (6-FAM) and labelled 
DNA fragments were electrophoretically separated using an ABI3730xl Genetic Analyser 
(available at the MGH Centre for Computational and Integrative Biology Core Facility).  
2.1.3. Embryo collection 
Zebrafish (Danio rerio) female and male pairs are set up in breeding tanks and kept 
physically separated in the same tank and released when eggs were required the following 
morning. Embryos were collected in Egg Water (also known as E3) (5.0mM NaCL, 
0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4 with 0.05% Methylene Blue (as an anti-
fungal)) shortly after having been laid. Embryos are then kept in a 28.5°C incubator and 
E3 changed the following day and dead embryos cleared. Embryos were then either 
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collected for experimentation or placed in the main zebrafish system after 5 days in a 
28.5°C incubator.  
For collection, zebrafish embryos were staged according to the morphological criteria 
(Kimmel et al., 1995), tricaine treated and subsequently fixed at least overnight in 4% PFA 
in phosphate buffered saline (PBS) at 4°C. Embryos younger than 48hpf were de-
chorionated with a short chemical treatment of pronase prior to fixation or by mechanical 
treatment using forceps. Following fixation, embryos were dehydrated in MeOH/1X PBST 
graduations (25%, 50%, 100%). Dehydrated embryos were then stored in 100% methanol 
at -20°C until required. Where bleaching is necessary, prior to dehydration, embryos were 
incubated in 1.5% H2O2/1.5% KOH until pigmentations were cleared, then surfixed in 4% 
PFA for at least 20 minutes, then dehydrated and stored in 100% MeOH at -20°C.  
2.2 General molecular biology techniques  
2.2.1. Bacterial Plasmid DNA preparation  
The Qiagen Miniprep kit was used for all small-scale plasmid preparations, according to 
manufacturer’s protocol. DNA was then quantified by spectrophotometry (NanoDrop) at 
260 nm following calibration with diluent used to elute the DNA. The ratio between 
260nm and 280nm provided an estimate of the purity of the nucleic acid preparation (DNA 
preparations should ideally have a OD260/OD280 values of around 1.8 and 2.0)  
2.2.2. Gel extraction of DNA  
The appropriate band from a DNA agarose gel run was excised under UV light (with 
appropriate eye protective wear) and DNA extracted using the QIAquick Gel Extraction 
Kit (Qiagen) according to manufacturer’s protocol. Samples were eluted in 30µL EB 
buffer or water and DNA quantified by spectrophotometry. Typically, 1µg of DNA is used 
for further ligation reactions.  
2.2.3. Restriction digestions 
Restriction enzyme digestions were performed at 37°C for at least 2 hours using 
commercially available restriction enzymes and buffers (New England Biolabs). At least 
1µg/mL of bacterial plasmid was used per 50µL reaction. For double digestion, the 
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appropriate buffers were used as suggested by the manufacturer. Following digestions, 
reactions were typically column purified, eluted with 20-30µL ddH2O or TE buffer then 
run 1-2µL on agarose gel to ensure complete and correct product size.  
2.2.4. Ligation reactions 
Intermolecular ligations were performed in small volumes, typically using 1:3 ratio of 
DNA insert to linearized bacterial plasmid of choice (expression or non-expression). 
Usually 20µL for approximately 20ng of vector DNA with 60ng of insert DNA is used.  
Ligation reactions are carried out overnight at 4°C with T4 DNA ligase (NEB Biolabs) 
with T4 DNA ligase buffer (NEB Biolabs). Sticky end ligation was performed either using 
enzymes giving compatible ends or primer-engineered restriction enzyme sites on the ends 
of PCR amplified DNA. Ligated plasmids were then ready for transformation into 
chemically competent bacteria or stored at -20°C until use.  
2.2.5. Transformation of chemically competent bacteria 
For plasmid transformation, ligated DNA or PCR generated DNA fragment was added into 
thawed competent TOP10 cells, Invitrogen (or using lab stock competent cells) followed 
by 30 minutes incubation on ice. Typically, 2-5µL of ligation mix was added to 50µL of 
cells. The cells were then subjected to a 30 second heat shock at 42°C (to allow DNA 
fragments to enter the cell) and immediately put on ice thereafter. For kanamycin or 
chloramphenicol resistant competent cells, 250µL of LB (or SOC media) was added and 
incubated for 1 hour at 37°C followed by plating on the appropriate antibiotic-containing 
LB agar plates and plates were incubated overnight at 37°C. For pGEM-T easy cloning, 
20µL of X-Gal and 40µL of IPTG was used to aid selection of positive colonies. Direction 
of insertion was then tested by DNA sequencing.  
2.2.6. DNA sequencing  
For bacterial plasmid sequencing, DNA solutions were sent to MGH DNA Core facility 
with an aliquot of appropriate primers for sequencing and concentrations per the core 
facility sequencing guidelines.  
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2.2.7. Polymerase Chain Reaction (PCR)  
PCR reactions were carried out per standard protocols using Eppendorf PCR Thermal 
Cycler Machines. Taq-DNA polymerase, Promega was used for most molecular 
characterizations. Platinum Taq DNA polymerase, Thermo Fisher Scientific or PhusionÒ 
High Fidelity DNA polymerase, New England Biolabs was used for amplifying sequences 
to be cloned into expression vectors or for RNA injection studies due to low error copying 
rate. For templates with high GC content, the addition of DMSO and GC buffer were used 
with the PhusionÒ High Fidelity DNA polymerase. Annealing temperatures specific to 
individual primer pairs were calculated using NEB Tm Calculator 
(http://tmcalculator.neb.com) and optimized.  
Table 2. Standard PCR mix 
Component Volume 
2X GoTaq Polymerase  5µl  
ddH2O  5µl  
Forward primer  0.25µl  
Reverse primer  0.25µl  
DNA template  0.5 – 1µl  
Total  11 – 11.5µl  
 
2.2.8. Tol2kit multisite Gateway cloning  
The GatewayÒ Technology is based on the att site-specific recombination system from 
lambda phage that allows efficient transfer of DNA constructs between plasmids (Hartley, 
2003, Walhout et al., 2000). We used the three-insert multisite Gateway system 
(Invitrogen) that combines three “entry” vectors (p5E, pME and p3E) into a “destination” 
vector (pDEST).  
2.2.8.1. 5’ Entry Clone 
5’ Entry Clone used in this study includes p5E-ubi:loxP-EGFP-loxP-mCherry (ubi:Switch) 
obtained from the Zon lab and p5E-sox10 generated in our laboratory which contains a 
7.2kb region upstream of the zebrafish sox10.  
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2.2.8.2. Middle Entry Clone 
Middle Entry clone contains full-length copa cDNA. copa was PCR amplified with a 4bp 
Kozak sequence on the 5’ end of the forward primer. The following primer sequences used 
are as follows:  
Forward: 5’ – CACCATGTTGACCAAATTTGAGACAAAGTCGGCCCG - 3’  
Reverse: 5’ – AGTCCACTGCAGTTCCGCTGA – 3’  
Start and stop codons of copa underlined, Kozak sequence in bold.  
 
Following PCR amplification, blunt-end PCR product is run on a 1% gel agarose gel to 
check the integrity and size of the DNA fragment. Subsequently, the following TOPO 
cloning ligation reaction was set up using a 2:1 molar ratio of PCR product:TOPO vector: 
Table 3. TOPO ligation reaction mix 
Component Volume  
Fresh PCR product 2µl 
Salt solution (provided) 1µl  
TOPO vector  1µl  
ddH2O  2µl  
Total  6µl  
 
The mixture was incubated for 5 mins at RT and preceded to transformation in One Shot 
chemically competent cells. These were then plated on a kanamycin treated LB plate and 
incubated overnight at 37°C. The following day, multiple clones were selected and colony 
PCR performed to identify clones with the insert. For clones that contained the insert, a 
larger bacterial preparation typically 100-200mLs of LB was set up and subsequent 
extracted plasmid DNA was sent for DNA sequencing to check for correct sequence 
insertion using a M13 forward (-20) and M13 reverse primers:  
M13 Forward (-20): 5’ – GTAAAACGACGGCCAG-3’  
M13 Reverse 5’ – CAGGAAACAGCTATGAC – 3’  
 
2.2.8.3. 3’ Entry clone 
3’ Entry clone contained a polyadenylation signal, p3E-polyA that comprises the SV40 late 
polyadenylation signal sequence derived from pCS2+.  
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2.2.8.4. Destination vector  
We used Tol2-based destination vectors to provide the Tol2 transposon ends needed for 
transposition. The destination vector used has an extra marker cassette featuring the 
crystalline promoter (α-crystallin:mCherry). This vector (pDESTTol2-α-
crystallin:mCherry) allowed transgenesis with a fluorescent red eye that enabled 
subsequent scoring and line maintenance by tracking the bright eye expression.  
2.2.8.5. LR Recombination reaction 
Invitrogen GatewayTM LR ClonaseTM II enzyme mix and buffer was used. The LR Clonase 
enzyme contained the bacteriophage lambda proteins Integrase and Excisionase to catalyze 
in vitro recombination between entry clones with attL-flanked gene and an attR-containing 
destination vector to generate an attB containing expression clone. The p5E contains attL4 
and attR1 sites, pME contain attL1 and attL2 sites, p3E contain attR2 and attL3 sites and 
the pDestTol2pA contains attR4 and attR3 sites. This is to allow LR reaction by 
recombination with attL1-attR1, attL2-attR2, attL3-attR3 and attL4-attR4. Once pENTR 
and pDEST constructs were assembled, MIDI preparations were done, plasmid sequences 
checked and DNA concentrations measured using the NanoDrop. The amount of DNA 
needed for each pENTR clone was calculated using the formula below:  
𝑛𝑔 = (𝑓𝑚𝑜𝑙)(𝑁)(++,	./.012 )(3	4/3,5 ). N = size of DNA in bp (i.e. length of plasmid)  
A mastermix was made for each ENTR clone (i.e. 1µl containing 10fmol) and 200fmol in 
10µl for the pDEST (i.e. 1µl containing 20fmol).  
Table 4. Gateway reaction mix 
Component Volume 
P5E 1µl (10fmol)  
pME  1µl (10fmol) 
P3E 1µl (10fmol) 
pDEST  1µl (20fmol)  
TE buffer pH 8.0 4µl 
Total  8µl  
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LR clonase enzyme was thawed on ice for about 2 minutes, briefly vortex and 2µl was 
added to the ENTR/DEST mixture and allowed to incubate at RT for 1 hour. 1µl of 
Proteinase K solution (provided in the kit) was then added to the sample and incubated at 
37°C for 10 minutes to stop the clonase reaction. 2µl of the mix was then transformed into 
Top 10 competent cells and plated on LB plates with ampicillin. Colonies were picked and 
colony PCR set up using primers specific to the p5E, pME and p3E. Positive colonies were 
then sent for full plasmid sequencing to ensure correct inserts, orientation and no mutations 
within the pME. Midi preparations of positive pDestTol2-(promoter)-(gene)-pA-a-
crystallin:RFP were set up, DNA concentration measured and stored at -20°C. An example 
of one of the final plasmid maps used in this thesis is shown in Figure 9.  
 
Figure 9. Plasmid map of pDEST-ubiswitch-copa-pA.  
Final plasmid sequence map (generated using SnapGene program) following LR recombination using 
ubi:switch as p5E, copa mRNA as the pME and a poly-A as p3E into a pDEST containing an a-crystallin 
promoter driving mCherry expression.  
2.2.8.6. Tol2 transposase RNA synthesis  
Transposase RNA was generated using the pCS2FA-transposase plasmid (Addgene). 1µg 
of Plasmid DNA was linearized with Not1 in a 50µl reaction and purified using the Qiagen 
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PCR Purification kit. Capped RNA synthesis was done using the mMessage mMachine 
Sp6 kit (Ambion) according to manufacturer’s instructions. RNA was then purified with 
the Qiagen RNeasy Mini Kit and ethanol precipitated. Capped RNA was stored at -80°C.  
2.2.9. Injection and generation of transgenic lines  
Zebrafish pairs were set up in breeding tanks the previous evening and separated with a 
divider. The following morning, dividers were pulled and eggs collected approximately 15 
mins after spawning and embryos were then placed in a cooled agarose tray with 
depression to align embryos. Embryos at the 1 cell stage were then aligned in a plastic 
trough, with their chorions intact. 100ng/µl of purified construct vector (20-30pg) was co-
injected with 50ng/µl of Tol2 transposase mRNA (20pg) directly into the cytoplasm 
(blastomere) of the cell. At least 100 embryos were injected with the construct using a 
borosilicate glass needle (O.D. 1.0mm, I.D. 0.5mm; Sutter) pulled with a Flaming/Brown 
Micropipette Puller, Model P-97 and injected using a PLI-90A Pico-Liter Injector 
(Harvard Apparatus). The injected embryos were left to develop at 28.5°C. Injected 
embryos are then transferred to petri dishes, washed with E3 water and allowed to develop 
in a 28.5°C incubator. 
Positive transgenic embryos (F0) were selected (based on the expression of the α-crystallin 
transgenesis marker), raised to adulthood and subsequently outcrossed to Tubingen lines to 
generate F1 with germline transmission. Positive F1 embryos were further selected and 
raised to adulthood.  
For mRNA rescue experiments, a similar protocol is carried out with a few variations. 
Different concentrations of mRNA were optimized to obtain a suitable dose for study and 
minimize toxicity effects. Common non-specific effects of toxicity includes cell death 
(usually in the brain) and developmental delay (Ekker and Larson, 2001). Additionally, 
300 pg of nontoxic injection solution such as GFP-encoding RNA is injected in 
conjunction with the mRNA of interest to monitor the injection success. Yolk injections 
rather than blastomere-targeted injections for mRNA rescues resulted in fewer toxic side 
effects and did not alter the zebrafish development (Ekker and Larson, 2001).  
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2.2.10. Quantitative reverse transcriptase polymerase chain 
reaction (qPCR) 
2.2.10.1. RNA extraction  
This protocol describes the extraction of RNA from a pool of embryos. Adjusting the 
volume of reagents appropriately allows for single embryo extraction. Following tricaine-
treatment, 50-100 embryos were thoroughly washed with 1X PBS and transferred to a 
fresh 1.5ml microcentrifuge tube. 1ml of TrizolÒ (Invitrogen) was added and embryos 
homogenized using either a hand-held homogenizer with an attached plastic rod or using a 
20G needle and syringe by pipetting until the embryo is fully dissociated. TrizolÒ is a 
monophasic solution of phenol and guanidine isothiocyanate that enables isolation of 
RNA, DNA and proteins from cells and tissue samples. 200µl of chloroform was then 
added and the tube shaken vigorously for 15 seconds and incubated at RT for 3-5 minutes 
(until layers start to appear). The tube was then centrifuged at 12,000 rpm for 15 minutes at 
4°C. The chloroform results in the separation of the aqueous and organic phases of the 
Trizol mixture with the RNA being held in the upper aqueous layer. The supernatant 
(upper) layer was then transferred into a fresh RNAse-free tube, precipitated by adding 
70% ethanol and left on ice for at least 10 minutes (or in certain circumstances, overnight 
at -80°C.  
To obtain clean RNA, an additional RNA clean up step was performed using a Qiagen 
RNAeasy MinElute Cleanup Kit (Cat 74204). The precipitated sample (approximately 
700µl) was then aliquoted into the spin column (Qiagen) available in the kit and 
centrifuged for 15 seconds at 8000xg. 700µl of wash buffer (Qiagen) was added to the 
column and centrifuged for 15 seconds at 8000xg. An additional DNAse step was 
performed. Following the wash buffer, 80µl of DNAse I solution (79254, Qiagen) was 
added to the column and incubated for 20 minutes at RT. A further 350µl of wash buffer 
(Qiagen) was performed and columns centrifuged at 8000xg. 500µl of 70% ethanol wash 
(Qiagen) was then added and centrifuged again at 15 seconds at 8000xg and repeated with 
an additional 500µl of 70% ethanol wash buffer and 2 minutes centrifugation. Centrifuging 
for 1 minute at maximum speed then dried the membrane. Elute RNA with 30µl RNAse 
DNAse free H2O, incubate for 1 minute and spin at 8000xg for 1 minute into a fresh new 
1.5ml RNAse free microcentrifuge tube. The sample was then quantified on a NanodropÒ. 
Only samples with a reading of approximately 1.8-2.0 (260/280 absorbance) and 
approximately 2.0-2.2 (260/230) were considered of quality. For further analysis, 1µl of 
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sample was sent to the bioanalyzer (Harvard University molecular biology core facility) 
for quality of the RNA obtained (aiming for a RNA Integrity Number of at least 8.0 for 
qPCR quality samples). RNA was then stored at -80°C.  
2.2.10.2. cDNA synthesis  
cDNA synthesis was performed using the iScriptTM  Select cDNA Synthesis Kit (BioRad 
170-8896) according to manufacturer’s protocol. In short, 4µl of 5X iScript reaction mix 
was added with 2µl of Oligo(dT)20 primer or random primer, 1µl of iScript reverse 
trancriptase, at least 1µg equivalent volume of RNA and made up to 20µl with nuclease-
free water. For qPCR reaction, random primers were used for synthesis. The tube was then 
incubated for 5 minutes at 25°C, then 30 minutes at 42°C. Finally, the reaction was 
stopped by incubating at 85°C for 5 minutes to heat-inactivate the reverse transcriptase. 
The cDNA products were then stored at -20°C, ready for qPCR analysis.  
2.2.10.3. qPCR reaction  
qPCR reactions were performed using the PowerUpTM SYBRTM Green Master Mix 
(applied biosystems A25741). 5µl of the 2X PowerUp SYBR Green Master Mix was 
added to 1µl of forward and reverse primers, at least 1µg of cDNA template and made up 
to 10µl with nuclease-free water. Triplicates were performed for each reaction with a no 
template control to help identify PCR contamination. The reactions were transferred to a 
96-well optical plate, sealed with an optical adhesive cover and centrifuge briefly to spin 
down the contents and eliminate any air bubbles. The plate was then placed in the real-time 
PCR machine (Applied Biosystems StepOneTM Real-Time PCR system) and ran using the 
StepOne Software. Standard cycling mode was selected using the following program:  
Table 5. qPCR program 
Step Temp Duration Cycles 
UDG activation 50°C 2 minutes Hold 
Dual-Lock DNA polymerase 95°C 2 minutes Hold 
Denature 95°C  3 seconds 40x 
Anneal/Extend 60°C 30 seconds 
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The ubiquitous housekeeping genes eukaryotic initiation factor 1A (eif1a) and 
glyceraldehyde 3-phosphate dehydrogenase (gapdh) were used as controls. Data were 
analysed according to the 2-ΔΔCTmethod on MicrosoftÒ Excel. Primers used in this study 
are presented in Table 6. 
Table 6. qPCR primers 
Gene primers fwd primers rev 
bip 5’ – ggtcggcggctccactcgtat- 3’ 5’ – agccggttctggtcgttggtaatg – 3’ 
atf6a 5’ – ctggaggcgctggtgaaaagtg- 3’  5’ – ccggacgggagatgggaaca – 3’ 
ire1a 5’ – atggcgtggggagtgtgc – 3’ 5’ – gtattctgtgcggccaaggtaaa – 3’ 
copa 5’ – aatttgagacaaagtcggcccg- 3’  5’ – gatgaacacgatggtccagtcaga- 3’  
 
2.3. CRISPR/Cas9 gene editing  
2.3.1. Introduction  
Gene-editing, a type of genetic engineering tool, offers the directed ability to change the 
chromosomal DNA sequence of a cell (Calos, 2016). The field arose from the 
understanding that cells could easily manipulate DNA through various processes in diverse 
entities such as restriction enzymes and phage genome integration in bacteria, retroviral 
genome integration in vertebrates, homologous recombination in yeast and VDJ joining in 
jawed vertebrates’ immune system to name a few. These methods have been harnessed to 
develop tools to help scientists unravel the mechanisms of genetic diseases at a molecular 
level.   
The understanding of cellular genetic material repair machinery has allowed us to exploit 
techniques to engineer genetic manipulation (Szostak et al., 1983). This came from the 
recognition that cells use double stranded breaks (DSB) to initiate recombination through 
either homologous-directed repair (HDR) or non-homologous end-joining (NHEJ) to repair 
the lethal breaks in genetic material (Ciccia and Elledge, 2010). NHEJ is error prone 
whereby the two broken ends of DNA are stitched back with insertions or deletion of 
nucleotides in a stochastic manner. HDR on the other hand, uses a DNA template with end 
homologous to the break site supplied and used to mend the DSB with precision (Szostak 
et al., 1983). Therefore, this understanding has led to the discovery of several enzymes that 
could induce DSBs and as potential genetic engineering tools.  
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Microorganisms’ restriction enzymes were found to have a diverse repertoire of 
endonucleases that recognizes specific short palindromic DNA sequences (4-8 basepair, 
bp) that induces a DSB with relatively high specificity (Roberts, 2005). These Type II 
restriction enzymes soon became essential tools for in vitro recombinant DNA and 
revolutionized the biotechnology industry. Several other meganucleases have also been 
employed but with great technical difficulty. In the late 80s, the new understanding of 
transcription factors regulating gene expression through the recognition of DNA sequence 
motifs uncovered zinc ion-coordinated protein structures (zinc fingers, ZFN) (Kim et al., 
1996, Horton et al., 1989). Coupled with a Type II restriction enzyme Fok I, these ZFN 
could bind to specific sequences and the endonuclease would induce the DSB. However 
their unpredictability in efficacy and laborious protein engineering led to a quick shift in 
focus to the newly identified transcription activator-like effectors (TALE), discovered in 
pathogenic bacteria of plants (Moscou and Bogdanove, 2009). TALE contained repetitive 
modules that are specific in recognizing one basepair each. They were easier to engineer 
and had more predictable efficacy. TALEs were also fused to Fok I nuclease (like ZFNs) 
to generate cutting domains thereby termed TALENs (Miller et al., 2011, Urnov et al., 
2005). However, the engineering of TALE protein was again laborious and technically 
difficult, dampening its popularity in functional genomics. The advent of clustered 
regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated-9 (Cas9) changed 
the field completely (Jinek et al., 2012).  
CRISPR/Cas9 has generated a wave of excitement in the medical and scientific community 
in the last few years, carrying much promise in effective genome manipulation both in vivo 
and in vitro (Jinek et al., 2012, Doudna and Charpentier, 2014). This system stemmed from 
studies aimed at understanding how bacteria and archaea fend off invading nucleic acids. 
A single-guide RNA (sgRNA) binds and directs the Cas9 endonuclease to the paired DNA 
sequence the complementary DNA sequence it recognizes with an added recognition to a 
2- to 4- base-pair conserved sequence named the protospacer-adjacent motif (PAM). This 
predictable Watson-Crick base pairing makes these sgRNA easier and quicker to engineer, 
thus eliminating the need for any complex protein designs. This ease and efficacy in 
virtually all cell types are the driving forces that led to an exponential rise in labs using 
CRISPR/Cas9 genome editing in medical breakthroughs and giving unprecedentedly rapid 
access to study gene function and its regulatory components.  
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2.3.2. CRISPR design and protocol  
The protocol is adapted from previous works in zebrafish (Auer and Del Bene, 2014, 
Hwang et al., 2013, Irion et al., 2014):  
2.3.2.1. Identification of efficient CRISPR target sequences in the gene of 
interest  
2-3 target sequences as close to 5’ UTR region or targeting exon 1 with zero potential off-
targets were selected in the gene of interest using available online tools: zifit.partners.org, 
www.crispr.mit.net, www.chopchop.com. Multiple target sequences were used to allow 
one to act as a positive control for the other when assessing for the phenotype. 
Oligonucleotides specific to the target sequence with the appropriate overhangs were 
obtained. For copa CRISPR generation, a target site was selected and modified 
oligonucleotides were ordered as follows:  
Forward: 5’ - TA-target sequence (20 bases) – 3’  
Reverse: 3’ – AAAC – reverse complement of target sequence (minus last 2 nt) – 5’ 
 
When annealed together, they will create a double-stranded targeting sequence flanked by 
4 bp single-stranded overhands, compatible with the overhangs generated by Bsa1 
digestion of pDR274 plasmid (Figure 10). 
 
Figure 10. A section of the pDR274 plasmid map.  
Dark blue bars shows the gRNA scaffold followed by the Bsa1 cut sites and the small portion removed 
during linearization. This leaves 4 bp overhangs that allows orientated ligation of the annealed gRNA oligo. 
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Figure 11. pDR274 plasmid map. Highlighted are the Bsa1 cut sites.  
 
Table 7. copa gRNA sequence and oligos 
 Target sequence Oligo 1 Oligo 2 
1 ggctgagtttccatccaaagcgg TAggctgagtttccatccaaagcgg AAACccgctttggatggaaactcag 
 
2.3.2.2. Annealing of the gene specific oligonucleotides  
The insert oligos were resuspended in DNase RNase free H2O to create a 100µM (1000x) 
stock solution. Then mix 10µl insert-Oligo 1 and 10µl insert-oligo 2 100µM stocks in 80µL 
H2O to generate a 10µM F/R stock. The two oligo-inserts were then annealed by boiling a 
mixture containing both oligos to 95°C for 5 minutes in a heatblock together with a T4 
DNA ligase buffer and the removing the heatblock and letting it cool on the bench top 
overnight. 
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2.3.2.3. Ligation and cloning of the annealed oligos  
Annealed oligos were ligated into pDR274 plasmid (Figure 11) that has been linearized 
with Bsa1-HR restriction enzyme using a T4 DNA ligase enzyme with its buffer. 
Table 8. Ligation mix.  
Component Volume 
Linearized pDR274 5µl  
T4 ligase (New England Biolabs M0202S, 400 U/µl) 1µl  
10x T4 ligase buffer  2µl  
10 µM annealed insert-oligos 10µl  
ddH2O  4µl 
Total  20µl  
 
The ligation mix was incubated at RT overnight. Following ligation, 2µl of the mix was 
added to thawed competent bacteria cells and left on ice for 15-30 minutes. The mix was 
then subjected to heat shock at 42°C for 30 seconds and then subsequently plated on 
Kanamycin LB plates and left to incubate overnight at 37°C. Positive clones were sent for 
sequencing following DNA extraction from a further culture of bacterial stock to ensure 
correct sequences.  
2.3.2.4. Transcription of the single guide-RNA and Cas9 mRNA  
Plasmid containing the ligated gRNA was linearized with Dra1 (Figure 12) and RNA 
transcribed with T7 mMessage mMachine (Ambion) kit, purified with the Qiagen RNeasy 
Mini Kit and ethanol precipitated. Approximately 5µg of the T3T9pCSCas9 plasmid were 
linearized with Xba1 restriction enzyme and PCR purified after incubating at 37°C 
overnight.  
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Figure 12. Linearization of pDR274 with Dra1.  
Highlighted in blue is the portion of plasmid cut out by Dra1 allowing transcription of the gRNA.  
2.3.2.5. Injection of the sgRNA and Cas9 mRNA in zebrafish embryos  
Injection protocol of gRNA and Cas9 are described previously in Section 2.2.9. Embryos 
are grown to 24hpf. A pool of 5 embryos per injection cohort were pooled, DNA extracted 
and using FAM PCR to determine efficiency of gRNA. Indel mutations were identified via 
multifragment DNA analysis and stable mutant lines were propagated and maintained.  
2.4. Tissue specific CRISPR/Cas9 using multisite 
Gateway Cloning  
2.4.1. Identification of target sequence 
Only target sequence (sgRNAs) that have shown effective targeting (generated using 
protocol 2.3 are chosen for further tissue specific CRISPR. The following oligonucleotides 
were ordered for the copa tissue specific CRISPR:  
Forward: 5’ - target sequence (20 bases)-GT – 3’  
Reverse: 3’ – reverse complement of target sequence-GA – 5’ 
 
When annealed, the insert oligos will generate a 2 bp overhang on both ends corresponding 
to the BseR1 cut sites in the destination vector (Figure 13).  
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Table 9. Tissue specific copa CRISPR oligos sequence 
 Target sequence Oligo 1 Oligo 2 
1 ggctgagtttccatccaaagcgg ggctgagtttccatccaaagcggGT ccgctttggatggaaactcagccGA 
The oligos were annealed following protocol 2.3.2. 
2.4.2. Tissue-specific CRISPR vector assembly  
The pcmlc2:GFP;U6:gRNA;Prom:Cas9 (Figure 14) destination vector was used for this 
study. The vector was digested with BseRI restriction enzyme and purified on a 1% 
agarose gel. The annealed oligonucleotides from section 2.4.1 were then ligated into the 
BseRI digested destination vector (1:20 vector:insert ratio) (Figure 13) and transformed 
into Top10 competent ccdB bacteria, plated on LB agar and selected with ampicillin and 
chloramphenicol. Plasmid DNA was extracted from a few colonies and sequence checked 
using the following primer: CCTCACACAAACTCTGGATT. Gateway reaction was then 
performed with the destination vector containing the gRNA, a p5’ with a ubi:switch 
promoter and sox10 promoter, pME containing a zebrafish codon-optimized Cas9 (Ablain 
et al., 2015) and p3E-polyA according to protocol in section 2.2.8.5. Following LR 
recombination, ligated vectors were transformed into chemically competent bacteria, 
plated on LB Agar and selected with ampicillin. Plasmid DNA from a few colonies were 
extracted and checked for correct recombination by sequencing.  
 
Figure 13. pDestTol2U6gRNA sequence map showing BseR1 cut sites.  
Followwing BseR1 diggestion, it leaves a 2 bp overhang for ligating annealed oligos next to the gRNA 
scaffold and U6 promoters 
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Figure 14. Plasmid map of pDestTol2pA2-U6gRNA.  
2.4.3. Injection of tissue-specific CRISPR construct in zebrafish 
embryos  
20-30pg of CRISPR vector with 20pg of Tol2 mRNA were injected into one-cell stage WT 
embryos. For the CRISPR vector with ubi:switch as the promoter, the vector mix was 
injected into one-cell stage embryos from a sox10:Cre zebrafish transgenic line. Embryos 
were allowed to develop at 28.5°C. F0 embryos were sorted based on expression of the 
transgenesis marker (i.e. cmlc:GFP – green heart). To generate stable lines, positive F0 fish 
were raised to adulthood and backcrossed to WT Tübingen strain and positive F1 embryos 
were selected and raised to adulthood. This is to ensure germline transmission and 
overcome the mosaic pattern of expression at F0 generation.  
2.5. Whole-mount RNA in situ hybridization  
2.5.1. DNA template  
DNA template for in situ hybridization was prepared either from cDNA PCR amplification 
with a T3 anchor attached to the reverse primer or from a linearized expression plasmid 
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containing the cDNA clone of interest. For the project, probes were generated using the 
former method to allow for higher throughput analysis.  
2.5.2. Digoxigenin labelled RNA probe synthesis  
For probe synthesis, PCR generated or plasmid linearized DNA template was added with 
5X transcription buffer, DIG-RNA labelling mix (UTP), RNAse inhibitor, T3 RNA 
polymerase (20U/µl), and incubated for at least 2 hours in a 37°C water-bath. 2µl of 
RNAse free DNAse I and Xµl of RNAse free H2O were then added and incubated for a 
further 30 minutes at 37°C. The mix was then put on ice and 5µl was run on a 1% agarose 
gel to quickly assess quality of transcription.  
The RNA was then precipitated with 1/10 volumes of 3M NaOAc pH5.2 and 2 volumes of 
100% ice cold ethanol at -20°C for at least 2 hours. The RNA was then centrifuged for 20 
minutes at 4°C, washed once with 2:1 volumes of 70% ethanol and re-centrifuged for 5 
minutes at 4°C to pellet the RNA. The ethanol was then removed and pellet left to air-dry 
and subsequently resuspended in 100µl ddH2O and stored at -20°C.  
2.5.3. Whole-mount RNA in situ hybridization (WISH) 
WISH was performed as previously described on appropriately staged embryos with minor 
modifications (Thisse and Thisse, 2008). Embryos were collected at the desired stages, 
fixed in 4% PFA/PBS, bleached with 1.5% H2O2/1.5% KOH and stored in methanol at -
20°C until further used.  
Embryos were placed in appropriate wells and rehydrated in a progressively decreasing 
concentrations of MeOH:PBST and subsequently washed 3 times in 1X PBST for at least 5 
minutes prior to digestion with 10µg/ml Proteinase K for 30 minutes. After a short rinse in 
pre-heated pre-hybridization transfer solution (HYB-), pre-hybridisation was performed at 
70°C for at least 4 hours in pre-hybridisation solution (HYB+) (50% formamide, 5X SSC, 
50µg/ml heparin, 200µg/ml torula yeast type VI RNA (Sigma R6225) and 0.1% Tween-
20). Digoxigenin-labeled anti-sense riboprobes (Roche Applied Science, Penzberg, 
Germany) were then added and allowed to incubate overnight at 70°C.  
Post-hybridisation washes were performed the following day at 70°C in solutions of 55% 
Formamide and 2X SSC/0.1% Tween-20 followed 55% Formamide and 1X SSCT, then by 
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1 x30 minutes washes in 1X SSCT and then by 2 times 30 minutes washes in 0.2XSSCT. 
Embryos were transferred in 1X MABT (0.1M maleic acid, 0.15M NaCl, pH 7.5 with 
0.1% Tween-20) before blocking in 1XMABT/10%BSA/2%FCS for at least an hour. After 
pre-blocking, embryos were transferred to the anti-digoxigenin-alkaline phosphatase 
conjugated Fab fragments (Roche) (1:10,000) in blocking solution and incubated overnight 
at 4°C with gentle rotation. The following day, embryos were extensively washed in 1X 
MABT and then equilibrated in alkaline phosphate buffer with 0.1% Tween-20 (NTMT; 
5M NaCl, 1M Tris-Cl pH9.5, 1M MgCl2) solution (60mM Tris-HCL pH 9.5, 60mM NaCl, 
30mM MgCl2 and 0.1% Tween-20) for at least 15 min. Nitro blue Tetrazolium Chloride 
(NBT) and 5-Bromo-4-chloro-3-ondolyl phosphate (BCIP) were used at a concentration of 
4.5mg/ml and 3.5mg/ml respectively dissolved in NTMT to achieve staining. During the 
colour reaction, embryos were kept from light exposure and monitored for staining. 
Rinsing with 1X PBST stopped the reaction. After staining, embryos were refixed in 4% 
PFA and dehydrated in 100% MeOH and stored in 70% glycerol. When assaying for 
differences in expression, the development of the staining reaction was monitored carefully 
and stopped at the same time. PFA fixed embryos were then dehydrated in 100% MeOH 
and either stored at -20°C or transferred unto glycerol 85% for RT storage and imaging. 
For imaging of ventral cartilage structures, the head was removed at the level of the 
pectoral fin, mounted on a cover slip with 100% glycerol and imaged using a Nikon 
Eclipse FN1 upright compound microscope.  
Table 10. Hybridization minus solution (HYB-) 
Component Volume 
50% formamide  250ml 
20X SSC 125ml 
Tween-20 2.5ml 
ddH2O 120ml 
 
Table 11. Hybridization plus solution (HYB+) 
Component Volume 
HYB-  500ml  
Torula Yeast tRNA  2.5g 
Heparin (50 µg/ml) 2.5mls  
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2.5.4. Probes used for in situ hybridization  
Probes were generated from PCR with a T3 anchor (ggatccattaaccctcactaaaggg) to the 5’ 
end of the reverse primer.   
Table 12. Primer pairs for in situ hybridiation PCR reaction 
Gene Forward 5’-3’ Reverse 5’-3’ 
wls attgcggatggagcttcgatc  tgccttcttcactggcatctat 
wnt9a cagcaactcaggacgaacgaaatg cacgaaattggcaagcagctca 
wnt5b aagtgtcatggcgtctcag ggttccaacagagggttttt 
gpc4 actgctggagcgcatgtttcgac cagtgtgtgttggagaaaggatcg 
sox9a ccgatgaacgcgtttatggtgt ctcctcccaccaccccgaaaa 
col2a1a Synthesized from plasmid with T3 RNA polymerase (ZDB-GENE-980526-
192) 
col10a1a tggacttaaaggagacactggtgc gtcctcaaggtgcaaagggttt 
col1a2 tggataaccgtattaccgcc cactagtcataccaggatc 
runx2a agtggaagaggaaagagcttcacg cctcatccgggtcataccaatt 
bapx1 gtgttgtgggtcagtttcag ctcgtgtttggaaagctctg 
copa  Synthesized from plasmid with T7 RNA polymerase 
 
2.6. Immunohistochemistry  
2.6.1. Antibodies and concentrations used 
Table 13. Antibodies and working concentrations 
Antibody Concentration Catalog number 
Monoclonal anti-acetylated tubulin mouse  1:200 Sigma T7451 
Monoclonal anti-BrdU mouse 1:400 Sigma B8434 
Donkey anti-mouse IgG secondary, Alexa 
Fluor® 568 conjugate  
1:400  ThermoFisher 
A11004 
Rabbit IgG anti-GFP, Alexa Fluor® 488 
conjugate  
1:400 ThermoFisher 
A21311 
Alexa Fluor® 647 Phalloidin  1:400 ThermoFisher 
A22287 
Alexa Fluor® 594 Phalloidin  1:400  ThermoFisher 
A12381  
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2.6.2. Whole-mount antibody staining 
For antibody staining, embryos at the desired stage were fixed with 4% PFA for 1-2 hours 
at RT with gentle agitation and then washed at least 3 times in PBST for 5 mins each. 
Embryos were then permeabilized with 100% ice-cold acetone for 7 minutes followed by 3 
further PBST washes. Embryos were then washed in multiple changes of PBS/1% 
dimethylsulfoxide (DMSO)/0.1% Triton-X (PBSDTx). Embryos were then blocked in 
PBSDTx with 10% goat serum (blocking solution) for at least 1 hour at RT. The embryos 
were incubated in the primary antibody diluted per published concentrations in blocking 
solution overnight at 4°C. The following day, the embryos were washed with multiple 
changes of PBSDTx the whole day to remove the primary antibody. The embryos were 
blocked again for at least 1 hour in blocking solution and secondary antibody added and 
allowed to incubate overnight at 4°C. The next day, the embryos were rinsed extensively in 
PBSDTx before storing in 35% glycerol/PBST at 4°C prior to confocal imaging.  
2.6.3. BrDU labelling  
BrDU incorporation was performed as previously described with some modifications 
(Verduzco and Amatruda, 2011). 6dpf embryos were pulsed with 15mM of BrDU (Sigma 
B5002) /15% DMSO E3 on ice for 20 minutes and chased for 4 hours in warm E3 at 
28.5°C. Embryos were then fixed in 4% PFA and stored in methanol at -20°C. Following 
rehydration in graded Methanol:PBST series, the embryos were digested in 10µg/mL 
Proteinase K for 30 minutes, washed in PBS/0.1%Triton-X  (PBSTx) and refixed in 4% 
PFA for 20mins. Embryos were then incubated in 2N HCL for 1 hour to denature the 
double-strand DNA and free the BrDU epitopes, rinsed with PBSTx and incubated in 
blocking solution (10% donkey serum, 1X PBSTx) for at least 1 hour before incubating in 
mouse anti-BrDU (1:400 Sigma) overnight at 4°C. Embryos were then washed all day with 
multiple changes of PBSTx and then incubated in secondary antibodies (donkey Alexa-
Fluor-594 1:400 and conjugated anti-GFP Alexa Fluor 488 1:400) overnight. Following 
multiple PBSTx washes, embryos were stored in 35% glycerol/PBST at 4°C. BrDU 
positive chondrocytes (yellow cells – sox10:GFP positive and BrDU red positive) were 
counted from confocal Z-stacks.  
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2.7. Sodium dodecyl sulfate Polyacrylamide gel 
electrophoresis (SDS-Page) Western blotting and 
Chemilluminuscent detection of proteins 
2.7.1. Protein extraction  
To determine protein levels in copa, wnt9a and wls mutants, embryos displaying the 
phenotype were collected for western-blot analysis. Yolks of individual embryos were 
carefully removed by manually separating it using forceps. Protein was extracted by 
adding 500µl of RIPA buffer (ThermoFisher, 89900) to at least 50 mg of embryos (pooled) 
(or 1:10 weight:buffer ratio). Using a needle and syringe, embryos were physically broken 
apart and then further sonicated for 5 seconds with a 1 second rest per 1 second pulse and 
immediately put on ice. The samples were then centrifuged for 20 minutes at 13,000 rpm 
to pellet any remaining debris. The suspensions were transferred to a fresh tube and stored 
at -80°C.  
2.7.2. Protein quantification  
Protein quantification was performed using the Pierce™ bicinchoninic acid (BCA) protein 
assay kit (ThermoFisher 23225) per the manufacturer’s protocol. A spectrophotometer set 
to 562nm was used to measure the absorbance of the samples. A standard curve was 
plotted using a BSA standard concentration and protein concentration determined. At least 
3 replicates of the sample were used and an average obtained for the final concentration 
measurement.  
2.7.3. SDS-PAGE electrophoresis (Western blotting) 
20µg/ml of protein per sample was mixed with appropriate volume of Laemli buffer with 
Beta mercaptanol and boiled to 95°C for 5 minutes and cooled on ice prior to loading onto 
a pre-cast 4-12% gradient Bis-Tris gel (Invitrogen-NUPAGE® Novex gels). Gels we ran 
using NuPAGE MES® running buffer (Invitrogen) at 150V for around 1-2 hours 
(following the dye front). Next, the proteins were electrotransferred to PVDF membrane 
sandwiched between sponges in the Invitrogen transfer cassettes, transferred at 15V at RT 
for 2 hours. Following transfer, the membrane was blocked in 5% skim milk/PBST for at 
least 1 hour and then incubated with primary antibody overnight at 4°C with gentle 
rotation (anti-copa, anti-wnt9a, anti-wls). The following day, the membrane was 
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extensively washed with multiple changes of PBST. The secondary antibody (in this case 
an anti-rabbit IgG conjugated with HRP, 1:5000) was diluted in blocking solution and 
incubated with the membranes at RT for at least 1 hour. The membrane was then washed 
extensively in PBST. Proteins were visualized using the ECL chemilluminescence 
detection kit (Thermo Scientific) and exposure on a film. For loading control, the same 
membrane was then stripped off to remove the bound antibodies, washed, blocks and 
counter probed with anti-b actin monoclonal antibody (Abcam) and visualized again with 
ECL and exposed on a separate film.  
2.8. Cartilage and bone staining 
2.8.1. Alcian blue cartilage stain  
Alcian blue dyes stain the proteoglycan components of chondrocyte extracellular matrix 
that can then be used to visualize cartilage patterns in zebrafish embryo or adults 
(Goldstein and Horobin, 1974, Walker and Kimmel, 2007). Cranial cartilage structures are 
best stained after 72hpf. Zebrafish embryos at the appropriate stages were fixed in 4% 
PFA/PBS at RT for at least 2 hours or 4°C overnight with gentle agitation. Embryos were 
then washed with 1X PBST to completely remove any trace of PFA. Then they were 
dehydrated in 50% Ethanol for at least 10 minutes prior to being transferred into a 0.04% 
solution of Alcian blue staining solution and incubated overnight with gentle rotation. The 
following day, the Alcian blue staining solution was removed, embryos rinsed with H2O 
briefly and bleached with 1.5% H2O2/1.5% KOH for 1 to 3 hours depending on stage of 
the embryos. The reaction was carefully monitored and stopped once eye pigmentation has 
completely cleared. The embryos were then rinsed in 1X PBST briefly and then their 
tissues were cleared with 0.1% trypsin/PBS for 10-30 minutes at RT. Trypsin digestion 
was stopped once brain tissue has cleared and embryos were then rinsed extensively in 1X 
PBST and stored in 75% glycerol at RT.  
Table 14. 0.4% Alcian Blue stock solution (100 ml) 
Component Volume 
100% EtOH 70ml 
ddH2O 30ml 
Alcian blue powder 0.4g 
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Table 15. Alcian Blue staining solution (100 ml) 
Component Volume 
95% EtOH 70ml 
ddH2O 6ml 
1M MgCl2 19ml 
0.4% Alcian Blue stock  5ml  
 
2.8.1.1. Microdissection and mounting of stained cartilage 
Following staining of larval skeleton with Alcian blue, stained cartilage elements were 
dissected out and mounted on a slide for further imaging. Forceps were used for 
dissections. First the eyes were carefully removed and discarded. Then, scraping the brain 
dorsal of the neurocranium and gently lifting the brain away helped removed the brain 
tissue. Next, one forcep is placed at the base of the notochord and the skull to stabilize the 
head. The ventral cartilage structures were removed by carefully pulling the quadrate 
process of the palatoquadrate away from the ethmoid plate and the hyposplenium away 
from the posterior neurocranium.  
For lateral jaw preparation, once the ventral cartilage structures are successfully detached 
from the neurocranium, the two ceratohyals are detached to split the posterior arches at the 
midline. Gently pressing down and cutting the midline then separate the Meckel’s cartilage 
halves. The remaining structures were then flat mounted on a slide containing a small 
droplet of pure glycerol and a 18x18mm coverslip placed on top and moved to achieve 
ideal orientation and placement of the structures.  
2.8.2. Alizarin red bone stain  
Alizarin red stains the calcified matrix associated with bone (Walker and Kimmel, 2007). 
It can be used as whole-mount preparations or live staining. Alizarin (1,2-
dihydroxyanthraquinon) emits a red signal under fluorescent green light and from personal 
experience, produced a more sensitive and specific method of visualizing the development 
bone compared to whole-mount staining. For live Alizarin red stain, live larvae were 
incubated in a 0.005% Alizarin Red S (Sigma) /0.01M HEPES buffer in E3 overnight at 
28.5°C. The following day, larvae were extensively washed with E3, anaesthetized with 
tricaine and mounted on a coverslip prior to confocal imaging. Alizarin red fluorophore 
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was excited at 580 nm. To distinguish cartilage and bone structures, alizarin red stain was 
performed in embryos with a Tg(sox10:GFP) background.  
2.9. Chondrocyte measurements, cell count and 
statistical analysis 
Meckel’s cartilage width (W) was measured from the distance between opposing 
retroarticular processes and the length (L) was measured from the midline to the tip of the 
retroarticular process. At least 10 different fish Meckel’s cartilage was used for 
measurement. Chondrocyte cell count was calculated by adding the total number of cells 
on one-half of the Meckel’s cartilage obtained from a flat-mounted Alcian blue image in 
10 different embryos. A one-way ANOVA test was used to compare means of 
representative groups and where the p-value is significant, a Bonferroni’s multiple 
comparison tests were performed to compare means of mutant to wild-type embryos. 
Where numbers were small, Kruskal-Wallis test with Dunn’s multiple comparisons test 
was used to compare medians across various groups. Rose plots were generated from 
Oriana Statistical program.  
 
Figure 15. Graphics showing measurement points. 
2.10. Live imaging  
Tg(sox10:GFP) background embryos were imaged using Nikon Ai scanning confocal 
microscope, mounted in 3.5% methylcellulose-0.013% Tricaine. Multiple embryos were 
imaged and traced till 4dpf when they reveal their phenotype. Embryos were additionally 
genotyped for confirmation.  
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2.11. Acridine orange staining 
Apoptosis detection by acridine orange was performed as previously described (Verduzco 
and Amatruda, 2011). 6dpf embryos were incubated in 2µg/mL solution of acridine orange 
(Sigma, A6014) in E3 for 30 min at room temperature. Embryos were subsequently 
washed extensively in E3, tricaine treated and mounted prior to confocal imaging.   
 69 
Chapter 3: Distinct roles of wls, wnt9a, wnt5b, 
gpc4 in endochondral ossification  
Published in Developmental Biology Jan 2017 15;421(2):219-232, PMID 27908786 (with 
cover image Vol 421 Issue 2)  
Work presented here overlaps with the work published but offers more detailed insight into 
some of the experiments, additional data, further hypothesis and data analysis.   
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3.1. Introduction  
During craniofacial development, CNCC are assembled into cartilaginous structures that 
prefigure development of the bony cranial skeleton (Olsen et al., 2000, Kague et al., 2012, 
Eames et al., 2012, Hammond and Schulte-Merker, 2009, Paul et al., 2016). After 
migrating into the first (mandibular) and second (hyoid) pharyngeal arches, CNCCs give 
rise to a series of cartilaginous anlage (Mork and Crump, 2015). Meckel’s cartilage is a 
first pharyngeal arch derivative that is considered a scaffold and template for mandibular 
development. As a recap to craniofacial development and anatomy in Chapter 1, the 
mandible develops in two distinct steps; first through intramembranous ossification 
supported by the body of the Meckel’s cartilage followed by endochondral or perichondral 
ossification of the distal and proximal regions (hereafter referred to as endochondral) 
(Frommer and Margolies, 1971, Savostin-Asling and Asling, 1973, Eames et al., 2013). In 
zebrafish, the mentomeckelian (distal midline) and retroarticulars (proximal jaw joint) 
forms through endochondral ossification while the dentary bone (body) forms through 
intramembranous ossification (Eames et al., 2013). These bones all later fuse together to 
form bony sutures. Other craniofacial bones that also undergo endochondral ossification 
include the ceratohyal and the ceratobranchials (Schilling and Kimmel, 1994, Schilling and 
Kimmel, 1997, Hammond and Schulte-Merker, 2009, Paul et al., 2016).  
Most craniofacial bones, including the mandibular bone are CNCC-derived compared to 
the limbs and trunk where they are mesoderm-derived. Bones that lie more posteriorly 
such as the cleithrum, occiput or parietal bones of the skulls have mixed origins from 
CNCC as well as mesodermal derived (Kague et al., 2012). Despite appearing 
histologically similar, CNCC-derived bones show distinct gene expression signatures, 
higher alkaline phosphatase activity, higher proliferation and greater regenerative 
capabilities (Quarto et al., 2010, Ichikawa et al., 2015, Hochgreb-Hagele et al., 2015, 
Heuze et al., 2014). Due to these differences, further work is required in understanding and 
characterizing their cellular mechanisms. Identifying the role of local signalling pathways 
that help to properly develop these cartilage structures is critical to understanding how 
craniofacial bones acquire their shape and size. Additionally, how the cartilage anlage 
supports endochondral ossification during mandibular development remains to be 
explored. The Wnt signalling pathway has long been implicated in bone development. 
Studying this pathway may shed light into the link between Meckel’s cartilage and 
mandibular ossification.   
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The Wnt family proteins are important in regulating acral bone formation, maintenance 
and remodelling (Olsen et al., 2000, Rodda and McMahon, 2006). Canonical Wnts have 
been extensively studied in mesoderm-derived bone biology and is important for 
mesenchymal precursor cells to differentiate into chondrocyte or osteoblast lineages during 
skeletogenesis (Rodda and McMahon, 2006). Loss- and gain- of function studies have 
highlighted the requirement for β-catenin to repress chondrogenesis by favouring 
osteogenesis and play a vital role in bone homeostasis by regulating osteoblastic and 
osteoclastic activity (Hill et al., 2005, Day et al., 2005). Many other Wnts can also act 
through a β-catenin-independent (non-canonical) pathway, which regulates cell polarity 
and migration during embryonic development (Semenov et al., 2007).  In chick, ectopic 
Wnt5a expression led to a delay in chondrocyte differentiation while ectopic Wnt4 
promoted differentiation (Hartmann and Tabin, 2000). Overexpression of Wnt14 in chick 
limbs led to ectopic joint formation (Hartmann and Tabin, 2001). In murine long bones, 
endogenous Wnt5a and Wnt5b in chondrocytes of long bones regulate endochondral 
skeletal development through coordinating cell proliferation (Yang et al., 2003). In 
zebrafish, non-canonical Wnts (Wnt4a, Wnt11r, Wnt5b, Wnt11) play a key role in early 
and late craniofacial patterning from the formation of pharyngeal pouches to the patterning 
and shaping of cartilaginous-structures (Curtin et al., 2011, Choe et al., 2013, Heisenberg 
et al., 2000, Sisson et al., 2015). These studies highlight the importance of non-canonical 
Wnt in skeletal development. However, how non-canonical Wnt ligands exert their 
function during cartilage maturation and how this may affect endochondral ossification 
remains to be explored.   
To determine the role of non-canonical Wnt in craniofacial development, we analysed 
mutants in different steps of Wnt signalling; wls, gpc4 (Wnt trafficking proteins) and 
wnt9a and wnt5b (ligands identified as non-canonical ligands) (Sisson et al., 2015, 
Topczewski et al., 2011). These Wnt mutants are described in Chapter 2 (Methods and 
Materials). In short, the wls mutant (c186) was a gift from Marnie Halpern laboratory and 
previously used to study habenular development (Kuan et al., 2015). The mutant was 
developed used ENU mutagenesis. The gpc4 and wnt5b mutants are viral insertional lines 
obtained from ZIRC and our wnt9a line (with a -4bp deletion) was generated using 
CRISPR/Cas9 gene editing technology (Rochard et al., 2016).  
We focused our study on detailed cellular events in Meckel’s cartilage morphogenesis and 
ossification by asking these questions:  
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1) Does the non-canonical Wnt pathway affect Meckel’s cartilage development? And 
if so, how does it affect chondrogenesis and why do their shape differ?  
2) Do defects in Meckel’s cartilage preclude defects in mandibular ossification? And 
if so, what is the mechanism and what role does the non-canonical pathway play 
during zebrafish mandibular endochondral ossification?  
Our data suggests that different Wnt genes have site-specific requirements during Meckel’s 
cartilage development and this affects timely cartilage maturation and the onset of the 
endochondral ossification program.   
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3.2. Results 
3.2.1. wls, wnt9a, wnt5b and gpc4 are expressed in discrete 
regions of the ventral craniofacial structures 
To first determine if Wnt signalling are important during craniofacial development, we 
sought to observe their expression patterns. Previous studies have showed that wls, wnt9a, 
wnt5b and gpc4 are expressed in ventral cartilage elements at an early time-point of 55hpf 
(start of palatogenesis) and 72hpf (Meckel’s cartilage formation) (Rochard et al., 2016, 
Curtin et al., 2011, Sisson et al., 2015). Sisson and colleagues showed that gpc4 is 
expressed in the pharyngeal endoderm, neural crest and mesoderm while wnt5b is 
restricted to the neural crest and mesoderm (Sisson et al., 2015). To understand the role of 
these genes in early ossification, we analysed their gene expression at a later craniofacial 
developmental stage by performing whole-mount RNA in situ hybridization (WISH) at 
96hpf, which is when ventral craniofacial cartilage structures have formed and ossification 
is initiated (forming the dentary, ceratohyals, ceratobranchial 5, opercle, cleithrum, 
maxilla, quadrate and one pair of brachiostegal rays).  
Here we show that wls, wnt9a and gpc4 transcripts were detected in the mesenchyme 
surrounding the chondrocytes of the ventral cartilage structures, with wls, wnt9a and wnt5b 
transcripts localized anteriorly. Clear expressions of wls, wnt5b and gpc4 were observed at 
the jaw joint (Figure 16A, C, D, arrowhead). wnt5b and wls transcripts co-localized to the 
oral epithelium (Figure 16A, C, black arrowhead) while wnt9a showed a discrete region of 
expression at the midline of Meckel’s cartilage (Figure 16B, arrowhead). wnt5b 
expression was observed within the ceratobranchials and mouth opening epithelium 
(Figure 16C). These detailed delineations of gene expressions supplements previously 
published gene expression patterns and provided us with greater insight into the 
craniofacial phenotype observed. 40X images shows detailed areas of expression described 
above.   
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Figure 16. Overlapping domains of gene expression of wls, wnt9a, wnt5b, and gpc4 in ventral 
craniofacial cartilages.  
(A-D) Whole mount RNA in situ hybridization with ventral views and 40X views focusing on Meckel’s 
cartilage in A’-D’. At 96hpf, wls (A) is expressed in the surrounding tissue including the Meckel’s cartilage 
and co-expressed with wnt9a (B) and gpc4 (D) in the posterior ceratobranchials (light blue) in contrast to 
wnt5b (C) that appeared to be expressed in the chondrocytes of the ceratobranchials and the blood vessels 
surrounding them. wls, wnt5b and gpc4 co-localized to the surrounding mesenchyme around the jaw joint 
(green). wnt5b is expressed in the oral epithelium with wls. There is discrete expression of wnt9a in the 
anterior midline (purple) adjacent to the intermandibulare anterior muscle. Annotation: Meckel’s cartilage 
(mc), palatoquadrate (pq), hyosymplectic (hs), interhyal (ih), ceratobranchial (cb), ceratohyal (ch), basihyal 
(bh). Scale = 50 µm.  
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3.2.2. Loss of Wnt signaling leads to abnormal Meckel’s cartilage 
chondrocyte arrangement 
Prior analyses by our group and others have shown that there is gross shortening of 
Meckel’s cartilage in wls, wnt5b and gpc4 mutant lines and wnt9a morphants showed a 
complete loss of Meckel’s and ventral cartilages (Curtin et al., 2011, Wu et al., 2015, 
Sisson et al., 2015). To gain better understanding of the cause of Meckel’s cartilage 
shortening, we performed a systematic and detailed analysis of Meckel’s in each of these 
existing mutants. Alcian blue was used which stains for the proteoglycans within the 
extracellular matrix secreted by chondrocytes. 96hpf was chosen as most cartilage 
structures have formed in WT and the full arched shape can be appreciated. A ventral view 
(Figure 17A) provides details of the ventral cartilage elements where the Width (W) of 
Meckel’s cartilage from both ends of the retroarticular can be calculated as well as the 
length (L) from the midzone of Meckel’s cartilage to an imaginary line between the 
retroarticulars. A lateral view (Figure 17F) allows for assessment of the ventral cartilage 
structures in relation to the neurocranium above (including the ethmoid plate and middle 
ear structures). Microdissection of the ventral cartilage structures is necessary to allow flat 
mounting and clearer visualization of the chondrocytes during imaging (Figure 17K, P). 
Zoomed in (40X) images of Meckel’s cartilages were used for cell count (Figure 17U).  
In wls mutants, obvious shortening of every cartilage element is observed with a smaller 
Meckel’s cartilage (Figure 17B, G, L, Q, V). wnt9a mutant display an obvious opened-
mouth phenotype by 96hpf. This can be appreciated on the lateral view where the Meckel’s 
cartilage is inverted (Figure 17H). Additionally, there is slight shortening of the 
ceratobranchials observed in the wnt9a mutant (Figure 17C, H, M, R, W). wnt5b mutants’ 
phenotype appears similar to wls mutants with shortening of all cartilage elements (Figure 
17D, I, N, S, X). Like wnt5b and wls mutants, gpc4 mutants also display marked 
shortening of all cartilage structures, having a more severe defect compared to wls (Figure 
17E, J, O, T, Y).  
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Figure 17. Alcian blue showing cartilage defects in wls, wnt9a, wnt5b and gpc4 mutants. 
(A-E) Ventral and lateral (F-J) view of whole-mount 96hpf Alcian blue stain  
(K-O) Dissected flat-mounted ventral and lateral (P-T) image of ventral cartilages 
(U-Y) 40X image of the Meckel’s cartilage lateral view. Length (L) calculated from the midline tip of the 
Meckel’s cartilage to the middle of the imaginary line (width (W)) between the retroarticular processes. Scale 
= 50 µm. 
Length/width (L/W) ratio of Meckel’s cartilage was then measured (Figure 18A) to allow 
appropriate assessment of the cartilage elements. At 96hpf, wild-type (WT) embryos have 
a larger mean L/W ratio of 0.804 ± 0.019 which was statistically significant compared to 
wls, wnt5b and gpc4 mutants; 0.566 ± 0.033, 0.447 ± 0.029, 0.542 ± 0.048 respectively 
(L/W ± standard deviation; p < 0.01 Kruskal-Wallis test with Dunn’s multiple comparisons 
test; Figure 18B, D, E, P). We did not observe a statistical difference in wnt9a mutants 
(0.756 ± 0.104; n=10, p = 0.125) but a prominent open-mouth phenotype prompted us to 
examine differences in the cause of this phenotype across the Wnt mutants.  
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Figure 18. Meckel’s cartilage length/width ratio  
A clutch of 10 embryos imaged separately was used during calculation (**p<0.01, ***p<0.001, 
****p<0.0001; Kruskal-Wallis test with Dunn’s multiple comparison test. Significance level at p<0.05).  
It is important to note that these morphological differences were not due to cell number 
differences, as chondrocyte count was not statistically significant amongst the different 
mutants (p = 0.1151, One-way ANOVA; Figure 19Q). These results, coupled with the 
gene expression data illustrate that Wnt signalling is essential for development of ventral 
craniofacial cartilages during zebrafish embryogenesis.  
 
Figure 19. Number of cells from one-half of Meckel’s cartilage  
Numbers was counted from figures 2U-Y from 10 different embryos. No statistically significant difference in 
cell number across wls, wnt9a, wnt5b and gpc4 (p=0.1151, NS; One-way ANOVA).  
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3.2.3 Cellular organization reveals two distinct zones in Meckel’s 
cartilage: midzone and body 
Now that we have established a significantly mishapened Meckel’s cartilage in our Wnt 
mutants, we sought to understand the morphologic phenotype displayed by these Wnt gene 
mutants. To achieve this, we measured the L/W of Meckel’s cartilage and the individual 
cell sizes during Meckel’s cartilage morphogenesis at different time points.  We performed 
live confocal imaging of each mutant using the Tg(sox10:GFP) line and tracked the L/W 
measurement from the earliest time Meckel’s cartilage forms a distinguishable structure 
(55hpf) to the time point when the arch is fully formed (96hpf) (Eames et al., 2013) 
(Figure 20A-E).  
By 55hpf in WT embryos, condensation of sox10 positive cells are observed just anterior 
to the heart and appears to converge in the midline. At this stage, Meckel’s cartilage has a 
L/W of 0.28 ± 0.01. By 60hpf, marked extension is observed with the midline protruding 
anteriorly and the arch of Meckel’s cartilage begins to take its shape. By 72hpf, a distinct 
arch is observed with cells within the body of Meckel’s cartilage starting to hypertrophy 
and form discs and stack above each other to aid within the elongation process. By 96hpf, 
Meckel’s cartilage has a L/W ratio of 0.78 ± 0.10 and at this stage, cells within the 
midzone have stacked. We observed a period of accelerated extension occurring between 
55-72hpf.  
In wls, wnt9a and wnt5b mutants, the Meckel’s cartilage appeared to extend at a similar 
rate between 55-60hpf but morphological defects in the Meckel’s cartilage were evident in 
wls and wnt5b mutants at 72hpf (Figure 20F) where they appear to lose the global arch 
shape, and remain smaller. gpc4 mutants displayed the slowest extension of Meckel’s 
cartilage with defects observed as early as 60hpf (Figure 20E). Meckel’s cartilage appears 
flattened throughout development and chondrocytes fail to form proper disc and stack, 
accounting for the alteration in global shape and size. Meanwhile, extension rate in wnt9a 
mutants appeared normal (Figure 20C) when compared to WT but obvious defects can be 
observed in the shape of Meckel’s cartilage. wnt9a mutants formed a more ‘V’ shape, 
evident by 72hpf compared to the ‘U’ shape as seen in WT.  
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Figure 20. Time lapse imaging across various time points of Meckel’s cartilage in wls, wnt9a, wnt5b 
and gpc4 mutants 
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 (A-E) Wnt mutants were crossed to Tg(sox10:GFP) transgenic line and homozygote embryos were imaged 
at difference time points starting at 55hpf when convergence of the Meckel’s cartilage occurs until 96hpf 
when the arch is complete. X’ 20X image of the Meckel’s cartilage and X’’ represents 20X image of the 
body of Meckel’s cartilage.   
Defects evident from 60hpf especially in gpc4 -/- and by 72hpf, obvious midline defect was seen in wls, 
wnt9a and gpc4 and body defects apparent in gpc4. wnt5b exhibited a smaller cartilage size throughout 
morphogenesis.  
In addition to altered global dimensions of Meckel’s cartilage, we observed two 
morphologically distinct regions: the midzone (Figure 20A, 96hpf pink box) and the body 
(Figure 20A, 96hpf white box) that differed in cell size and organization. As observed in 
WT embryos by 72hpf, chondrocytes within the body were seen to stack (like coin discs) 
in a single cell layer. In contrast, chondrocytes within the midzone remained smaller, more 
cuboidal in shape and consist of multi layers. By 96hpf, cells within the midzone acquired 
a more columnar shape with a L/W of 2.53 ± 0.35 and stacked to align with cells within 
the body that have a L/W of 4.47 ± 0.56. This alignment completes the arch of Meckel’s 
cartilage.  
In contrast, wls, wnt9a and gpc4 mutants display a different chondrocyte phenotype. 
Chondrocytes within the midzone at 96hpf did not align and the chondrocytes remained 
small and rounded with a L/W ratio of 1.31 ± 0.05, 1.36 ± 0.14 and 1.51 ± 0.25 
respectively. Interestingly, wls and wnt9a mutants displayed more elongated cells within 
the body (3.74 ± 0.59 and 3.66 ± 0.34 respectively) compared with gpc4 where cells within 
the body is significantly smaller and rounded (1.88 ± 0.24) (Figure 21A-C). In wnt5b 
mutant, there was some degree of alignment of the cells within the midzone but cells were 
also smaller compared to WT in both the midzone and the body (1.93 ± 0.33 and 2.90 ± 
0.37 respectively) (Figure 21B, C). The analysis presented here suggests that there are two 
distinct morphologic zones in Meckel’s cartilage that differ in cell shape, organization. It 
also suggests that these distinct zones have different responses to non-canonical Wnt 
signalling. As non-canonical Wnt signalling is important in cellular polarity, we then 
wanted to examine whether polarity differs within these zones.  
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Figure 21. Global and cellular size differences between wls, wnt9a, wnt5b and gpc4 mutants.  
(A) L/W ratio of Meckel’s cartilage of 5 different embryos were measured and plotted over time. wls (red), 
and wnt5b (orange) mutants showed defects from 72hpf onwards while defects in gpc4 (purple) were evident 
from 60hpf and remained small throughout lower jaw morphogenesis. wnt9a (green) does not show any 
obvious Meckel’s cartilage L/W defect compared to WT.  
(B-C) Individual cell L/W ratio were measured and plotted over time from the body (B) and midzone (C) of 
Meckel’s cartilage of 5 different embryos. Closer examination of the cell shape and size within Meckel’s 
cartilage showed that cells within the body differ from the midzone area. wls (red) and wnt9a (green) both 
showed an almost similar cell L/W in the body compared to WT with a more cuboidal shape. wnt5b (orange) 
appeared overall smaller in L/W while gpc4 (purple) remained smaller and rounder. In contrast, when the 
cells within the midzone were examined, wls, wnt9a and gpc4 mutants all showed a significant size 
difference at 96hpf where cells remained small and round compared to WT.    
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3.2.4. Wnt signaling is required for chondrocyte polarity in 
Meckel’s cartilage 
Given the differential requirement observed for the chondrocyte morphology and 
organization between the midzone and body regions of Meckel’s cartilage, we examined 
whether chondrocyte polarity is also disrupted differently between the wls, wnt9a, wnt5b 
and gpc4 mutants. Cell polarity may hint towards cellular behaviour and interaction with 
extracellular cues during development Chondrocyte polarity was visualized using 
acetylated-alpha tubulin to mark microtubule-organizing centres (MTOC) indicative of 
primary cilia, at 3.5dpf, a time point when all Wnt mutants displayed distinct abnormalities 
between the midzone and the body (Figure 22) (Sepich et al., 2011).  
 
Figure 22. Cell polarity pattern within the midzone of Meckel’s cartilage in wls, wnt9a, wnt5b and gpc4 
mutants.  
 (A-E) 72hpf WT and homozygote embryos were stained for actin with phalloidin (green) to delineate cell 
membranes and acetylated-tubulin (red) to reveal microtubule organizing centres (MTOC).  
(F) Polarity pattern for Meckel’s cartilage at 72hpf showing 2 inflection points; A and B; point A where the 
hemi-Meckel’s cartilage meet in the midline and point B within the body of each hemi-Meckel’s cartilage.  
(H-L) Rose plots of cell polarity as indicated by MTOC measured from cells within the midzone portion of 
Meckel’s cartilage. Red box indicates the expected distribution of the MTOC that is observed to be 
positioned in a narrow area along the x-axis; proximal (0°) and distal (180°). (M; black dotted box). Scale = 
50µm.  
In WT embryos, the primary cilia were aligned to the centre of the cell following the curve 
of the Meckel’s arch. In addition, cell polarity staining revealed three apparent zones of 
uniform polarity with 2 inflection points of the primary cilia (A and B) (Figure 22F). Point 
A was observed to be at the anterior midline and Point B was located at a position that has 
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been observed to provide musculoskeletal attachment and pre-osteoblast condensation 
(Figure 22A, F). In contrast, all Wnt mutants displayed disorganized primary cilia 
arrangements in the midzone resulting in a malformed midzone and loss of the Meckel’s 
cartilage arch shape (Figure 22B-E). In all mutants, chondrocyte polarity appeared 
randomized and we were unable to localize points A and B.  
We then measured the angle at which the MTOC were positioned within the midzone of 
Meckel’s cartilage (Figure 22H). In WT embryos, 76.3% of cells had primary cilia 
oriented in a narrow distribution along the x-axis in the proximal (0°) and distal (180°) 
directions (red boxes, Figure 22H). This distribution pattern was lost in all Wnt mutants as 
their chondrocytes localized primary cilia were randomly positioned without restriction 
about the X-axis (Figure 22I-L).  
 
Figure 23. Cell polarity summary of Meckel's cartilage and direction of bony ossification 
The figure represents a ventral view of Meckel’s cartilage in beige, mental nerve in black, ossification 
centers in red (dentary anteriorly). The green arrows represent the direction of MTOC within chondrocytes 
and the black arrows represents the direction of ossification 
We then observed that the anatomic location of point B coincides with the first ossification 
point of the dentary bone as well as mesenchymal condensation (Figure 22, Figure 23). 
Therefore, we next examined how loss of chondrocyte polarity affects other craniofacial 
structural features to shed insight into whether the underlying Meckel’s cartilage 
development influences mandibular ossification. 
3.2.5. Wnt is required for timely bone ossification 
Given that cartilage structures constitute a scaffold that prefigure for ventral skeletal 
ossification, we studied how the loss of polarity and cartilage defects affected bone 
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development in wls, wnt9a, wnt5b and gpc4 mutants. Early bone development occurs as 
early as 3dpf in zebrafish, permitting analysis of ossification events in wls, wnt9a, wnt5b 
and gpc4 mutants that typically survive until 12-15dpf (Bird and Mabee, 2003). Bone 
phenotype at two time points were compared to ascertain the dynamic changes of 
ossification: 1) 4dpf when cartilage elements have established their structures and 2) 8dpf 
when most craniofacial bones (both intramembranous and endochondral) have initiated 
ossification, evidenced by Alizarin red staining.  
At 4dpf, WT embryos started to develop intramembranous bones (red in Figure 24U 
diagram); dentary, branchiostegal rays, opercle, and cleithrum (Figure 24A). By 8dpf, the 
endochondral bones (orange Figure 24U); ceratohyal, mentomeckelian, retroarticular and 
ceratobranchial-5 initiated ossification and the previously noted intramembranous bones 
enlarge (Figure 24F). The positions of these bones correlated to the transgene expression 
of osteocalcin, a marker of mature osteoblast (green in Figure 24K) and osterix, a marker 
of osteoblast (red in Figure 24P). Focusing on the mandible, the dentary, mentomeckelian 
and retroarticular bones will all fuse at a later stage and a shorter Meckel’s cartilage 
remains within the core of the ossified mandible. Comparing the bony development to the 
Wnt mutants, we found significant defects.  
In wls mutant, only the opercle and cleitrium formed at 4dpf and this remained unchanged 
at 8dpf (n=25), arguing against developmental delay as we would expect more bones to 
have started to develop between these two-time points as observed in WT. The lack of 
ossification phenotype correlated with the loss of bone specific transgene expressions: 
osteocalcin (green in Figure 24L) and osterix (red in Figure 24Q). It is important to note 
that larvae at 8dpf were examined from confocal stacks in WT and mutants in the 
Tg(ocn:GFP;sox10:mCherr)y and Tg(osx:mCherry;sox10:GFP) reporter backgrounds, 
where it is clear that the Meckel’s cartilage is developed but dysmorphic, providing 
additional morphologic data to support that the lack of ossification is not due to 
developmental delay. These results suggested that osteoblasts not only failed to secrete 
bone matrix as detected by Alizarin red stain, but also failed to differentiate into mature 
osteoblast in the wls mutant.  Despite the opened mouth phenotype in wnt9a mutants, all 
intramembranous bones formed appropriately at 4dpf (Figure 24C) and enlarged like WT 
embryos by 8dpf (Figure 24H). wnt5b mutant also displayed a similar appearance of larval 
cranial bone elements as wnt9a mutant (Figure 24D, I, N, S). However, for both wnt5b 
and wnt9a mutants, many defects were seen within endochondral bones; mentomeckelian 
(n=0/18 and n=0/11), retroarticular (n=4/18 and n=0/11), ceratobranchial 5 (n=0/18 and 
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n=1/11) and ceratohyal bones (n=7/18 and n=6/11) (summary in graph; Figure 24AA). 
Expressions of osterix and osteocalcin expression in wnt5b and wnt9a mutants indicated a 
reduction in the number of mature osteoblast compared to WT in structures where 
endochondral bone occurs (Figure 24M, N, R, S). High-resolution images of Alizarin red 
staining in WT reveals a thin, flat perichondral bone, termed the mentomeckelian that is 
distinct from the thicker dentary bone (Figure 24K). A clear boundary at 8dpf helps 
differentiate the two bones, allowing quantification and analysis. wnt9a, wnt5b and gpc4 
all lack the mentomeckelian despite staining for the dentary (Figure 24M-O). wls 
completely lacks both the dentary and mentomeckelian (Figure 24L). Double transgenic 
line with sp7:GFP and sox10:mCherry at 8dpf shows a perichondral cell expressing sp7 
(Figure 25). This cell is observed directly adjacent to the perichondral cells as oppose to 
the sp7 positive cells of the dentary lying above the perichondrium. In gpc4 mutant, a 
similar bone phenotype as wls mutant was observed at 4dpf with only the opercle and 
cleithrum present. Interestingly, despite a more severe Meckel’s cartilage shortening, all 
intramembranous bone formations were detected by 8dpf in gpc4 mutants (Figure 24E). 
This correlated with the detection of osterix and osteocalcin transgene expressions (Figure 
24J, O). However, like wnt9a and wnt5b mutants, defects were observed by the absence of 
endochondral bone in all gpc4 mutant embryos imaged (n=12;  
Figure 24Q). In addition, no endochondral bone developed in gpc4 even when observed at 
8dpf.  
Taken together, these results showed that wls is required for both intramembranous and 
endochondral ossification while wnt9a, wnt5b and gpc4 are required only for endochondral 
ossification as evident by the loss of differentiation of ventral chondrocytes to osteogenic 
progenitors. In addition, ossification can occur despite significant Meckel’s cartilage 
dysmorphology as seen in gpc4 mutant. When wls requirement for ossification is 
considered in the context of intramembranous ossification that are present in wnt9a and 
wnt5b mutants, it is likely that other ligands that requires wls for secretion are important 
for direct osteogenesis from NCC progenitors.  
Discovering the bony defects in our Wnt mutants we then sought to elicit why these 
defects come about. We then considered whether the cartilage joint (jaw and hinge joints) 
plays a role in providing the chondrocyte defects as this was previously thought to be the 
growth centres of the mandible. Additionally, we examined whether muscle structure 
contributes to these defects.   
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Figure 24. Bone defects in wls, wnt9a, wnt5b and gpc4 mutants.  
 (A-J) Maximum intensity projections of live confocal imaging stacks of 4dpf (A-E) and 8dpf  
(F-J) Wnt homozygotes in Tg(sox10:GFP) background stained with Alizarin Red S.  
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(K-O) 40X confocal maximum intensity projections of alizarin red stain focusing on the dentary bone (de) 
and mentomeckelian (mm). The mentomeckelian is a flatter bone attached to the distal end of the dentary that 
is thicker and broader.  
(P-T) Confocal maximum intensity projections of osteocalcin transgene expression in Wnt mutants in a 
Tg(sox10:mCherry) background.  
(U-Y) Confocal maximum intensity projections of osx transgene expression in Wnt mutants in a 
Tg(sox10:GFP) background.  
(Z) Graphical map of neural-crest cell (NCC)-derived bone (red; intramembranous ossification and orange; 
endochondral ossification) and mesoderm derived bone (blue). Dentary (de), retroarticular (ra), quadrate (q), 
ceratohyal (ch), branchiostegal rays (bsr), opercle (op), ceratobranchial 5 (cb5), cleithrum (cl).  
(AA) Percentage of mutant with bony phenotype of different bones in the craniofacial region where 100% 
indicates that all mutant embryos do not have that bone. Scale = 50µm. 
 
Figure 25. Osterix-expressing cells in 8 dpf WT embryos.  
40X Confocal maximum intensity projection images of 8 dpf Meckel’s cartilage. Osterix expressing cells are 
observed at the position of the dentary adjacent to the body of Meckel’s above the perichondrium. A single 
osterix-expression cell (arrow) is observed at the level of the perichondrium indicating the differentiation of 
perichondral cells to osteoblast to form the future mentomeckelian perichondral bone. 
3.2.6. Cartilage joint and muscle defects in wls, wnt9a, wnt5b and 
gpc4 mutants 
In addition to cartilage formation, shaping the craniofacial structures requires properly 
formed joints and muscles. In zebrafish, the jaw and hinge joints are the two major joints 
in the craniofacial region. We examined the retroarticular and coronoid process of 
Meckel’s cartilage that articulates with the palatoquadrate to form the jaw joint and the 
interhyal that forms a sesamoid-like bone between the ceratohyal and hyosymplectic.  
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Figure 26. Joint and muscle defects in wls, wnt9a, wnt5b and gpc4 mutants.  
(A-E) Alcian blue stained ventral cartilage lateral whole-mounts of 8 dpf embryos and 40X zoomed image in 
A’-E’ of the jaw joint (jj; left) and hinge joint (hj; right). Meckel’s cartilage (mc), pterygoid process (ptp), 
palatoquadrate (pq), hyosymplectic (hs), and ceratohyal (ch). Jaw joint defects evident in wls and gpc4 
mutant whilst wnt9a exhibited a slightly malformed retroarticular process. wls displayed a clump of cells 
within the hinge-joint compared to the neatly stacked layered chondrocytes in wild-type. In contrast, wnt9a, 
wnt5b and gpc4 were only a single cell layer in thickness 
(F-J) Maximum intensity projections of 20X zoom confocal stacks showing muscle stain with phalloidin 
(purple) and anti-GFP (green) for cartilage elements. Muscle length defects apparent in all Wnt mutants with 
gpc4 displaying disorganized intermandibularis posterior (imp) invading the gaps in Meckel’s cartilage. 
Adductor mandibulae (am), intermandibularis anterior (ima), intermandibularis posterior (imp), hyohyoideus 
(hh), interhyoideus (ih), sternohyoides (sh) F’-J’’ Single channel phalloidin fluorescence.  
(K) Graphical representation of retroarticular measurement 
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(L) Measured length of retroarticular process and (M) cell count per interhyal in WT and Wnt mutants of 10 
embryos per mutant line. (*p<0.01 ***p<0.001, ****p<0.0001; Kruskal-Wallis test with Dunn’s multiple 
comparison test. Significance level at p<0.05). Scale = 50µm.  
For the interhyal bone, alcian blue staining at 8dpf shows a two-cell layer structure 
attached by ligaments to the palatoquadrate and the ceratohyal, forming a rounded 
sesamoid-like cartilaginous structure. The magnified view showed that in wls, wnt9a and 
gpc4 mutants, there is a significantly reduced number of chondrocytes within the interhyal 
bone at the hinge joint (Figure 26B’-E’ right). In addition, the retroarticular process in wls 
and gpc4 mutants were significantly malformed and shortened (Figure 26L) compared to 
WT (p <0.0001 for both). Even though there was no evidence of fusion of the cartilage 
structure, chondrocytes within the interhyal were more rounded and not properly stacked in 
wls mutants. wnt9a, wnt5b and gpc4 mutants displayed a single-cell layer thick interhyal 
bone. While functional assessment of the joint has not been examined, we theorized that 
this defect would impinge on ventral cartilage movement during respiration. For the 
Meckels-palatoquadrate joint (jaw joint), the retroarticular process and coronoid process 
forms a disc to accommodate the palatoquadrate process. In wls and gpc4 mutants, the 
retroarticular processes were malformed and shortened indicating a defect in jaw joint 
which may perturb mouth opening. Interestingly, we did not observe any overt jaw joint 
defects in wnt9a considering the opened mouth phenotype nor in wnt5b mutants.   
Due to evidence highlighting the role of muscles in maintaining joint integrity, the 
craniofacial muscles in our Wnt mutants were observed (Shwartz et al., 2012). For this, we 
stained Wnt embryos in sox10:GFP background with phalloidin (Figure 26F-J). The 
staining revealed that wls and wnt5b mutants have normal muscle appearance and pattern, 
although both exhibited some muscle shortening potentially secondary to the craniofacial 
cartilage dysmorphologies (Figure 26G - I). Interestingly wnt9a mutants did not appear to 
have any muscle defects, which was surprising since we expected that muscle defects 
would affect mouth opening. The most severe muscle defect was observed in gpc4 mutant 
where the intermandibularis posterior muscle that normally attaches to the Meckel’s 
cartilage appeared disorganized and invaded ectopic gaps between the chondrocytes 
(Figure 26J, red arrows). The muscle defect in gpc4 mutant may explain the more severe 
Meckel’s cartilage length/width ratio and cell shaped compared with wls mutant. These 
data also suggest that cranial muscles were properly patterned in wls, wnt9a, and wnt5b 
mutants and they do not contribute to the cartilage morphology phenotypes. It also 
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suggests that Wnt mutants may have a greater effect on NCC-derived tissues since the 
craniofacial muscles are head paraxial mesoderm-derived.  
3.2.7. Loss of wls leads to decrease chondrocyte proliferation  
Our data showed that abrogation of the Wnt signalling led to Meckel’s cartilage 
malformations and that wls, wnt9a, wnt5b and gpc4 have distinct roles in shaping the 
ventral cartilage structures. For endochondral bone formation, following condensation of 
NCC cells to sites of future skeletal structures, subsequent proliferation of chondrocytes is 
key for their expansive linear growth and enlargement. Therefore, we wanted to determine 
on a cellular level whether growth through proliferation is affected in our Wnt mutants. To 
achieve this, chondrocytes undergoing mitotic division were assayed with BrDU in 6dpf 
mutants to determine if Wnt mutants also affect chondrocyte proliferation. We assayed at 
6dpf as this is the time point in previous studies when chondrocytes start dividing to extend 
the jaw (Eames et al., 2013).  
In WT larvae, chondrocytes at 6dpf were noted to be actively proliferating in Meckel’s 
cartilage and the surrounding mesenchyme, consistent with previously report findings in 
zebrafish (Figure 27A) (Hammond and Schulte-Merker, 2009). However, chondrocyte 
proliferation was severely affected in wls mutants (p<0.0001; Figure 27B) compared to 
wnt9a, wnt5b and gpc4 mutants. Since proliferation was decreased in wls mutants at 6dpf, 
we examined if NCC condensation surrounding Meckel’s cartilage at 60hpf was also 
affected. We found no difference in positive BrDU cell in wls mutants compared to WT 
(Figure 28). Moreover, 96hpf wls mutant embryos had the same number of cells within 
Meckel’s cartilage (Figure 27L, Q) indicating that wls has a more important role later in 
chondrocyte proliferation, maturation and differentiation for endochondral ossification. 
The data also suggest that wnt9a, wnt5b and gpc4 are dispensable for chondrocyte 
proliferation but may be required later in chondrocyte maturation.  
Given that proliferation defect may be associated with cell survival, we next performed 
live acridine orange assay to visualize cell apoptosis. There was no increase in the number 
of apoptotic chondrocyte or mesenchymal cells in wls mutant to account for the severity of 
the bone phenotype displayed (Figure 27C, D).  
 91 
 
Figure 27. Chondrocyte proliferation defect in wls mutant precludes differentiation defects 
 (A, B) Representative BrDU assay confocal stacked image in WT 6dpf (A) and wls -/- (B) embryo with 
zoomed views of WT BrDU (red) colocalizing with chondrocytes (A’) in the Meckel’s cartilage (green). 
Arrowhead points to a representative chondrocyte that expressed both sox10 and BrDU and used for 
quantification 
(C) Quantification of BrDU positive cells in Wnt mutants taken from 5 different embryos per mutant line and 
imaged separately. Proliferation significantly differed in wls -/- compared to WT (****p < 0.001; Kruskal-
Wallis test and Dunn’s multiple comparison test, NS = not significant)  
(D, E) No difference in chondrocyte apoptosis as showed with Acridine orange live staining at 6dpf in wls -/-
. Scale = 50µm 
 
Figure 28. No difference in cell proliferation between WT and wls mutants at 60hpf. 
Maximum intensity projections of confocal Z-stacks for BrDU assay in WT larvae sox10:GFP at 60hpf (A) 
and wls -/- (B) 
These data suggest that the gross shortening of Meckel’s cartilage in mutants is not due to 
cell death in chondrocytes or surrounding tissues. However, these works seem to point 
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towards the requirement of Wnt signalling for late proliferation of chondrocytes in 
Meckel’s cartilage but not for cell survival. Indeed, mesenchymal expression of wls is 
necessary for the expansion and differentiation of chondrocytes to enable growth of 
Meckel’s cartilage (Rochard et al., 2016). The data underlines the spatiotemporal 
regulation of Wnt signalling in ventral cartilage development.  
3.2.8. Endochondral ossification requires non-canonical Wnt  
To examine downstream effects of Wnt pathway perturbations, WISH analysis was 
performed in 4dpf embryos to examine the key steps of chondrogenesis (sox9a), 
extracellular matrix remodelling (col2a1, col10a1a, col1a2), osteoblast differentiation 
(runx2a) and joint patterning (bapx1) (Flores et al., 2004, Miller et al., 2003, Eames et al., 
2012, Yan et al., 2002, Schilling and Kimmel, 1997). WISH images are presented in 
Figure 29 and summarized in Table 16.  
By 4dpf, sox9a expression, a key gene in chondrocyte differentiation, was observed 
throughout the ventral cartilages with increased expression at the distal edges of the 
cartilage elements. Normal sox9a expression was found in wnt9a, wnt5b and gpc4 mutants 
(Figure 29A, C-E). However, wls mutant seemed to display enhanced sox9a expression 
throughout the craniofacial structures (Figure 29B). Since sox9a is necessary for col2a1 
expression (Yan et al., 2002), we examined col2a1 expression and found no overt 
difference in staining or ectopic expression across the different Wnt mutants (Figure 29F-
J).  
We then examined the expression of col10a1a that indicates the maturation step of hyaline 
cartilage chondrocytes. In contrast to tetrapods, zebrafish osteoblast has also been found to 
express col10a1a (Eames et al., 2012). At 4dpf, col10a1a expression was observed in most 
craniofacial NCC-derived osteoblast, mesoderm derived osteoblast (parasphenoid, 
cleithrum) and chondrocytes in the ceratohyal adjacent to the ceratohyal bone (Figure 
29K). In wls mutant, only expression within the parasphenoid, opercle and cleithrum was 
observed (Figure 29L). A similar pattern was observed in wnt5b mutant (Figure 29N). 
However, wnt9a and gpc4 mutants exhibited expression in many the facial osteoblast but 
loss of expression in the ceratohyal (Figure 29M, O).  
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To examine whether mineralization occurred in wls, wnt9a, wnt5b and gpc4 mutants, we 
looked at col1a2 expression patterns that is expressed in mineralized bone and 
perichondrium, tendons and epidermis but not the chondrocytes (Eames et al., 2012). At 
4dpf, col1a2 expression was observed in the dentary, opercle and cleithrum, the only bones 
that stained for Alizarin red at 4dpf (Figure 29P) (Eames et al., 2013). No staining of the 
dentary was detected in wls or wnt5b mutants (Figure 29Q, S) but expression was present 
in wnt9a and gpc4 mutants (Figure 29R, T). Meanwhile, tendon development appeared 
intact since the expression of col1a2 in the sternohyoides tendon, palatoquadrate ligament, 
and intermandibularis posterior tendon appeared normal in all Wnt mutants. 
runx2a (runt-related transcription factor) expression was then used to indicate osteoblast 
differentiation (Eames et al., 2004, Flores et al., 2004). By 4dpf, runx2a was expressed in 
all craniofacial dermal osteoblast as well as perichondral-osteoblast within the ceratohyal 
(Figure 29U). This marker was misexpressed in wls mutant but normal levels observed in 
wnt9a, wnt5b and gpc4 (Figure 29V-Y).  
Due to the joint defects observed in the Wnt mutants, we examined the expression levels of 
bapx1 (bagpipe-related transcription factor), involved in joint specification (Miller et al., 
2003, Nair et al., 2007). bapx1 transcripts localized to the jaw joint (Figure 29Z), a pattern 
that is strongly expressed in wls and wnt5b mutants in addition to a smaller ventral midline 
domain (Figure 29AA black arrowhead) in the hyoid arch of wls mutants indicating a 
potential delay in joint specification (Figure 29AA, AC). Interestingly, jaw joint bapx1 
expression was completely lost in gpc4 mutants indicating a failure in patterning the joint 
(Figure 29AD). wnt9a mutant showed a weaker expression that may indicate defective 
joint integrity (Figure 29AB).  
In summary, in all wls mutants observed, we noted the enhanced expression of sox9a and 
runx2a with concurrent loss of col10a1a and col1a2 expression. In wnt9a, wnt5b and gpc4 
mutants, there was a loss of col10a1a in endochondral bones. Altogether, our data showed 
a defect in the differentiation process of chondrocytes in the absence of Wnt signalling, a 
process required for its maturation and subsequent initiation of the endochondral 
ossification process.  
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Figure 29. Lower jaw gene expression pattern of chondrocyte and bone markers in wls, wnt9a, wnt5b 
and gpc4 mutants.  
Whole-mount RNA in situ hybridization of chondrocyte differentiation markers; sox9a (A-E) and 
chondrocyte matrix; col2a1 (F-J). Hypertrophic chondrocyte marker; col10a1a (K-O), Bone and tendon 
marker; col1a2 (P-T), osteoblastic progenitor marker; runx2a (U-Y) and joint marker; bapx1 (Z-AD). 
Apparent increase in sox9a, runx2a expression pattern in wls -/- with concomitant loss of col10a1a. Arrow 
points to the position of Meckel’s cartilage. Scale = 50 µm.   
 95 
Table 16. Summary gene expression comparison within Meckel’s cartilage 
Markers in ventral cartilage structures  wls -/- wnt9a -/- wnt5b -/- gpc4 -/- 
Chondrogenesis sox9a ++ + + + 
ECM remodeling collagen type 2a1 + + + + 
ECM remodeling collagen type 10a1a - + - + 
ECM remodeling collagen type 1a2 - + - + 
Osteogenesis runx2a ++ + + ++ 
Joint patterning  bapx1 ++ +/- + - 
Qualitative scoring of whole-mount RNA in situ hybridization expression patterns compared with their WT 
sibling within a given clutch. Annotation: ‘++’ = high detectable expression, ‘+’ = normal expression, ‘+/-‘ = 
low detectable expression and ‘-‘ = undetectable expression. 
Table 17. Summary gene requirements in ventral cartilage development.  
Processes  wls  wnt9a wnt5b gpc4 
Chondrocyte polarity and orientation ✔ ✔ ✔ ✔ 
Chondrocyte proliferation ✔ ✕ ✕ ✕ 
Chondrocyte maturation/hypertrophy ✔ ✔ ✔ ✔ 
Articular cartilage ✔ ✔ ✔ ✔ 
Endochondral ossification ✔ ✔ ✔ ✔ 
Intramembranous ossification  ✔ ✕ ✕ ✕ 
Muscle ✕ ✕ ✕ ✔ 
✔ = required, ✕ = not required  
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3.3. Discussion 
Wnt signalling plays important roles in craniofacial cartilage and bone development. Once 
chondrocytes form distinct cartilage structures, differentiated chondrocytes can then either 
maintain their chondrogenic state to form articular cartilage or undergo hypertrophic 
maturation in the process of endochondral ossification (Kronenberg, 2003). The canonical 
Wnt/β-catenin pathway is key in promoting chondrogenesis, initiating chondrocyte 
hypertrophy and regulating osteogenesis (Day et al., 2005, Glass et al., 2005, Hill et al., 
2005). The non-canonical pathways, both the PCP and Ca2+ have been shown to induce 
cytoskeleton reorganization, chondrocytes stacking and axial patterning (Fanto and 
McNeill, 2004, Le Pabic et al., 2014, Rochard et al., 2016, Sisson et al., 2015). Here we 
showed that wls, wnt9a, wnt5b and gpc4 each have distinct requirements in chondrogenesis 
and osteogenesis during craniofacial ventral cartilage development.  
3.3.1. wls, wnt9a, wnt5b and gpc4 are required for proper 
craniofacial cartilage and joint development 
In ventral cartilage development, Wnt signalling is required for early CNCC induction and 
later in CNCC migration, specification and proliferation by participating in a gene 
regulatory network with Edn1 and Bmp (Alexander et al., 2014). Heat-shock studies 
inhibiting Wnt through the overexpression of dkk1, a Wnt antagonist and dntcf3, a 
dominant negative form of the Tcf3 transcription factor, showed ventral patterning defects 
in the mandibular arch (Alexander et al., 2014). Recent studies using Wls to manipulate 
Wnt signalling, implicated its role in skeletal development by regulating osteogenesis and 
chondrogenesis (Maruyama et al., 2013, Zhong et al., 2012, Rochard et al., in press). In 
zebrafish, a previous study suggested that wls modulates fgf3 expression to direct cell 
proliferation (Wu et al., 2015). We recently highlighted the importance of wls in 
mediolateral and dorsal-ventral patterning during palate morphogenesis (Rochard et al., 
2016). Despite differences in upper and lower jaw development, we showed that wls 
affected ventral cartilage elements, like the ethmoid plate, where Meckel’s cartilage 
appeared shorter and their chondrocytes were smaller and rounder. Cartilage analysis of 
gpc4 and wnt5b mutants also recapitulated previously published work (Sisson et al., 2015). 
However, we noted that a later expression analysis of gpc4 appeared in the tissues 
surrounding cartilage structures as opposed to an earlier expression found within the NCC 
and chondrocytes. This may suggest a more dynamic modulation of gpc4 during 
craniofacial development as previously published by Sisson and colleagues (Sisson et al., 
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2015) with earlier requirements in chondrogenesis and later in development of surrounding 
structures such as muscles. 
When we examined cartilage structures at 8 dpf, we observed more profound articular 
cartilage phenotypes across our Wnt mutants with the loss of joint integrity and extension 
of the retroarticular process. Wnts have all been implicated in joint development through a 
role in articular cartilage formation (Hartmann and Tabin, 2001, Spater et al., 2006). In 
mice, Wnt9a has been shown to maintain joint integrity by suppressing chondrocyte 
differentiation within the joint interzones (Spater et al., 2006). Wnt4 and Wnt16 are also 
expressed in joints (Guo et al., 2004, Hartmann and Tabin, 2001) and mice double mutant 
Wnt9a -/-;Wnt4 -/- developed bony fusions and synovial chondroid metaplasia or acral 
bones(Spater et al., 2006). Here we showed that wls and gpc4 displayed the most severe 
joint defects but through two different mechanisms. Both show opposite bapx1 expression 
pattern with gpc4 showing a complete loss and wls an exaggerated expression pattern. 
bapx1 is a downstream target of edn1, specifying the jaw joint by shaping and maintaining 
articular cartilage through the activation of chordin and gdf5 (Miller et al., 2003, 
Nakayama et al., 2004, Storm and Kingsley, 1999). The loss of expression in gpc4 and the 
strong expression seen in wls may imply that either under or over-expression of bapx1 can 
both result in jaw joint issues.  
Studies from mouse model determined that mammalian Wnt9a loss-of-function mutation 
was lethal at birth (Spater et al., 2006). Wnt9a mutant embryos displayed partial joint 
fusion of the carpal and tarsal joints, shortened appendicular long bones. In contrast, they 
showed that ectopic activation of Wnt9a resulted in joint induction. We previously showed 
that zebrafish wnt9a morpholino knockdown resulted in the loss of ventral cartilage 
structures by affecting NCC migration (Curtin et al., 2011). Here, we found that wnt9a 
mutation is embryonic lethal as well but the phenotype appeared less severe than in mouse. 
Our wnt9a mutants develop craniofacial structures but were unable to close their mouth, an 
anteriorly displaced Meckel’s cartilage, which resulted in an inability to feed properly. 
Interestingly, wnt9a’s anteriorly displaced Meckel’s appears very similar to the phenotype 
of the spitzmaulm636 mutant previously described in a large scale mutagenesis screen that 
has not yet been characterized (Neuhauss et al., 1996). Further analysis shows that cells 
within the midzone of Meckel’s cartilage were smaller, rounder and less stacked compared 
to WT, suggesting a distinct midline anterior role of wnt9a in craniofacial development 
compared to other Wnt mutants. Additionally, we found that although wnt9a mutants have 
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a similar L/W of Meckel’s cartilage and cell L/W in the body of Meckel’s compared to 
WT, the cell L/W at the midline is disrupted and significantly smaller. This resulted in an 
elongated lower jaw that is abnormally arched due to the ventral displacement of Meckel’s 
cartilage. Indeed, previous mutants with elongated lower jaw also displayed a ventrally 
displaced ceratohyal, such as the doolittlem636 mutant resulting in abnormal mastication and 
respiration (Neuhauss et al., 1996). While we have not directly assessed for movement of 
the lower jaw, we observed distinct patterning differences of the interhyal in wnt9a and 
together, with low bapx1 expression levels in wnt9a mutants, we believe that joint integrity 
may explain this malocclusive jaw phenotype that plays a crucial role in feeding.    
3.3.2. Shaping Meckel’s cartilage by Wnt  
For proper shaping and patterning of Meckel’s cartilage, chondrocytes must first undergo 
convergence, intercalation, elongation and proliferation. Thereafter, cells are required to 
align, stack and polarize to maintain the organ structure. Previous work done in the 
laboratory focused on palate development in the context of cleft lip and palate disorders. 
Using lineage tracing and photoconversion experiments with the sox10:kaede line, it was 
shown that: first, the ethmoid plate in zebrafish is a homologous structure to the 
hard/primary palate of mammals and second, that the development of the palate undergoes 
distinct steps whereby the lateral maxillary prominences converge with the middle 
frontalnasal prominence (Dougherty et al., 2013, Dougherty et al., 2012). Thereafter, 
chondrocytes are seen to intercalate with each other and then soon after begin elongating to 
extend the palate further. Failure in the convergence of the prominences has been shown to 
result in clefting defects (Rochard et al., 2016). Like the ethmoid plate in zebrafish, the 
Meckel’s cartilage and the ventral cartilage structures are also seen to undergo a similar 
development process. It has been documented that the condensation of NCC around the 
future lower jaw can be seen at around 55hpf where the two hemi-Meckel’s cartilage fuses 
in the midline. Thereafter, the cells within the body of Meckel’s cartilage stack like “disc 
of coins” to extend the lower jaw further. However, we have been interested in how the 
lower jaw acquires its unique shape and how cells behave. 
Our study identified two regions within Meckel’s cartilage with distinct cell behaviours; 
the midzone and the body. In all our Wnt mutants, the cells within the midzone remained 
smaller and rounded throughout cartilage development. This affected the shaping and 
length of Meckel’s cartilage. When we analysed cell polarity within this midzone, we 
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found that in our Wnt mutants, cells in the midzone were disorientated and lose the 
directional polarization we observed in WT. Our study extended the polarity map of Le 
Pabic et al. and found that these opposing points of polarity (Points A and B, Figure 22) is 
what gives Meckel’s cartilage its unique arched shape and rounded midline pattern (Le 
Pabic et al., 2014). When polarity is lost, as in our Wnt mutants, the Meckel’s cartilage 
remains shortened and misshapen.   
Interestingly gpc4 displayed the most severe Meckel’s cartilage with rounded cells 
observed in the midzone and body. We reasoned that the intermandibularis posterior 
muscle defect prevented cell intercalation and extension. Indeed, previous studies on 
chemically paralyzed mice, chick and zebrafish showed defects in cell convergence-
extension and intercalation (Kahn et al., 2009, Nowlan et al., 2008, Shwartz et al., 2012).  
However, wls mutation did not recapitulate the gpc4 mutant phenotype with some degree 
of stacking within the body of Meckel’s cartilage and less severe AP shortening. One 
reason as argued before could be due to the defective muscle phenotype. Another 
hypothesis could be that gpc4 integrates several other signalling pathways. Therefore, gpc4 
mutant phenotype could be a consequence of the loss of several other signalling pathways 
and not just Wnt signalling alone (e.g. Fgf), while Wls to date has only been shown to be 
necessary for the secretion of some Wnt proteins. There is also the existence of possible 
Wls-independent Wnt secretion that may contribute to Wnt signalling and result in the less 
severe phenotype compared to gpc4.   
In this section, I eluded to the role of muscles in craniofacial development. While I have 
not explored it in greater detail, an interesting project might uncover the role of 
mechanosensing and tension in maintaining the arch of Meckel’s cartilage as well as the 
integrity of the ventral cartilage structures.  Below is an illustration of the ventral cartilage 
structures (Figure 30 in thick black lines) and muscles/ tendons/ ligaments (in thin black 
lines). The intermandibularis anterior provides tension to keep the arch narrower anteriorly 
(Figure 30, red arrows) while the intermandibularis posterior and interhyoideus provide 
traction to allow movement of the lower jaw (for mastication) as well as the ceratohyals 
(for respiration) (blue arrows). The large adductor mandibularae, as its name suggests, 
helps with the adduction of the posterior ventral cartilage structures during respiration but 
at the same time, probably aid with limiting lateral growth of the structures and directing 
the chondrocyte proliferation towards the midline and anteriorly. This overall interplay of 
muscles allows the Meckel’s cartilage to maintain its arch with an overall growth in a 
 100 
catenary curved manner (green arrows). Therefore, it comes as no surprise that muscle 
paralysis or hypotonia in patients may result in micrognathia (Kahn et al., 2009, Shwartz et 
al., 2012). In fact, a mutation in CAPZB, an actin-caping protein resulted in a patient with 
micrognathia (Mukherjee et al., 2016).  
 
Figure 30. Diagram of potential forces imparted by craniofacial muscles to help shape ventral cartilage 
structures.  
Thick black lines represented the cartilage structures. Thin black lines represent muscles/ligaments/tendons. 
Red arrow represents the forces acting on Meckel’s cartilage to maintain the arched shape. The blue arrows 
represent the forces the muscle potentially creates. Green arrows represent the overall force directions to aid 
in the extension of the face.  
Another idea regarding the midzone of Meckel’s cartilage is that this area acts a keystone 
for the arch. Without proper signals, chondrocytes in this zone fail to differentiate and 
thereby the resulting shape of Meckel’s cartilage becomes flattened anteriorly (as observed 
in all Wnt mutants) and losing the convex shape anteriorly. In other words, the loss of the 
keystone results in the collapse of an arched structure. The next logical question might be 
what regulates the length of Meckel’s cartilage resulting in such diverse sizes and length 
across species.  
Lower jaw or bird’s beak patterning have been studied in the past with many different 
secreted factors such as SHH, FGFs, WNTs and BMPs emanating from surrounding 
tissues to play a crucial role in mediating the shape and outgrowth of the ventral cartilage 
structures (Eames and Schneider, 2008, Merrill et al., 2008, Schneider and Helms, 2003). 
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Using a quail-duck chimeric system (quck), regional regulation of NCC have illuminated 
events involved in mediating the size of the lower jaw, in particular, the number of 
progenitors destined to form the jaw skeleton (Ealba et al., 2015, Eames and Schneider, 
2008). The chimeric ‘quck’ embryos, which are duck hosts with quail donor cells, will 
form quail-like beaks and jaw joints and vice versa.  The molecular mechanisms have been 
shown to involve the surrounding mesenchyme heavily influencing stage-specific and 
species-specific size and shape by exerting precise control over gene regulatory programs.  
A recent study by Schneider’s group has now shown that osteoclast bone resorption is 
another determinant thrown into the equation that regulates species-specific jaw length 
(Ealba et al., 2015). To maintain skeletal homeostasis, osteoclast work alongside osteoblast 
to regulate growth of skeletal structures. The study showed that when NCC destined to 
form the jaw skeleton transplanted from quail to a duck host (i.e. osteoclasts from donor 
NCC and osteocytes from host mesoderm), they observed an increase in tartrate-resistant 
acid phosphatase (Trap), Matric metalloproteinase 13 (Mmp13) and Mmp9. They further 
blocked bone resorption, which resulted in a significant lengthening of the jaw. On the 
contrary, activating resorption shortens the jaw. This interplay between NCC-derived 
osteocytes and mesoderm-derived osteoclasts adds another dimension to the regulation of 
the lower jaw by shedding light on the role of bone resorption in regulating size and shape 
of the jaw. What determines this species-specific NCC variation and what are the genetic 
regulatory networks involved remains an interesting question in this evolutionary biology.  
From out study, further work looking closely at the regulation of Meckel’s cartilage may 
add another component to size and shape determinants. Indeed, work done by over and 
underexpressing BMP showed variations in the size of the retroarticular cartilage (Parsons 
and Albertson, 2009). Given the different response of the midzone and body of Meckel’s 
cartilage, we hypothesize that WNTs may play a crucial role in the anterior extension of 
Meckel’s cartilage. Indeed, work on Lake Malawi cichlids by expanding Wnt signalling 
(using a Wnt agonist LiCL and a Wnt antagonist IWR-1) resulted in variation in skull 
morphology (Parsons et al., 2014). Due to the importance of WNT in craniofacial 
development (Liu et al., 2010), here I find that Wnt have precise control of not only 
specific regions of Meckel’s cartilage that may have an importance in jaw size and shape 
but also in bone development.  
 102 
3.3.3. Non-canonical Wnt is required for proper spatiotemporal 
control of endochondral bone formation  
Perturbations in Wnt signalling have been studied extensively. The role of the canonical 
Wnts in bone biology has been better defined in the literature (Clevers and Nusse, 2012, 
Logan and Nusse, 2004, Zhong et al., 2012, Hartmann, 2006, Krishnan et al., 2006). 
Compared with mammals, endochondral bone formation (e.g. mentomeckelian or 
ceratohyal) occurs first by transdifferentiation of perichondral cells into osteoblasts that 
then forms a shell of bony mineralization (Eames et al., 2012, Hammond and Schulte-
Merker, 2009, Jing et al., 2015, Paul et al., 2016).  Here, we extended previous work in 
zebrafish by highlighting the role of the non-canonical Wnt signalling in temporal 
regulation of the endochondral ossification process.  
Cartilage maturation and hypertrophy is the principal engine of endochondral bone 
formation. It requires chondrocytes to mature, proliferate and then produce collagen type 
10 (Noonan et al., 1998). Here, we showed that chondrocyte proliferation that occurs at 
around 6 dpf is severely affected in wls compared to the other mutants studied, concordant 
with mice studies (Maruyama et al., 2013). We then observed a failure in differentiation in 
wls mutant, marked by the loss of col10a1a expression in the clear majority of craniofacial 
bones and cartilage. This is confirmed by the loss of osterix expression. Interestingly, we 
observed a high expression of sox9a and runx2a in wls mutant suggesting that cells remain 
in a pre-cartilage and pre-osteoblast stage but do not exit the cell cycle to undergo cell 
division. Together, this indicated that chondrocyte failed to proliferate and osteoblast failed 
to differentiate leading to a severe loss of bone formation. This points towards the essential 
role of wls regulating Wnt activity which is independent of wnt9a and wnt5b to direct 
chondrocyte proliferation, maturation and differentiation as well as osteogenesis.  
While we did not observe any significant difference in proliferation in wnt9a, wnt5b or 
gpc4 mutants, we did observe a loss of col10a1a and osx expression in the ceratohyal. This 
suggests that timely maturation and differentiation of chondrocyte is more prominent in the 
non-canonical Wnts. Previously published work on gpc4 have noted that a small 
proportion of gpc4 mutants survive to adulthood with robust formation of endochondral 
and dermal bones (LeClair et al., 2009). However, they noted the failure to form the 
symplectic bone and that other zebrafish mutants also affecting the biosynthesis of heparin 
sulfate proteoglycans, dackel (dak) and pinscher (pic) failed to form bones (Clement et al., 
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2008). Since we did not observe the formation of the ceratohyal, mentomeckelian or 
retroarticular in gpc4 mutants at 8 dpf, a delay in chondrocyte maturation may be a 
contributory factor to the delay in endochondral ossification. The loss of endochondral 
bones in our wnt5b mutant is like Wnt5a and Wnt5b knockout mice where both have been 
shown to inhibit hypertrophic maturation by down regulating Runx2 (Bradley and Drissi, 
2010, Bradley and Drissi, 2011).  
Along with the results of our study, we showed that wls, wnt9a, wnt5b and gpc4 are all 
required for: 1) proper chondrocyte organization to shape the cartilage anlage and 2) timely 
chondrocyte maturation to initiate endochondral ossification. In contrast to the 
endochondral ossification process, wls additionally plays a key role in intramembranous 
ossification where osteoblasts directly differentiate from NCC-derived progenitors and do 
not require a pre-cartilage anlage (Table 17). Since intramembranous bones are not 
affected in wnt9a, wnt5b, and gpc4 mutants, it is likely that another ligand, perhaps wnt14 
acting through the β-catenin canonical Wnt pathway that requires wls for its secretion is 
essential for the commitment of NCC precursor cells to osteoblastic lineage. Therefore, the 
non-canonical Wnts acting through wls results in the loss of cell polarity and a delay in 
chondrocyte maturation, as seen in wnt5b and wnt9a mutants and confirmed with gpc4 
mutants. On the other hand, it is possible that the canonical Wnts acting through wls may 
account for the chondrocyte proliferative defect and severe loss of both endochondral and 
intramembranous bone.  
In summary, we report the combined roles of wls, wnt9a, wnt5b and gpc4 during zebrafish 
craniofacial cartilage and bone development by highlighting the interaction of these genes 
in juxtaposed cell types to regulate jaw morphogenesis.  
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Figure 31. Summary diagram indicating role of Wnt signaling in endochondral and intramembranous 
ossification process 
Skeletal primordium can be formed from both the lateral/paraxial mesoderm and neural crest cells. Focusing 
on neural crest derived bones, they will then form osteochondrocyte progenitor population is bipotential into 
a chondrogenic (blue) or osteogenic (light orange) fate. Once fated to become chondrocytes, they are 
required to align prior to maturing and hypertrophying. In the classical endochondral ossification model, 
these hypertrophic chondrocytes apoptose to leave behind a matrix for osteoblast protenitors to invade and 
deposit bone. In a newer concept, these hypertrophic chondrocytes can transdifferentiate into osteoblast 
progenitors. In our study, wls (and therefore Wnt signalling) is a key gatekeeper at points A and C for both 
chondrocyte and osteoblast progenitors to mature. gpc4, wnt9a and wnt5b (non-canonical Wnt) appears to act 
at point A and B (i.e. a more promiment role in the endochondral process as well as the transdifferentiation 
of hypetrophic chondrocyte into osteoblast progenitors).   
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3.4. Conclusion  
We highlighted the combined roles of wls, wnt9a, wnt5b and gpc4 during craniofacial 
cartilage and bone development. Moreover, we demonstrated the interdependence of 
various surrounding tissues to appropriately shape and form the facial architecture. 
Generating mutants harbouring double knockouts of different genes will promise insight 
into the different Wnt requirements, redundancies, rescues and interactions to properly 
shape and size cartilage structures. In addition, further investigation focusing on the role of 
both the canonical and non-canonical Wnt signals in the gene regulatory networks that 
differentiates the midzone and body of Meckel’s cartilage will promise new insights into 
the diverse jaw lengths and sizes across species as well as insights into mandibular 
malformations and diseases. Understanding chromatin remodelling in NCC will provide a 
comprehensive understanding of how genes are being regulated during craniofacial 
development. A wider question might address the issue of environmental interactions in 
influencing not only the phenotype but also the genetic changes. Future directions for this 
project will help answer the question: What are the broader roles for Wnt in shaping the 
jaw? How does modulating this signal affect the regulatory networks and how does the 
spatiotemporal regulation influence jaw length? Additionally, further work is required 
understanding the transdifferentiation process will provide insight into the role of various 
crosstalks and signals during endochondral ossification. To help address these questions, 
we are developing the use of the confetti zebrafish transgenic line, termed Zebrabow (like 
the Brainbow mice) which will be discussed in the next chapter.  
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Chapter 4: Visualization of chondrocyte dynamic 
cell behaviour  
Published in Journal of Visualized Experiments, 2015 Oct 21; (104): 52935, PMID: 
26555721 
Work presented here overlaps with the work published but offers more detailed insight into 
some of the experiments, additional data, further hypothesis and data analysis.   
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4.1. Introduction 
CNCCs migrate and populate the first pharyngeal arch, then form paired mandibular 
processes that extend to form the Meckel’s cartilage, which prefigures the mandible. 
Morphogenesis of the Meckel’s cartilage requires chondrocyte arrangements via 
directional proliferation, cell polarization and differentiation (Dougherty et al., 2013, Le 
Pabic et al., 2014). However, the intricacy of chondrocyte organization in the growth and 
extension of the Meckel’s cartilage remains unclear. Understanding dynamic cell 
behaviour is critical to understanding congenital malformations affecting mandibular size, 
such as hypoplastic mandible phenotypes (Ricks et al., 2002). Zebrafish embryos offer 
many developmental and genetic advantages for detailed study of Meckel’s cartilage 
morphogenesis. Their genetic tractability, transparency, ex vivo and rapid development are 
powerful advantages lending it well for observation of cell movement and organization by 
live imaging (McCollum et al., 2011). Using lineage-tracing tools, such as sox10:kaede 
transgenic line, others and we have delineated the neural crest origins of the embryonic 
craniofacial skeleton (Gfrerer et al., 2013, Dougherty et al., 2013). Using the sox10:ERT2-
Cre with the ubi:Zebrabow transgenic line, it is now possible to explore details of cellular 
movements during craniofacial development. The Zebrabow-M, is a transgenic line 
engineered with the ubiquitin promoter driving the expression of different fluorophores, 
each flanked by Lox sites (Pan et al., 2013). The Zebrabow default fluorophore is Red, 
expressing RFP. After induction of Cre expression, the Zebrabow construct recombines 
and cells express a combination of different fluorophores (RFP, CFP and YFP) creating 
multi-spectral expression in the embryo. All the daughter cells that divide from the labelled 
cells after the recombination event are then clonally labelled, so that cell populations that 
derive from different juxtaposed progenitors are clonally labelled. By this cloning cell 
labelling, cells proliferation and migration with clonal resolution can be followed.  
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Figure 32. Methodology for inducing multispectral colour in Zebrabow transgenic line.  
A double transgenic line with sox10:CreERT2 and Zebrabow are set up, embryos collected and induced with 
tamoxifen. Embryos are then mounted with methylcellulose and imaged with the confocal.   
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4.2 Results 
Traditional cartilage visualization by whole mount Alcian blue stains has been invaluable 
in observing the developing Meckel’s cartilage (Javidan and Schilling, 2004). To further 
analyse the developing chondrocytes over time, lineage tracing using sox10:Kaede 
transgenic lines has enabled us to study cell migration, convergence and extension 
(Dougherty et al., 2013, Javidan and Schilling, 2004). However, the organization of 
chondrocytes in the craniofacial skeletal structure remains poorly understood. The 
Zebrabow-M transgenic line can reveal, in live imaging, the chondrocytic intercalation and 
elongation process that mediates extension and growth of the Meckel’s cartilage (Figure 
33).  
4.2.1. Generation of Tg(ubi:zebrabow;sox10:creERT2) transgenic 
line  
The Tg(ubi:zebrabow-M) line was a generous gift from Alex Schier’s laboratory, Harvard 
University (Pan et al., 2013). The Tg(sox10:creERT2) was generated in the laboratory. The 
targeting vector pDESTTol2-sox10:creERT2 was constructed using standard molecular 
cloning methods and Gateway technology (Invitrogen, CA). A p5’ containing a 7.2kb 
clone of the sox10 promoter along with a gateway middle clone pME-creERT2 and a p3’ 
containing a polyA tail were combined in a LR reaction with a lens destination vector 
pDestTol2-a-crystallin:YFP. The final pDest-Tol2-sox10:creERT2 construct was then co-
injected with Tol2 transposase mRNA into WT 1-cell stage Tubingen embryos. F0 adult 
founders were screened for germ-line transmission based on the YFP lens marker.  
Stable Tg(sox10:creERT2) line was then crossed to the Tg(ubi:zebrabow-M) line to 
generate a double transgene fish identified by a ubiquitous RFP signal and a YFP lens 
marker (Figure 32).  
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Figure 33. Zebrabow construct and recombination 
(A) Diagrammatic scheme of the Zebrabow construct driven by a ubiquitous promoter (above) and the sox10 
promoter driving the ERT2 inducible Cre (below).  
(B) With broad Cre activity (using an ubi:Cre or Cre mRNA injection into Zebrabow for example), will 
result in recombination in every cell. Using a sox10 promoter driving an ERT2 inducible Cre, only sox10 
derivatives will be labelled.  
(C) Meckel’s cartilage at 72hpf showing all sox10 derivatives labelled with the surrounding non-neural crest 
cells expressing the default RFP colour  
(C’) Zoomed in of the midzone of Meckel’s cartilage showing at least 10 colours following tamoxifen 
induction.  
4.2.2. Cell recombination  
ubi:Zebrabow-M;sox10:ERT2-Cre embryos were treated with tamoxifen at 10 somites and 
CNCC migration followed over time. Chondrocytes in the lower jaw were visualized at 
different time points of craniofacial structures development (from 3dpf to 5dpf). The lower 
jaw is best pictured ventrally to allow clear views of the Meckel’s cartilage without the 
interference of the ethmoid plate and neurocranium dorsally. The stably maintained and 
inherited colours allow easy lineage tracing and CNCC cells fate mapping as indicated by 
the black arrows in (Figure 36). The single blue cell appears to migrate and intercalate 
with its neighbouring cells. It then elongates along the anterior-posterior axis to form a 
uniformly shaped chondrocyte thus maintaining the global shape of the Meckel’s cartilage 
as it extends anteriorly. This technique allows the study of lower jaw growth 
malformations at the cellular and organ level in conditions such as Robin sequence where 
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micrognathia is one of the prominent features described. Failure in proliferation, extension 
or intercalation can be effectively visualized in the growing chondrocytes over time.  
 
Figure 34. Zebrabow recombination with sox10:creERT2.  
(A-D) Split channels of a representative image of Meckel’s cartilage at 72hpf. Channels were imaged 
separately and excitation optimized to minimize bleed through, especially between the YFP and RFP 
channels. Colour diversity can be observed (D) after image processing of the individual channels in either 
Image J or Photoshop.  
4.2.3. Zebrabow as a technique to analyse clonal population  
Addition of tamoxifen to the double transgenic fish (Tg(ubi:zebrabow) and 
Tg(sox10:creERT2) during embryogenesis generates recombination in all cells derived 
from neural crest cells, as the sox10 promoter is NCC specific. Since craniofacial cartilage 
and bone structures are all NCC derived, the generation of the Zebrabow fish allows 
assessment of clonal relationship between chondrocytes. At 55hpf, osteochondrogenic 
progenitors from NCC are seen to be labelled and undergone recombination (Figure 35). 
Other tissue structures such as the intermandibularis anterior/posterior (paraxial mesoderm 
derivative) or the epidermis are not labelled (remained default RFP). Subsequent imaging 
at different time points (72, 96, 120hpf) will allow tracking of a single cell (black arrow 
head) to examine localized clonal analysis (Figure 35B, C, D). In this case, there does not 
appear to be any expansion of chondrocytes between these time points, supporting the 
argument that proliferation of cells within ventral cartilage structures occur at a later stage 
(>6dpf).  
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Figure 35. Clonal analysis using Zebrabow.  
(A-D) Following Cre induction with tamoxifen at the 10 somites stage, Meckel’s cartilage of a single embryo 
was imaged at different time points, 55 (A), 72 (B), 96 (C) and 120 (D) hpf. Following a single blue cell 
(black arrow), one may be able to observe any expansion of a certain cell clone over time. In this case, no 
cell division or clonal expansion was observed.  
4.2.4. Zebrabow as a technique to visualize dynamic cell 
behaviour  
In addition to the ability to trace the clonal population of a single cell using the cell’s hue, 
an added advantage of the stochastic nature of the recombination allows us to study the 
dynamic behaviour of each cell over time. Analysing a group of cells (Figure 36A-C; 
dotted circle), we observed that at 55hpf, the group of cells appear as a 2-3-cell layer thick 
within Meckel’s cartilage. By 72hpf, cells have appeared to intercalate and stack on top of 
each other. By 96hpf, cells are then seen to grow in dimension to further extend the 
cartilage structure. This intercalation process is key in defining an organ shape and this 
technique has given us unprecedented ability to study cell behaviour. 
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Figure 36. Dynamic cell behaviour using Zebrabow illustrates cell intercalation within Meckel’s 
cartilage.  
(A) At 55hpf, cells within the body of Meckel’s cartilage appear to be in a 3-4 cell layer thick. By 72hpf (B), 
cells have intercalated and stack on top of one another like discs to extend the cartilage rod. At 96hpf (C), 
cells hypertrophy to enlarge the structure and subsequently undergo proliferation to further extend the ventral 
cartilage structures.  
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4.3. Discussion  
Alcian blue staining has been commonly used to visualize final cellular organization of 
cartilage. In addition, photoconvertible transgenic lines in zebrafish such as sox10:Kaede 
allows for direct observation of cellular migration and proliferation in live zebrafish 
embryos (Dougherty et al., 2012). Each technique complements each other to define the 
intricate process of cartilage and bone development. However, live cellular migration and 
organization during organogenesis has long been hypothesized and indirectly demonstrated 
but never visualized. Zebrabow transgenic line coupled with a cartilage specific Cre 
permits simultaneous live observation of all these distinct events involved in bone and 
cartilage formation.  
4.3.1. Colour diversity optimization 
Optimizing Cre levels by titrating the concentration of 4-hydroxytamoxifen can control the 
extent of recombination and colour diversity without resulting in embryo lethality. 
Oestrogen is critical for normal retinal development and therefore, higher doses of 
tamoxifen (>25µM) can induce retina degeneration, high mortality rates (~60 to 80%), 
craniofacial malformations and developmental delays. In addition, 4-hydroxytamoxifen is 
diluted in ethanol, which is toxic during embryonic development (McCarthy et al., 2013). 
Therefore, it is important to determine the best concentration and duration of exposition to 
obtain a good recombination rate but limit the toxicity for embryos.  
The desired concentration of 4-hydroxytamoxifen has been optimized in this protocol. 
Different concentrations (5-25µM), induction time points (10 somites, 24, 36 & 48hpf) and 
duration (30 min to 6hours) were tested. A low dose of tamoxifen (5 µM) produced a 
limited recombination while higher dose (from 10µM to 20µM) produced similar 
recombination and colour diversity (Figure 37). Doses greater than 20µM compromised 
normal development of embryos and therefore not suitable for studying craniofacial 
malformations. Induction durations less than 2 hours were not sufficient to create adequate 
recombination while over 6 hours of induction induced toxicity and developmental 
anomalies in the embryos. Induction for 3 or 4 hours did not differ in the amount of 
recombination and results.  
Induction after the 24hpf embryonic stage did not produced desired recombination and 
fluorescent expression. Therefore, the best compromise between normal development and 
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suitable number of colours without resulting in significantly high numbers of embryonic 
mortality was determined to be 3 hours of induction at 10 somites with a 10µM 
concentration of tamoxifen. Induction in adult Zebrabow lines is not covered in this study 
but tamoxifen dissolved in system water may be insufficient to cause any recombination. 
Therefore, for later stage zebrafish, tamoxifen injections may be a more effective method 
to induce any Cre activity.  
 
Figure 37. Different concentration of tamoxifen results in different colour diversity and labelling.  
(A-A’’) Using 25 uM with a 3 hours pulse results in more recombination compared to a 10 uM pulse where 
only a small subset of cells were effectively labelled. 
4.3.2. Image quality  
Obtaining consistent and high quality images can be challenging. If a single field of view 
is unable to visualize the whole Meckel’s cartilage or craniofacial structure of interest, the 
whole structure can be mapped by taking montage images or Z-stacks. However, obtaining 
Z-stacks can be challenging in live embryo imaging due to movement artefacts. Therefore, 
it is important to have a compromise between the quality of the Z-stack image, the amount 
of information required during the imaging session and prevention of laser-induced photo-
bleaching during longer term laser exposure.  
Fluorescent proteins do not show the same stability during imaging. For example, RFP is a 
stable protein but YFP can be fragile. The colour diversity in zebrabow system is a key 
point for lineage tracing. Therefore, during the imaging process it is important to determine 
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empirically the best imaging settings to detect the maximum number of colours in each 
embryo with suitable intensity. A limitation in confocal imaging used in this protocol is 
that most confocal microscopes are unable to read CFP and YFP together. This is because 
the emission from CFP is detected in both 470nm and 535nm channel. Also, this emission 
spectrum of CFP (470-535nm) and the excitation spectrum of YFP (530nm) overlap, 
creating fluorescence resonance energy transfer (FRET) artefact. In other words, when the 
CFP fluorescence is detected, it excites YFP fluorescence and therefore creates a non-
specific signal. For this reason, all fluorescence channels were scanned separately in this 
protocol and merged separately using an imaging processing software (Image J or 
Photoshop). This may compromise some permutations of colour recombination. To 
overcome this, two-photons microscopy can be used as described in Pan et al’s paper 
where all three fluorescence expressions can be read concomitantly allowing for more 
colour diversity (Pan et al., 2013). Other confocal microscope that allows for adjustable 
excitation ranges has also been shown to produce a spectrum of colour diversity with 
minimal bleed through (tested on a Leica TCS SP8 STED 3X, Zeiss LSM 800 and 
Olympus FV3000 confocal). In addition, Pan et al has described a large spectrum of colour 
diversity in their Zebrabow lines (up to 30 colours). With the conditions described in this 
protocol, different intensities of fluorescence were obtained, compatible with results 
obtained by Pan and colleagues 
4.3.3. Colour inheritance and clonal analyses 
Pan and colleagues have described the stably maintained colour inheritance in Zebrabow 
from progenitor to progeny that allows for fate mapping (Pan et al., 2013). This protocol 
focused on neural CNCC cells to characterize the formation of the Meckel’s cartilage. The 
use of CreERT2 in zebrafish allows for efficient tamoxifen induced loxP cassette 
recombination and the ability to control the onset of CNCC lineage labelling during 
craniofacial development. This method can easily be adapted to visualize all neural crest 
derivatives besides the Meckel’s cartilage. In addition, using a different transgenic reporter 
line for clonal analysis in various organ systems will highlight different modes of cell 
growth during organogenesis. The method also allows identification of other cell 
populations that has not been previously shown in other transgenic lines (Figure 38). 
Figure 38 shows a panel of different transgenic lines used to visualize Meckel’s cartilage 
ventrally. Figure 38A and C shows 2 different transgenic line; sox10:GFP showing 
chondrocytes and sp7:GFP showing osteoblast progenitors. The zebrabow:sox10creERT2 
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line shown in Figure 38B and induced at 10 somites revealed not only the chondrocyte 
population but also the osteoblast condensation (white circle). Interestingly, using a nerve 
specific line (isl2:GFP), we showed that the end of the mental nerve also coincided with 
this primary condensation point. Therefore, the zebrabow line is invaluable for further 
work looking at not only cell dynamics but also clonal analysis.  
 
Figure 38. Zebrabow allows identification of other sox10 derived cells within ventral cartilage 
structure 
A. Ventral view of Meckel’s cartilage at 3dpf using a Tg(sox10:GFP) line. B. The Zebrabow line crossed to 
sox10:creERT2 and induced at 10 somites. Here we can see a clear condensation of clonal NCCs (within the 
dotted circle) that may be the site of osteoblast progenitor (C) as shown in the Tg(sp7:GFP) line.,Tthis point 
also coincides with the end of the mental nerve as shown in D using a Tg(isl2:GFP) line that highlights 
nerves.  
4.3.4. Imaging deeper structures 
Superficial structures such as ventral cartilage elements are easily imaged using a 
confocal/single photon microscope. However, for deeper cartilage structures such as the 
neurocranium in a whole-mount embryo, live imaging using a single-photon microscope 
can be challenging (>1 mm in depth) due to scattering of UV light by the tissues. This can 
be overcome by multiphoton imaging using the deep focus mode, allowing precise 
excitation of the fluorophores at the desired depth and minimizing scattering and over 
excitation of the fluorophores above and below the plane of focus (Figure 39). Here we 
imaged the ethmoid plate to determine if we can visualize the cellular intercalation 
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between the frontal nasal prominence and the two lateral maxillary prominence. In Figure 
39A, we can just about make out cellular details of the chondrocytes when using the 
confocal but contrast this to the multi-photon microscope in Figure 39B where clear 
resolution of the chondrocytes and colour diversity can be appreciated. This provides an 
exciting tool to help study palate development and cellular dynamics within this complex 
process.  
 
Figure 39. Zebrabow of the zebrafish ethmoid plate.  
(A) Confocal image at 4 dpf showing rough outlines of chondrocytes compared with a two-photon image of 
the same structure (B). Cells have a clearer outline with more colour diversity. Note autofluorescence from 
the parasphenoid and the melanocytes within the eye.   
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4.4. Summary and future directions  
The double transgenic Zebrabow and tissue specific sox10 has shown to be a valuable tool 
in uncovering dynamic cell behaviour during craniofacial development. I am currently 
propagating this line into all the Wnt mutants to determine whether stacking defects are 
apparent in homozygote mutants. Additionally, this tool will be useful in studying cartilage 
regeneration. Recent studies have looked at the remarkable regenerative capability of 
zebrafish lower jaw (Paul et al., 2016). By utilizing Zebrabow, one would be able to trace 
where the regenerative cells originate, the periochondral cells, mesenchymal cells or 
chondrocytes within Meckel’s cartilage. This will allow further transcriptomic studies to 
understand gene regulation during cartilage and bone regeneration. I am also using a 
UAS:Zebrabow line instead of the ubi:Zebrabow line. This will rid of the ubiquitous RFP 
background that hinders Z-stack confocal imaging. Preliminary study and imaging showed 
difficulty with the UAS promoter as the colour is sporadic and mosaic. This may be due to 
inefficient transgene expression within each chondrocyte likely due to the UAS promoter 
that tends to methylate with subsequent generation. Further characterization of the 
UAS:Zebrabow (terms cytabow) line is required for this to be useful in lineage tracing 
experiments.  
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Chapter 5: The role of coat protein complex 
mechanisms during craniofacial development 
This next chapter is a parallel unpublished project we have been working on to 
complement not only our understanding of chondrogenesis but also Wnt trafficking during 
craniofacial development.   
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5.1. Introduction 
Endocytosis and vesicle trafficking are vital processes that regulate many aspects of 
development and cellular homeostasis. It governs cell communication via secretion and 
uptake of signalling molecules, enzymes, proteins and lipids (Glick and Nakano, 2009). 
The secretory pathway sequentially involves the endoplasmic reticulum (ER), Golgi and 
the trans-Golgi network. Highly dynamic, this pathway responds acutely to specific 
cellular demands. It delivers newly synthesized proteins, lipids and carbohydrates 
manufactured from the ER to the cell surface with pre-secretory modification being made 
as these molecules move through the network (Glick and Nakano, 2009). Membrane traffic 
between the ER and the Golgi is bi-directional where forward (anterograde) and reverse 
(retrograde) transportation provides a fundamental gateway to the endomembrane system. 
Several families of coat proteins are conserved across species from yeast to mammalian 
systems. Three major coat proteins are: 1) clathrin/adaptor protein (AP-1 and AP-2), 2) 
coat protein complex I (COPI) and 3) coat protein complex II (COPII) (Schekman and 
Orci, 1996). These machinery are central to the transportation mechanism: coat protein 
complex II (COPII) operates in the anterograde (ER-Golgi) (Barlowe et al., 1994) while 
coat protein complex I (COPI) operates in the retrograde route (Golgi-ER) (Bednarek et 
al., 1995) (Figure 40).  
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Figure 40. Secretory mechanism within a cell.  
COPII (blue) represents anterograde transport from ER to the Golgi complex while COPI (pink) represents 
retrograde transport and recycling of WLS (green figure) 
There are currently several models of secretion/trafficking within different cells; 1) 
vesicular transport, 2) cisternal maturation and 3) a combination of both pathways (Glick 
and Luini, 2011, Glick and Nakano, 2009, Luini, 2011). The vesicular transport model 
argues that cargo proteins are transported from late to early cisternae by COPI and COPII 
coated vesicles. The cisternal model is based on the concept that cargo is maintained 
within Golgi compartments and through a progressive series of Golgi cisternae maturation, 
move through Golgi stacks. This cisternae maturation work essentially as anterograde 
carriers for secretory protein transport. This model has been supported in the past through 
direct observation that large procollagen aggregates effectively move through the Golgi 
stacks without leaving the lumen (Bonfanti et al., 1998). More recently, a combination of 
both models has been proposed where large cargos progress through cisternae maturation 
while smaller cargos will move rapidly through vesicular transport (Martinez-Menarguez 
et al., 2001). However, how different cells regulate these processes and underlying 
molecular mechanisms remains to be answered.  
COPII trafficking has been explored in the past to be highly important during craniofacial 
development by playing a fundamental role in chondrocyte maturation (Lang et al., 2006, 
Garbes et al., 2015, Fromme et al., 2007, Sarmah et al., 2010, Townley et al., 2008). More 
recently human mutations affecting COPI activity have also been found to result in 
craniofacial phenotype including micrognathia and microcephaly (Izumi et al., 2016). 
 123 
COPI-coated vesicles are widely known for retrograde transportation of Golgi resident 
proteins. COPI coat consists of seven coatomer proteins and one small GTP-binding (G) 
protein, ARF (ADP-ribosylation factor). The seven COPs are termed α, β, β’, ϒ, δ, ε, ζ 
with molecular masses ranging from 160 kDa (α) to 20 kDa (ζ) (Waters et al., 1991, 
Dodonova et al., 2015). COPI forms two layers the α, β’ and ε subunits forming the B 
trimeric inner complex and β, ϒ, δ, ζ subunits forming the F tetrameric outer complex 
(Dodonova et al., 2015). The recent paper highlighting COPI functions in craniofacial 
development has added it to the complex network of mechanisms underlying the proper 
patterning and shaping of the head.  
To further clarify the role of COPI proteins in this process, we decided to use a novel viral 
insertion mutant copahi1872Tg to study the role of COPI in craniofacial morphogenesis. We 
compared this mutant to existing ENU mutants and previous morpholino data and found 
similar phenotype involving defective notochord and melanogenesis. In addition, we 
sought out to develop a tissue specific loss-of-function of copa in zebrafish using 
CRISPR/Cas9 gene editing methodology to specifically dissect the role of COPI during 
NCC development. While further work is required to test these transgenic lines, we also 
aim to study retrograde transport of wls that has been previously found to be shuttled back 
from plasma membrane to the ER via COPI vesicles. Since wls is central to Wnt secretion, 
studies into this aspect will help understand how wls modulates Wnt activity during 
development and in return, understand what factors regulate wls.  
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5.2. Results 
5.2.1. Molecular genetic nature of the copahi1872Tg mutation 
The copa gene was identified in a craniofacial and pharyngeal arch expression analysis 
screen using the zfin online database as a reference. Dr. Sun Zhao at Yale University 
kindly provided us with the copahi1872Tg mutant zebrafish line.  The hi1872 fish was 
previously isolated in a retroviral insertion screen previously described and affects the 
copa gene (Amsterdam et al., 1999) (Figure 41). Larvae homozygous to the hi1872 
mutation produces an approximate Mendelian ratio of offsprings displaying similar 
phenotype; wavy notochord, dramatic loss of pigmentation and widespread degeneration 
by 72hpf (Figure 41).   
A previous ENU-induced sneezym456 mutation affecting the copa gene was also identified 
in a large-scale systematic screen affecting embryogenesis (Coutinho et al., 2004). The 
m456 mutation resulted in a nucleotide substitution (G à T) in the splice donor of 
predicted exon 30 in the copa gene. This point mutation causes abnormal splicing and 
subsequently a frameshift mutation resulting in a premature truncation of the protein. 
Larvae homozygous for snym45 are significantly shorter than WT siblings due to failure of 
notochord cells to differentiate and lengthen properly, fail to form pigmented 
melanophores in the trunk, and do not survive past 72hpf (Coutinho et al., 2004). The 
notochord is a rod-like embryonic structure arising from the dorsal organizer forming the 
chordamesoderm and is located in the midline ventral to the neural tube (Harland and 
Gerhart, 1997). It plays an essential role in permitting normal development by providing 
not only signalling cues to pattern surrounding tissues but also integral skeletal support for 
early locomotion (Adams et al., 1990, Cleaver and Krieg, 2001, Cleaver et al., 2000). As 
the notochord cells acquire large vacuoles, they exert turgor pressure against the thick 
perinotochordal basement membrane providing the notochord with rigidity, thus allowing 
proper elongation and development of surrounding tissues (Harland and Gerhart, 1997). 
Previous large-scale screens in zebrafish identified mutants lacking basement membrane 
genes such as Laminin b1 and Laminin g1 results in failure of notochord cells 
differentiation (Parsons et al., 2002). Three other genes in the same study by Parsons and 
colleagues, affecting three subunits of the coatomer vesicular protein coat complex 
produces the same phenotype as the Laminin mutants resulting in dramatic reduction in 
pigmentation and degeneration by 2dpf (Parsons et al., 2002). The snym456 mutant showed 
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failure to assemble the perinotochordal basement membrane caused by defective transport 
mechanism to form the axial mesoendoderm, leading to notochord cells remaining in an 
undifferentiated state and subsequently cell apoptosis due to disruption of the endoplasmic 
reticulum and Golgi networks (Coutinho et al., 2004).  
 
Figure 41. copa gene and protein domains.  
Full-length copa gene stretches 29.27 kbs and contains 1,224 amino acids with a molecular weight of 138 
kDa. Viral insertion for the copahi1872Tg mutant line occurs at the 5’ UTR region.  
 
Figure 42. WT and copahi1872Tg mutant at 48hpf.  
Bright field live imaging of WT embryo at 48hpf (top) and two separate copa homozygote at 48hpf.  
To be sure of the genotype-phenotype correlation (Figure 42), we scored a clutch of 
heterozygote hi1872 incrosses for their genotypes by PCR. The mutant and WT alleles 
were distinguished by the reverse primer 5’MSL4 which binds in the viral insertion and a 
second reverse primer, R2 (as shown in Table 18) which binds in intron-1. When these 
primers are paired with a common forward primer C1 which binds in the 5’ UTR, the 
5’C1/MSL4 primer pair amplified a band of 180bp with mutant genomic DNA but no band 
with WT DNA. The 5’C1/R2 paid gave a 350bp fragment with WT DNA and no band with 
 126 
homozygote mutant DNA. Heterozygote genomic DNA will therefore produce 2 bands 
(Figure 43).  
 
Figure 43. Genotyping of copahi1872Tg.  
Three primer PCR used for genotyping. WT allele is at 350bp while mutant allele is 180bp. 2 bands indicate 
heterozygote embryos. 
Table 18. Genotyping primers for copahi1872Tg 
Primer Sequence 
1872C1 Forward 5’ – gacgtggagcttgcgatgctg – 3’ 
R2 reverse  5’ – ctgtgtggtgtatttcttgaggcc – 3’ 
MSL4 reverse (on retrovirus) 5’ – gctagcttgccaaacctacag – 3’  
 
5.2.2. copahi1872Tg mutation inhibits production of mature message 
and protein 
An allele with a molecular lesion that deletes protein function would strengthen 
interpretation of the mutant phenotype observed. Given the position of the primers, we 
conclude that the viral insertion is not in the coding regions but within the 5’ UTR region 
of the copa gene. The UTR regions are key in stability and the 5’ UTR sequence is 
required for ribosomes to bind and initiate translation of the mRNA to protein. Therefore, 
to ensure that viral insertion within the 5’ UTR in hi1872 leads to a loss in mRNA, we 
prepared cDNA from mutant and WT embryos and performed real time quantitative-PCR. 
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Figure 44. qPCR of copa transcript levels.  
48hpf homozygotes were isolated and copa mRNA transcript levels were measured compared to a stage-
matched controls (ET embryos). Two separate clutches were used. Significant downregulation of copa 
mRNA levels in both clutch.  
To learn the extent to which copa message is reduced in the hi1872Tg  homozygotes, we 
prepared cDNA from 48hpf mutant and WT animals. We then conducted qPCR using 
probes that amplifies 48bp of exon 1 and 126bp of exon 2. The ubiquitously expressed 
housekeeping gene, eukaryotic initiation factor 1 alpha (eif1α) provided an internal 
standard. Experiments were performed in triplicates as well as a negative control with no 
cDNA added to the qPCR mix. The results revealed that copahi1872Tg mutants possess a 
drastically reduced copa transcript assessed in two different homozygote clutches (Figure 
44).  
To confirm whether protein function is destroyed, western blot analysis run on protein 
lysates of pooled homozygote copahi1872Tg embryos revealed absence of protein at 138 kDa. 
b-actin was used as the control (housekeeping gene) (Figure 45). These sets of 
experiments allowed us to conclude that copahi1872Tg disrupts copa gene production.  
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Figure 45. Western blot of copa protein levels.  
48hpf copa homozygotes were isolated, protein extracted and subjected to SDS-PAGE analysis. WT copa 
protein molecular weight is predicted to be approximately 138 kDa. B-actin was used as a loading control.  
5.2.3. Full-length copa mRNA rescues homozygote phenotype  
Given that the genotype correlates with the phenotype and that we found that the hi1872 
mutant does not produce any copa mRNA and protein, we sought to determine the 
specificity of phenotypes observed in copa mutants. We injected 200pg of full length copa 
mRNA into 1 cell-stage embryos from an incross of copa heterozygotes. We then observe 
the phenotypes at 4dpf and stain for cartilage with Alcian blue. Appreciable rescue of the 
phenotype at 48hpf showed craniofacial structures formed, albeit defective formation of 
the ethmoid plate and ventral cartilage structures (Figure 46). Staining with Alcian blue 
indicates sufficient extracellular matrix is being secreted by the chondrocytes. Despite an 
appreciable ethmoid plate structure, defects can be observed by incomplete fusion of the 
frontal nasal prominence with the bilateral maxillary prominence anteriorly. Additionally, 
ventral cartilage structures are notably smaller and shorter compared to its WT sibling 
(Figure 46). This may be due to the depletion of the injected mRNA thereby suggesting a 
later essential and functional role of copa in proper embryonic development. Within the 
same clutch, overexpression of the copa mRNA was also observed which interestingly, 
displayed a similar phenotype as the copa homozygote mutants; loss of pigmentation and 
wavy notochord (Figure 46). Embryos survive to 96hpf, allowing analysis of the 
craniofacial structures. This showed severely defective craniofacial cartilage structures, 
rounded chondrocytes, smaller ethmoid plate, a malformed Meckel’s cartilage and weak 
staining of the ceratobranchials. The chondrocytes within Meckel’s cartilage appears in 
clumps and have a reduced width and length ratio.  The weak staining of Alcian blue may 
indicate failure of sufficient ECM being excreted by the chondrocytes due to defective 
transport mechanism. Following Alcian blue analysis, embryos were genotyped to confirm 
the phenotype observed. Different concentrations of copa full length mRNA were injected 
into separate clutches of copa incrosses (50pg, 100pg, 200pg, 300pg, 500pg). 
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Concentrations lower than 200pg did not rescue the phenotype and concentrations greater 
than 200pg resulted in high percentage of death and toxicity (as seen by brain 
malformation with a dusky appearance). This further shows that a fine balance of copa 
function is required to maintain proper cellular function during chondrogenesis.   
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Figure 46. copa mRNA injection overexpression and mRNA rescue.  
Injection of 200pg of copa full length mRNA rescues the 48hpf lethal phenotype allowing craniofacial 
analysis at 4dpf. Injection of 200pg copa full length mRNA in copa homozygotes at the 1 cell stage shows 
defect in craniofacial structures at 96hpf with a clefting defect of the ethmoid plate as well as a reduced size 
of the Meckel’s cartilage compared to WT. A similar concentration of 200pg of copa full length mRNA into 
WT Tübingen embryos showed severe craniofacial defects with smaller, rounded chondrocytes and a 
misshapen Meckel’s cartilage. 
5.2.4. Zygotic copa activity 
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Whole mount RNA in situ hybridization was carried out to delineate the spatiotemporal 
requirements of copa during early embryogenesis. A full length copa probe was then used 
to examine the expression of copa in staged WT embryos; at 10 somites (onset of NCC 
migration), 24hpf (organogenesis), 48hpf (craniofacial morphogenesis), 72hpf (ethmoid 
plate fused and formed) and 96hpf (Meckel’s cartilage shaped and aligned) (Figure 47). 
Previous studies have observed copa expression at the 32-cell stage that continues through 
to shield stage. This demonstrates the presence of maternal transcript early in gastrulation.  
At 10 somites, strong expression is observed at the polster (forms future forebrain), 
throughout the notochord and mild expression within the NCCs bilaterally (Figure 47A-
C). By 24hpf, the brain, pharyngeal arches, notochord, endoderm and blood vessels around 
the yolk also show strong expression of copa (Figure 47D, E). By 48hpf, expression 
localizes the pharyngeal arches, cranial sutures, liver bud, pectoral fin, gut, renal tract and 
swim bladder lining (Figure 47F, G). No expression observed at the notochord, somites or 
brain tissue. A similar pattern of expression persists at 72and 96hpf but without expression 
of the pectoral fins (Figure 47H-M). At 96hpf, embryos showed expression in the head 
and flat-mount of the dissected embryo head showed clearer outlines of all ventral cartilage 
structures. To determine if the expression is within the chondrocytes of surrounding 
mesenchyme, we performed sagittal sections. These sections revealed that expression 
underlines all craniofacial cartilage structures (Figure 47N-P). Further sagittal sections 
through the midline of the body showed strong expression within the epithelium of the 
swim bladder and entire length of the gut tube extending to the cloaca (Figure 47Q). These 
patterns of expressions suggest a less ubiquitous role of the coatomer trafficking complex 
during development and greater spatial temporal regulation in a highly coordinated timely 
manner.  
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Figure 47. copa WISH analysis at different time points during craniofacial development.  
(A-C) 10 somites; ventral and lateral views with clear expression at the polster and notochord.  
(D) 24hpf with a zoomed view of the tail area (E) highlighting the posterior notochord expression.  
(F-G) 48hpf lateral and ventral view showing expression in the pharyngeal arches, pectoral fin, liver bud and 
cranial sutures.  
(H-I) 72hpf lateral and ventral view showing clear expression within the craniofacial region, liver bud, lining 
of the gut and cranial sutures.  
(J-M) 96hpf ventral, lateral, zoomed tail, zoomed head views with clear expression within the craniofacial 
cartilage structures, liver, gut lining and swim bladder.  
(N-P) Sagittal sections of the craniofacial region of a 96hpf embryo showing expression with the surrounding  
mesenchyme as oppose to within the chondrocytes.  
(Q) Sagittal section of the stomach showing strong expression within the epithelial lining.  
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5.2.5. copa knockout results in failure of NCC specification and 
differentiation 
To determine if early NCC specification and differentiation is affected in copa mutants, we 
carried out molecular analysis of key neural crest genes at the 10 somites stage (onset of 
NCC migration) and 48hpf (prior to craniofacial morphogenesis). Analysis of early NCC 
markers sox9a, sox10 (NCC migration and survival), foxd3 (NCC induction and 
specification) and dlx2a (NCC migration, survival and differentiation) at 10-somites stage 
in the copa mutants was largely unaffected with similar expression patterns (Figure 48). 
Note: we performed gene expression analysis on the whole clutch for each marker in order 
to conserve mendelian ratio. These embryos with corresponding expression pattern were 
then confirmed by genotyping.  
In 48hpf WT embryos, sox9a expression in WT localizes to the preformed ethmoid plate, 
pharyngeal arches, cranial sutures and pectoral fin. However, in copa mutant, there appears 
to be a greater expression of sox9a (Figure 48D). sox10 expression in WT is expressed 
within the pharyngeal arches and otic vesicle by 48hpf (Figure 48G). copa mutants did not 
show any increase in distribution pattern of sox10 expression, with extensive ectopic 
expression within the melanocytes throughout the embryo and strong expression within the 
pharyngeal arch (Figure 48H).  
To assess NCC induction and development, we assess the expression of forkhead box D3 
(foxd3). foxd3 is a critical gene for NC development including survival, and maintenance 
of NC progenitor pools (Montero-Balaguer et al., 2006, Dottori et al., 2001, Teng et al., 
2008). In WT, at 48hpf, foxd3 expression appears within the cranial satellite glia associated 
with the cranial ganglia within the pre otic and post otic placodes (Figure 48K). In copa 
mutants however, this expression pattern appears greater and stronger especially within the 
cranial ganglia (Figure 48L).  
We looked at the expression of dlx2a, a gene key in NCC migration, survival, 
differentiation of CNCC into sensory ganglia and maturation of craniofacial cartilage 
elements. In WT, dlx2a expression at 48hpf appears within the gill arches, otic vesicle, 
mandibular and hyoid arches as well as the diencephalon anteriorly (Figure 48O). In copa 
mutant, we observed greater expression of dlx2a (Figure 48P). 
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Overall, we observed a change in NCC marker patterns by 48hpf with stronger expressions 
of sox9a, foxd3 and dlx2a and ectopic expression of sox10 in copa mutant. These suggests 
that copa mutation seem to affect early NCC development.  
 135 
 
Figure 48. WISH of NCC markers in copa mutant at 10 somites and 48hpf.  
(A-D) sox9a, (E-H) sox10, (I-L) foxd3, and (M-P) dlx2a expression levels in copa mutant compared to WT 
sibling within the same clutch.  
 
Figure 49. copa WISH genotyping.  
Following in situ hybridization, embryos at 10 somites (in figure 34) were genotyped to ensure 
homozygocity due to similar expression pattern. Above is an example gel electrophoresis for the sox9a clutch 
where 7 embryos were imaged and then subsequently genotyped. Two homozygotes were identified in the 
genotyping experiment and therefore the previous figure represented this result.  
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5.2.6. Upregulation of UPR genes in copa mutant 
Protein folding within the ER is extremely sensitive to altered changes within its 
microenvironment such as nutrient status, protein synthesis or external pathogenic stimuli 
(Wang and Kaufman, 2014). Perturbations in protein folding cause an accumulation of 
unfolded or misfolded proteins leading to ER stress (Sovolyova et al., 2014). Trafficking 
defects has also been described to induce ER stress by disrupting the ER protein-folding 
environment (Sovolyova et al., 2014). The build-up of ER stress causes the activation of 
the unfolded protein response (UPR) system, a critical signalling pathway in maintaining 
productive ER protein folding and cellular stress. The UPR pathway has been described in 
various pathological diseases such as tumorigenesis (Kim et al., 2012, Scriven et al., 2009, 
Wang and Kaufman, 2014) and in early development (Coutinho et al., 2004).  
(BIP; also known as GRP78 and HSP5A), a binding immunoglobulin protein has been 
described as being important in the UPR activation cascade. Misfolded proteins bind to 
BIP and the reduction in free BIP levels in turn induces further transcription of BIP and the 
activation of the UPR pathway (Kozutsumi et al., 1988). This activation causes a transient 
attenuation of protein synthesis, increases protein trafficking through the ER, protein 
folding, and increased protein degradation pathway and autophagy. If the ER stress 
exceeds these adaptive responses and protein—folding defects are not resolved, cells will 
enter apoptosis (Kozutsumi et al., 1988).  
The UPR has several parallel signalling branches, two of which focused on this study: 1) 
inositol-requiring protein (IRE1a)-X-box binding protein (XBP1) and 1) activating 
transcription factor 6a (ATF6a). IRE1a is a type 1 transmembrane protein with a cytosolic 
serine/threonine kinase domain. When not stressed, HSP90 and HSP72 bind to IRE1a 
cytosolic domain to stabilize it (Gupta et al., 2010, Marcu et al., 2002) and BIP binds to 
IRE1a luminal domain to prevent dimerization. During ER stress, misfolded proteins will 
bind to BIP, thereby releasing IRE1a for autophosphorylation and oligomierzation that in 
turns activates its kinases to cleave Xbp1 mRNA. This cleavage removes a 26-base intron 
to create a transcriptionally active form of Xbp1 that then enters the nucleus to regulate 
target genes and enhance protein folding and trafficking (Calfon et al., 2002).  
ATF6 is another transmembrane protein that under non-stressed conditions remains within 
the ER through its interaction with BIP (Guan et al., 2009, Ye et al., 2000). During ER 
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stress, ATF6 is released from BIP and traffics to the Golgi apparatus for processing by 
protease and then activate the regulated intramembrane proteolysis process. Other evidence 
has also shown that upon induction of ER stress, ATF6 induces BIP that binds to unfolded 
proteins and relieve the stress (Guan et al., 2009, Ye et al., 2000).  
Since these genes are important in the UPR pathway, we examined mRNA transcript levels 
of bip, ire1a and atf6a (a zebrafish duplicate gene of ATF6) in 48hpf copa mutant 
homozygotes and found statistically significant upregulation of these genes compared to 
WT (Figure 50). Therefore, loss of copa can be seen to induce a stress response.  
 
Figure 50. Upregulation of UPR pathway genes in copa mutant.  
qPCR on bip, ire1a and atf6a, essential genes in the UPR signalling pathway. 48hpf copa mutant 
homozygotes cDNA were used for analysis. Ubiquitous housekeeping gene eif1a was used as an internal WT 
stage-matched controls. Two-paired T-test was used where **** indicates p<0.0001.  
5.2.7. Tissue-specific CRISPR copa knockout  
Early embryonic lethality represents a major hurdle in assessing craniofacial development 
that only starts around 55hpf. In fact, in zebrafish, it has been estimated that over 1400 
genes are embryonic lethal before 55 hpf (Amsterdam et al., 2004). Therefore, in this 
circumstance, whole gene knockout using the copahi1872Tg mutant may not be informative. 
We then sought to overcome the early death of copahi1872Tg mutants attributed to failure in 
notochord differentiation by generating NCC-specific knockout of copa. Additionally, this 
will enable us to address cell autonomy questions. To achieve this, we use needed to 
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generate a spatio-temporal loss-of-function mutant line. Therefore, we combined the 
CRISPR/Cas9 gene editing technology as well as the Cre-lox system to spatio-temporally 
induce indel mutations (see Methods and Materials).  
5.2.7.1. Limitations of other existing gene-silencing methods in zebrafish  
In zebrafish, transient knockdown of a gene using morpholino enables assessment of loss-
of-function in embryos (Nasevicius and Ekker, 2000). Morpholinos acts by binding to the 
transcription site or splice sites of pre mRNAs, thus blocking translation or splicing of the 
mRNA (Summerton and Weller, 1997). However, morpholinos present their own 
limitations, with nonspecific toxicity and off-target effects, limiting its utilization (Eisen 
and Smith, 2008). Additionally, morpholinos functions for about 3 days where its effects 
then taper off, thus precluding studies in older embryos and adults.  
Other gene editing methods have been employed including Zinc-finger nucleases (ZFN) 
and transcription activator-like effector nucleases (TALEN) (Miller et al., 2011, Urnov et 
al., 2005). These are enzymes engineered to cleave specific DNA sequences by inducing 
double-strand breaks and activating the repair mechanism via non-homologous end 
joining. Even though these methods allow loss-of-function studies in both embryos and 
adults through stable mutant line generations, the design of new nuclease is incredibly 
tedious, racking in high cost and compounded by its low mutation efficiency.  
The CRISPR/Cas9 gene editing technology uses just a single endonuclease, Cas9 to target 
a specific sequence within the genome. One of the many advantages of CRISPR/Cas9 to 
the other methods includes an ease of use and high efficiency, making it a fundamental 
tool to easily assess loss-of-function phenotype (Jinek et al., 2012). This improved 
specificity of mutagenesis uses dimeric RNA-guided Folk nuclease and with an optimized 
CRISPR-associated 9 (Cas9) that also reduces off-target effects (Jinek et al., 2012). The 
codon-optimized Cas9 nuclease in zebrafish has such high efficiency, that biallelic 
mutagenesis can be achieved in the F0 generation, allowing assessment of phenotype in the 
injected embryos (Hwang et al., 2013). Engineered gRNAs comprises of a 20-nucleotide 
complementary to the target DNA sequence with a 3’ motif that forms a secondary 
structure that interacts with the Cas9 endonuclease. The Cas9 loads the gRNA and search 
the genome for the complementary target sequence. When the sequence is followed by a 
proto-spacer adjacent motif (PAM), Cas9 will cleave the DNA within the gRNA seed 
 139 
(Sternberg et al., 2014). This cleavage causes a double strand break within the genome. 
This break is repaired most likely by alternative nonhomologous end joining (also called 
NHEJ), which favours apparition of mutations; insertions, or deletions (indels). Therefore, 
if these indels occur within coding sequences, the targeted gene may be disrupted for 
example through the introduction of frameshifts of early stop codons.  
However, to allow spatiotemporal control over gene inactivation, a new tissue-specific 
CRISPR/Cas9 knockout has been employed by taking advantage of the conditional Cre/lox 
technology (Mosimann et al., 2011, Ablain et al., 2015). Successful disruption of the urod 
and mitfa gene showed that the CRISPR/Cas9 knockout technology could be spatially 
controlled in blood lineage in zebrafish (Ablain et al., 2015).  
5.2.7.2. Generation of copa CRISPR knockout line 
Prior to generating tissue-specific loss of function, we tested the guide RNAs (gRNA) by 
generating whole organism knockouts with the designed gRNA. Using CHOPCHOP 
(hyyps://chopchop.rc.fas.harvard.edu) prediction algorithm, a gRNA for copa was 
designed (on exon 2) to contain a 20 bp target sequence with two GG residues at the 5’ end 
for efficient transcription from the T7 promoter and ends with the PAM NGG for the 
efficient Cas9 binding (Figure 51).  The seed gRNA is then cloned into the pDR274 vector 
that contains the gRNA scaffold and a T7 promoter.  
The desired single targeting gRNA is then generated by in vitro transcription with a T7 
promoter after linearizing the pDR274 plasmid and subsequently purified. The mix of 
gRNA and Cas9 RNA was co-injected into one-cell staged embryos to induce RNA-guided 
targeted DNA double-strand breaks mediated by the codon optimized Cas9 enzyme. The 
injected F0 were then screened to observe the efficiency of the gRNA. This was achieved 
by extracting DNA from the embryos 24-48hpf and by performing microsatellite DNA 
fragment analysis following PCR amplification of the region. Here, the WT fragment is 
285 bp and the mutant allele we have successfully generated is 275 bp, thus potentially a 
10 bp deletion has been incurred (Figure 51B). Further cloning experiments will elucidate 
the nucleotide deleted from the allele. This will be achieved by ligating the amplified PCR 
product from the identified heterozygote into a pGEM-T-easy vector and following 
selection of positive colonies, subjected to sequencing to identify the deletion.  
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Figure 51. copa CRISPR target site and microsatellite DNA fragment analysis of mutant line 
generation.  
(A). Target site generated from online bioinformatics software and target site at exon 2 chosen. PAM sites 
indicated in blue highlight. (B, C). Microsatellite DNA fragment analysis of F0 adult (B) mutant and (C) WT 
control. WT peak at 285 bp while mutant allele peak at 275 bp indicating a potential 10 bp deletion incurred 
by CRISPR/Cas9.  
5.2.7.3. Generation of sox10-specific CRISPR knockout line 
Having determined that the target gRNA induces an effective indel, we then used the target 
sequence to construct vectors based on the Tol2 transposase (Gateway) technology 
(Kawakami et al., 2004). The Gateway technology allows the Cas9 sequence codon-
optimized for zebrafish to be inserted with a tissue-specific promoter. For the final 
gateway construct, we used three separate approaches: 1) using a ubi:hulk (ubi:loxP-
STOP-loxP-GFP), 2) ubi:switch (ubi:loxP-GFP-STOP-loxP) (Mosimann et al., 2011) and 
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10X Upstream activating sequence (UAS)  as promoters within the p5’. We then cloned 
the CRISPR seed sequence under the control of a zebrafish U6 promoter at the 5’ end of 
the gRNA scaffold into a destination U6:gRNA cassette with a heart transgenesis marker 
(cmlc:GFP) (Ablain et al., 2015). A Gateway reaction then allows the assembly of a Cas9 
sequence (pME) under the control of the promoters (p5E’) and followed by poly-A (p3E’) 
inserted into the destination U6:gRNA vector.  Three separate constructs were generated to 
address the need of three different promoters. These constructs were subsequently injected 
with Tol2 mRNA (20 ng/uL) into one cell-stage embryos (Figure 52).  
 
Figure 52. Tissue specific CRISPR constructs strategies.  
(A). Ubiquitous switch from dark to GFP (ubi:hulk) upon Cre induction to drive cas9 and U6 promoter 
transcribing the copa gRNA. (B). Ubiquitous switch GFP to dark (ubi:switch) upon Cre induction to drive 
copa gRNA. (C). Upstream activating sequence (UAS) promoter 10X repeat sequence during the cas9/copa 
gRNA construct. UAS promoter will activate upon a tissue specific gal4.  
The use of the ubi:switch/ubi:hulk/UAS promoters is to take advantage of the tamoxifen-
inducible Cre/lox system by crossing a tissue specific Cre-ERT2 stable fish line (in this 
case, sox10:CreERT2) to allow spatiotemporal assessment of copa gene function during 
craniofacial development. As a positive control, we crossed the CRISPR copa fish line 
with a ubi:CreERT2 line to determine if tamoxifen treatment will recapitulate the 
phenotype of the whole-organism CRISPR knockout and the copahi1872Tg mutant line. 
Additionally, other tissue specific lines made in our laboratory such as a krt4:creERT2 line 
enables assessment of copa within epithelial cells. This will enable us to answer key 
questions regarding the requirements of copa within craniofacial chondrocytes or 
surrounding mesenchyme.  
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5.3. Discussion 
Intracellular trafficking systems, including COPI, COPII and clathrin complexes are 
fundamental in maintaining cellular homeostasis. Various disorders such as cranio-
lenticulo-sutural dysplasia and osteogenesis imperfect due to mutations in the COPII 
complex have underscored the importance of these intracellular transport mechanisms. 
Only recently mutations in components of COPI have been found to cause germline 
diseases. A mutation in COPA, which encodes the a-COP subunit of COPI was described 
in patients with hereditary autoimmune-mediated lung disease and arthritis (Watkin et al., 
2015). They showed that there was impaired binding of proteins targeted for retrograde 
Golgi to ER transport. This subsequently led to ER stress and upregulation of Th17 
priming cytokines, an effector T cell population implicated in autoimmunity. A more 
recent paper linked a loss-of-function heterozygous mutation in ARCN1, which encodes 
the delta-COP subunit of COPI (Izumi et al., 2016). They found that ARCN1 deficiency led 
to defective type 1 collagen transport and therefore a reduction in collagen secretions 
leading to skeletal defects (including micrognathia and microcephaly). Like the mutation 
in COPA, the authors found that the COPD mutation disrupted intracellular trafficking 
causing an accumulation of proteins within the ER and upregulation of the unfolded 
protein response (UPR) pathway. However, the authors noted that ARCN1 is directly 
responsible for the intracellular transport of type 1 collagen and that the collagen defect is 
not secondary to the UPR upregulation. This paper appeared to contradict findings from 
previously published work showing COPI loss-of-function using copa morpholino 
injections (Izumi et al., 2016). Izumi and colleages also compared COPI-knockdown fish 
to a sec23a-deficient fish (part of the COPII mechanism) and found that copa does not 
have a role in trafficking of ECM proteins during chondrogenesis (Lang et al., 2006). 
However, ventral craniofacial structures and the neurocranium were noticeably smaller and 
shorter than their WT sibling. Although patterning is unaffected, hypertrophy and 
maturation of chondrocytes could account for the smaller size, but was not addressed in the 
paper. Additionally, previous studies have found a significant difference between 
morphant-induced phenotype (morpholino knockdown) versus mutant-induced phenotype 
(knock-out) (Kok et al., 2015). In fact, up to 80 percent of published morphant defects with 
the Sanger Zebrafish Mutation Project were not observed in the mutant embryos (Kok et 
al., 2015). Rossi and colleagues found that there was genetic compensation in knockouts 
compared to gene knockdowns that could account for the large phenotypic differences 
(Rossi et al., 2015). However, more than a decade of morpholino use in various 
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developmental model organisms have transformed the field of developmental biology. 
While new gene editing nucleases has great promise, it is still at its infancy and when use 
in conjunction with other approaches like morpholinos can provide better conclusion on 
functional relevance (Blum et al., 2015). Therefore, this project aims to elucidate copa 
requirements in craniofacial chondrogenesis by generating neural crest cell specific 
knockouts and addressing the role of trafficking in neural crest cell induction, migration 
and specification.  
5.3.1. hi1872Tg mutant disrupts copa function  
Using a viral insertion mutant line, we found that the hi1872Tg mutant successfully 
recapitulated the homozygote phenotype from an ENU mutagenesis (sneezy) previously 
described to encode the copa subunit (Coutinho et al., 2004). The coatomer complex 
consists of seven polypeptides that form the coat of COPI vesicles. These vesicles are 
important for membrane trafficking in the secretory pathway and essential for Golgi 
functions. Without it, normal transport of proteins from the ER and Golgi is disrupted and 
cells undergo apoptosis (Schekman and Orci, 1996). Previous studies as well as the in situ 
assays in this project have characterized early expression profiles of copa and showed that 
it is provided maternally and ubiquitously expressed within the chordamesoderm and 
notochord (Coutinho et al., 2004). Once the notochord has differentiated, later expression 
time points reveal strong levels within metabolically active organs such as the liver as well 
as the pharyngeal arches. Interestingly, given its essential function in intracellular 
processes, copa does not remain ubiquitously expresses. Instead, it appears to be regulated 
in a spatiotemporal manner. Previously reported expression analysis of copb1, copb’, cope, 
copd and copg2 share a similar profile. However, copz differed from the observed 
expression of the other coatomer subunits. copz1 does not appear to be upregulated within 
the chordamesoderm and notochord during development. A copz1 insertional mutagenesis 
line showed no defects in the notochord or melanocytes but presented with a degenerate 
eye (Golling et al., 2002). Although we cannot rule out that other coatomer subunits are 
not involve in eye development due to early lethality, it is interesting that copz is 
dispensible for notochord development. It is possible that copz2 compensates for the loss 
of copz1. Double knockout mutant lines will highlight this possibility. Therefore, to 
underscore the importance of COPI requirements during craniofacial development; we 
generated tissue specific knockout lines taking advantage of both the Tol2 transgene and 
Cre/lox system.  
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5.3.2. Tissue specific knockout of copa using CRISPR/Cas9  
The advent of new genome editing technologies has generated waves of excitement within 
the scientific community. The ability to target any part of the genome with ease using 
RNA guided endonucleases has given investigators unprecedented rapid access to study 
gene function and its regulatory components (Cong et al., 2013, Jinek et al., 2012, Zhang et 
al., 2011). In addition, their potential use as therapeutic tools has been demonstrated in 
several studies using precise homologous recombination based editing (Perez et al., 2008, 
Shwartz et al., 2012, Yin et al., 2014). In the CRISPR/Cas9 system, Cas9 make targeted 
double stranded DNA breaks that is then repaired using either homogous recombination or 
non-homogous end joining (NHEJ) (Jinek et al., 2012). The latter is the predominant repair 
pathway in cells, which is a highly inefficient process that usually leads to mutagenic 
changes due to small insertions or deletions. The CRISPR technology has now become the 
genome editing tool of choice predominantly due to the low cost, high efficiency and ease 
of synthesis, access and use (Mali et al., 2013, Jinek et al., 2012). 
Tissue specific CRISPR/Cas9 in zebrafish represents a recent advancement in zebrafish 
genome editing (Ablain et al., 2015). The targeting vector contains a tissue-specific 
promoter driving Cas9 towards the gRNA that is specific for the gene. The advantages of 
this system with copa gene is that it allows for: 1) the generation of stable zebrafish lines 
with a tissue-specific gene knockout that can be spatially controlled, 2) the assessment of 
cell autonomy in loss-of-function studies and 3) avoidance of embryonic lethality due to 
notochord defects. To test the potential of this approach, we first tested the copa gRNA 
designed to target exon 2 with a predicted truncation and disruption of protein function. 
The results showed that the CRISPR gRNA can make targeted breaks at a high efficiency. 
Therefore we inserted this gRNA with the ubi:switch promoter action.  The reason for not 
using a sox10 promoter was to act as a control for the efficiency of tamixofen induction. 
By inducing as early as 6hpf, we may be able to recapitulate the whole-organism loss-of-
function and reproduce the previous phenotype as previously described (Coutinho et al., 
2004) as recovered in the T7 CRISPR knockout system line. This will serve as a landmark 
to determine the suitable concentration and duration of tamoxifen induction as well as the 
efficiency of the tissue-specific vector construct. From here, we could perform spatio-
temporal loss-of-function of copa on NCC during craniofacial development. Preliminary 
analyses from gene expression of sox9a, sox10, dlx2a and foxd3 shows that NCC induction 
is primarily unperturbed and migration does not appear to be affected at 10 somites. 
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However, 48hpf analysis shows marked upregulation of all 4 gene expressions. A potential 
explanation lies in the activation of the stress response pathway/unfolded protein response 
(UPR) during development when COPI mechanism is disrupted.  
5.3.3. Loss and gain of function in COPA leads to ER stress   
Previous studies have showed that loss of COPI function in response to Brefaldin A 
treatment causes a disruption in the secretory organelle structure (Coutinho et al., 2004). 
This led to a build-up of unfolded protein and the activation of the UPR pathway that 
ultimately triggers the stress-response mechanisms, the apoptotic and authophagy 
pathways (Coutinho et al., 2004). This finding was also true in COPA variants in patients 
with autoimmune-mediated lung disease and arthritis. Lung biopsies in COPA deficient 
patients showed evidence of increase in molecular chaperone binding immunoglobulin 
protein (BiP), a key factor and indicator of ER stress (Watkin et al., 2015). They 
consolidated this finding by performing siRNA COPA knock-down experiments in Human 
Embryonic Kidney (HEK) cells and observed that reducing COPA expression led to ER 
stress and increase in BiP expression. Interestingly, when they then overexpressed human 
mutant variants of COPA, they found a similar elevation of BiP compared to WT (Watkin 
et al., 2015). These findings  are alighed with our own results that also showed an 
upregulation of UPR genes in 48hpf copa mutants.  
Similarly, the loss of ARCN1, which encodes COPD resulted in the overexpression of ER 
stress response genes, ATF4, DDIT3 and HSPA5 (Izumi et al., 2016). Interestingly, when 
they treated skin fibroblast line with thapsigargin, an inhibitor of the ER Ca ATPase 
(Namba et al., 2007) and tunicamycin, an inhibitor of glycoprotein synthesis (Oslowski 
and Urano, 2011), artificial ER stress was achieved and triggered ARCN1 overexpression, 
although the amount of ARCN1 remained unchanged. This suggests the increase ARCN1 
turnover during stress response. This effect was also observed in Brefaldin treated 
zebrafish embryos where copa mRNA expression was increased within the notochord 
(Coutinho et al., 2004). These suggest that COPI may play a major role in ameliorating the 
induction of ER stress response. Therefore, the reduction in COPI mechanism will trigger 
ER stress response and when the rate of protein synthesis exceeds the capacity of proteins 
folding and proteins degradation machinery, cell death occurs (Sovolyova et al., 2014). 
This may explain why all 4 genes; sox9a, sox10, foxd3 and dlx2a were seen to be 
overexpressed in our in situ experiments. There may be over-activation of these genes to 
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compensate for the lack of specification. This is more evident with sox10 where ectopic 
expression is observed within presumed melanocytes. It may be worth determining the 
expression of microphthalmia-associated transcription factor (mitf), a gene involved in 
melanogenesis.  
Interestingly expressions of these genes (sox9a, sox10, foxd3 and dlx2a) at 10 somites were 
unaffected in our experiments. These results and the copa expression time course analysis 
may indicate that cope may not have a major role in early NCC development. As we have 
shown, copa is highly expressed in the forebrain and notochord, but it is not until 48hpf 
that its expression is seen within the pharyngeal arches and then, the craniofacial 
structures. This expression has been shown in previous studies (Coutinho et al., 2004). By 
24hpf, an elevated demand of coatomer has been shown to be required to accustomed to 
the high secretory demand of notochord cells as seen by the upregulation of copa in the 
chordamesoderm (Coutinho et al., 2004). This therefore led to the earlier appearance of the 
defects. Therefore, the tissue specific knockout will help shed light into specific 
requirements of COPI subunits in NCC development. In addition, knockouts of the UPR 
genes, in particular bip, will determine if the persistent overexpression of NCC genes we 
observed here is specific to COPI loss-of-function or whether the similar phenotype could 
be induced by disrupting the UPR pathway.  
It is interesting how copa is regulated in a tissue specific and temporal manner. One would 
expect that an essential cellular trafficking function would be ubiquitously expressed 
during development. However, it may be that once sufficient coatomer subunits are made 
to form the COPI vesicles, these can be recycled rather than exhausting further efforts into 
manufacturing more cargo subunits. Therefore, increased requirements shifts from one 
tissue type to the other based on cellular demands during critical developmental stages.  
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5.4. Summary and future directions 
Mutations affecting the trafficking mechanism have demonstrated essential and specific 
roles of coatomer during early development and craniofacial malformations. This project 
has concentrated on describing a novel viral insertional mutant, studying the effects of 
copa loss of function on NCC development and UPR pathway and finally development of 
a tissue-specific knockout CRISPR line. Though many questions remain to be answered, 
especially concerning the spatio-temporal role of COPI during NCC development and 
possible signalling pathways that acts through this mechanism, much has been learnt about 
trafficking during early development.  
Future directions and link with Project 1 will include studying WLS retrograde transport 
via COPI and spatio-temporal control of Wnt secretion during craniofacial development.  
A recent study showed how Wnts are transported from the ER to the Golgi through WLS 
retrograde shuttling (Yu et al., 2014). They identified the basis for early step Wnt 
signalling where newly palmitoleated Wnts binds to WLS and moves from the ER to the 
plasma membrane via the Golgi. Subsequently, WLS is then recycled back using key 
elements of the ER-Golgi intermediate compartment. However, many questions remain 
such as whether the ER stores a pool of unused WLS to be used for recycling and if so, 
what is the half-life of WLS and what regulates WLS activity? 
Retrograde trafficking is a growing area of scientific interest. COPI and COPII vesicles 
play clear roles during craniofacial development predominantly found to be due to failure 
of collagen deposition by developing chondrocytes. However, the tissue specific 
requirement of COPI vesicles opens the field to how other cells transport proteins and 
maintain tissue homeostasis. A recent RNAi screen identified ERGIC2 as a key component 
of the Golgi-ER pathway traffic used by exotoxins such as ricin, Shiga toxin and 
Pseudomonas (Moreau et al., 2011). This remarkable ability of bacteria to highjack the 
trafficking mechanism remains to be understood.  
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Chapter 6: Final summary and future directions  
This thesis will hopefully shed some light onto the importance of Wnt signalling in 
patterning the cartilage anlage to direct future bone development. We have found that the 
non-canonical Wnt signalling pathway is key in orientating chondrocytes appropriately 
along their polarity lines. The alignment of cilia allows them to receive signals from the 
surrounding mesenchyme to activate the endochondral ossification process and 
transdifferentiation into osteoblasts. The lack of non-canonical Wnt signalling severely 
affects the way chondrocytes dynamically interact with each other, thereby affecting the 
normal stacking and intercalation process, key for lengthening and building the arch of the 
mandible. Previous work in the lab also showed that apart from the mandible, the maxilla 
is severely affected by this signalling pathway which could underlie a cause for orofacial 
clefting defects (such as cleft lip and palate). Future areas of research will include 
understanding the gene network involving various signalling pathways and transcription 
factors to control and fine tune the shape of the face that makes each of us unique. 
Modulating Wnt signalling by overexpressing and knocking out key Wnt genes followed 
by RNA-seq will help provide insights into the different genes regulated during 
craniofacial development.  
The second take away message is the powerful model organism; the zebrafish in studying 
craniofacial defects. It represents a cheap, quick and reliable model to understand 
genotype-phenotype correlation which is an excellent translation tool for novel genes 
discovered in genome-wide studies. With a high homology to the human genome, 
organogenesis and development of various structures involves similar key genes and 
regulatory networks. Future areas of research will be using this model to perform large 
scale chemical screen to test for drugs that can potentially mitigate craniofacial defects 
during development. This forms the basis of functional biology by understanding gene 
causing diseases and through this, discover new drugs that can then be directly used for 
patient care.  
Craniofacial development represents a complex field in developmental biology with many 
human malformations unexplained on both the genetic and mechanistic level. While most 
genetic studies focus on mutations in coding regions of important genes, an area vastly 
unexplored is the non-coding regions and cis-regulatory elements that influences 
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transcription factor bindings and ultimately the larger gene regulatory network that help 
specify a certain tissue. This for me is the real beauty in craniofacial developmental 
biology - the precise orchestration of transcription factors, enhancers/silencers and 
promoters to sculpt the face and produce a unique architectural masterpiece in every single 
individual. This represents an interesting work for future investigations. Functionally 
assessing non-coding gene variants and how human mutations (such as single nucleotide 
polymorphism) affects craniofacial development will help understand the role of ‘junk 
DNA’. This will involve employing chromatin accessibility assays (such as ATAC-seq, 
DNAse1-seq), transcriptomics work (RNA-seq) and detailed bioinformatics analysis 
coupled with non-coding region knockouts to functionally test their significance.  
Additionally, other open questions remain in the context of Wnt secretion. Such as, where 
exactly do Wnt proteins load onto cargos? How do cells recognize a fully loaded cargo 
versus empty cargo? How much Wnt can be loaded into one cargo? What differentiates 
anterograde and retrograde routes? How long do these vesicles or cargos last for and how 
many times can they be recycled prior to constructing a new one? Mechanisms of 
hijacking these cargos may provide new avenues for drug delivery intracellularly without 
the need for vectors. Furthermore, investigating where other parallel intracellular delivery 
mechanisms can help determine tissue-specific trafficking needs. Indeed, previous studies 
where removal of vesicle-bound Wnts only partially reduce Wnt activity suggesting other 
secretion routes are present (Gross et al., 2012).  
In the context of endochondral ossification, further work looking at the crosstalk between 
Hedgehogs and Wnts remains to be explored. The newer concept of transdifferentiation of 
hypertrophic chondrocytes into osteoblast has been explored in the literature (Yang et al., 
2014). This changes our view on how endochondral bone is formed and have important 
implications in bone regeneration. However, the underlying mechanisms which cause this 
molecular switch remain to be explored. Here, I implicate the non-canonical Wnts in 
making this switch by potential cross-talk with Indian Hedgehog signalling. Further work 
is required and may uncover downstream effectors which activate the transdifferentiation 
process.  
Craniofacial development remains a niche yet complex research field. However, it is 
populated with exciting avenues to explore and provide insight into the evolutionary 
diversity across species.  
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